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“Science is facts; just as houses are made of stones, so is 
science made of facts; but a pile of stones is not a house and 
a collection of facts is not necessarily science.”  
 
Henri Poincare 
French mathematician & physicist (1854 - 1912) 
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Summary 
Streptomyces are Gram-positive bacteria with some specific features as filamentous 
growth and morphological differentiation. They are among the most numerous and 
wide-spread soil bacteria, playing an important role in degradation of biological 
polymers like proteins, cellulose, hemicelluloses, chitin and others. Streptomyces are 
famous for making biologically active compounds: they produce more than half of 
naturally derived antibiotics in current use as well as anticancer drugs, 
immunosuppressants, antihelmintic agents, etc. These natural products are 
synthesized in complex secondary metabolites pathways and there is a lot of interest 
to understand how these pathways are regulated and what influences the secondary 
metabolites productivity. The ultimate aim is to decrease the production costs and to 
produce novel biologically active compounds.  
 
To approach the problem we decided to use the genomic information available for 
the most studied Streptomyces species – S. coelicolor A3(2) – to connect genes to 
enzymatic function in the form of a genome-scale metabolic model. We see these 
models as a focal point of systems biology as they allow collection of various data 
types in a form suitable for mathematical analysis.  
 
We reconstructed a genome-scale metabolic network of Streptomyces coelicolor 
A3(2) based on annotated genes, physiological and biochemical information. The 
stoichiometric model included 700 unique reactions and 500 metabolites, describing 
the function of 711 genes. In a comparative analysis with the S. avermitilis genome 
we showed that metabolic genes are highly conserved between Streptomyces 
species and therefore the model is suitable for use with other Streptomycetes. We 
used the model to assess metabolic capabilities for growth and polyketides 
production, to identify essential reactions, to predict knock-out phenotypes, and to 
identify gaps in genome annotation. 
 
The model was useful in interpreting the flux data from isotope labeling experiments 
and for analyzing gene expression data. We employed it in integrated analysis of an 
overproducing S. coelicolor A3(2) mutant with deletion of one phosphofructokinase 
isoenzyme. We also applied the model for studying amino acids metabolism and 
stringent response in S. coelicolor A3(2) and its relaxed mutant. 
 
Finally we used the model to predict knock-outs, which would lead to improved 
production of polyketides, and validated the best predictions experimentally. 
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Sammenfatning 
Streptomyceter er Gram-positive bakterier, som har nogle unikke egenskaber såsom 
filamentøs vækst og morfologisk differentiering. Denne type bakterier findes udbredt i 
jord, hvor de spiller en vigtig rolle i nedbrydning af biologiske polymerer såsom 
proteiner, cellulose, hemicellulose og chitin. Streptomyces er kendte for at producere 
en række forskellige bioaktive stoffer, og mere end halvdelen af de antibiotika der er I 
brug i dag produceres af disse bakterier. Streptomyceter anvendes også til 
produktion af andre bioaktive stoffer der anvendes til kræftmedicin og 
imunohæmmende stoffer. Alle disse produkter er såkaldte sekundære metaboliter, 
som produceres af bakterierne via komplekse pathways. For at udnytte 
Streptomyceter kommercielt er det vigtigt at forstå hvordan disse pathways er 
reguleret og hvilke faktorer der påvirker cellernes produktivitet. Hermed kan 
bakterierne forbedres ved gensplejsning og produktionsomkostninger kan nedbringes 
og endvidere vil det være muligt at fremstille helt nye bioaktive stoffer.  
 
I dette projekt er der opstillet en detaljeret matematisk model der beskriver en meget 
stor del af de mange forskellige pathways der opererer i den mest studerede 
Streptomyces art - Streptomyces coelicolor. Den opstillede model er baseret på 
information om hvilke enzymer der er kodet for i cellens genom, men anden 
information er også blevet anvendt i modelopstillingen. Foruden anvendelse til 
analyse af cellens stofskifte er modellen også vigtig i system biologi fordi den tillader 
at integrere analyse af forskellige –omic data typer.  
 
Den metaboliske model af Streptomyces coelicolor A3(2) blev rekonstrueret ud fra 
genomsekvens og oplysninger om organismens fysiologi og biokemi. Den 
støkiometriske model indeholder 700 unikke reaktioner og 500 metaboliter og den 
beskriver funktioner af 711 gener. Ved at sammenligne S. coelicolor og S. avermitilis 
genomerne kunne vi bevise at metaboliske gener er meget bevarede mellem 
forskellige Streptomyces stammer og derfor kunne vores model bruges som 
udgangspunkt for opstilling af modeller for andre Streptomyceter. I løbet af model 
opbygning kunne vi endvidere tilskrive funktion til flere gener. Modellen er brugt til at 
beregne cellernes muligheder for at vokse og producere polyketider og til at finde de 
gener som er absolut nødvendige for vækst under forskellige betingelser. 
 
Modellen er endvidere anvendt til at analysere flux data fra isotop mærkning forsøg 
og for at analysere gene ekspressionsdata. Modellen blev brugt i integreret analyse 
af en overproducerende S. coelicolor mutant, hvor et gen der koder for en 
phosphofruktokinase er slettet. Modellen blev også anvendt til at forstå 
aminosyremetabolismen og stringent respons i S. coelicolor A3(2). 
 
Endelig er modellen brugt til at forudsige hvilke gener der skal deleteres for at 
forbedre polyketidproduktionen i S. coelicolor. De bedste varianter identificeret med 
modellen blev testet i laboratoriet. 
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Functional genomics is a rather recent branch in biology. It aims at understanding the 
functions of the genes from the vast wealth of information generated by post-genomic 
tools: genome-sequencing, gene expression analysis, proteomics, metabolomics and 
others. 
 
While perhaps the most important information we want to uncover is the role of the 
human genes, those are quite a challenge to study, both experimentally and from the 
ethical perspective. The studies of genes from the simplest organisms – bacteria – 
have provided us with immense amount of information both on genes function and on 
their regulation. This knowledge can be transferred to higher organisms thanks to 
evolutional conservation of DNA and protein sequences.  
 
Streptomyces bacteria distinguish themselves by a high GC content, filamentous 
growth, complex regulation that allows morphological differentiation and sporulation 
and most of all by production on numerous bioactive secondary metabolites. Many 
different species of Streptomyces are used in industry for production of antibiotics, 
anticancer drugs, immunosupressants and others. One Streptomyces species – S. 
coelicolor (lat. heaven blue) has, however, been particularly in focus of academic 
research. The bacterium was chosen by Dr. David Hopwood, when he started his 
PhD. study in early 50’s. He thought that the blue pigment would make a convenient 
marker so that mutants are easily detected from the changed color [1]. Until early 
80s’ the genetic research was mainly done by generating random mutants and 
mapping the mutations to certain locus of the chromosome. With the revolutionary 
discoveries of molecular biology techniques in early 80’s the scientists could make 
more targeted changes in the genome. Still in the absence of genomic sequence, it 
could take months to map a mutation to a particular region in the chromosome and to 
identify the function of the gene. Some years later sequencing technology started to 
advance fast, making sequencing a more routine procedure. Finally, whole genomes 
could be sequenced, marking the entrance into a post genomic era. A real push to 
Streptomyces research was the sequencing of the S. coelicolor A3(2) genome in 
2002 [2]. At that time this was the largest sequenced bacterial genome of more than 
8 Mbp and with almost 8,000 open reading frames (ORFs), which were twice as 
many as in the Escherichia coli and also more than about 6,000 ORFs that have 
been identified in the eukaryote Saccharomyces cerevisiae. In was found that in 
Streptomyces a large number of metabolic genes were duplicated, but it’s not known 
yet why. About 30% of the open reading frames did not have any match in the protein 
databases, so it is also a challenge to understand what these genes are doing. 
 
Currently there is much interest in functional genomics of S. coelicolor as it is 
expected that this may lead to improving industrial processes but also improve our 
understanding of secondary metabolism in general and hereby help us to search for 
novel natural products (Figure 1-1). In this context a key issue is how the genetic 
information is translated to information concerning the physiology of the cells. This 
requires an integrated analysis of the cellular metabolism, and for this it is valuable to 
reconstruct the metabolic network and use the concept of metabolic flux balancing for 
analysis of how the network operates. A review in Chapter 2 describes how 
metabolic networks help us to understand the cellular function, making an important 
part of functional genomics. 
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In this project the metabolic network of S. coelicolor was reconstructed using the 
annotated genome, pathway databases and knowledge about the organism’s 
biochemistry and physiology (Chapter 3).  Due to the large size of the genome of this 
organism and the many redundant metabolic genes identified it was very useful to 
map all the metabolic functions and use the reconstructed metabolic network in 
future functional studies. The reconstructed network was analyzed for its topology 
structure and other structural features. The S. coelicolor model was used as a 
template for quick reconstruction of a less studied parasitic S. scabies, recently 
sequenced, but not yet annotated (Chapter 4). 
 
Figure 1-1. Connections between functional genomics and metabolic engineering 
and contribution of the thesis to different areas.  
 
 
We used various post genomic techniques to characterize antibiotics overproduction 
caused by phosphofructokinase A2 deletion (Chapter 5) and to study the global role 
of stringent response mediator ppGpp (Chapter 6). Our model was helpful in data 
interpretation. 
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The knowledge accumulated in functional genomics studies can be used in metabolic 
engineering to rationally improve product formation or cellular properties of the 
producing organism. On the other hand, the results of the metabolic engineering add 
to our understanding of the cellular function. Therefore, functional genomics and 
metabolic engineering are tightly interconnected (Figure 1-1). We describe the 
strategies for metabolic engineering of Streptomycetes as well as application of the 
post-genomic data for choosing rational strategies in a review (Chapter 7). We 
demonstrate how metabolic model could be used for improving polyketides 
production in S. coelicolor (Chapter 8). We also show that detailed physiological 
characterization including isotope-based flux analysis is useful in guiding metabolic 
engineering strategies in industrial Streptomyces strains (Chapter 9). 
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2.1 Summary 
Genome-scale metabolic models are the focal point of systems biology as they allow 
collection of various data types in a form suitable for mathematical analysis. High-
quality metabolic networks and metabolic networks with incorporated regulation have 
been successfully used for analysis of phenotypes from phenotypic arrays and gene 
deletion studies. They have also been applied for gene expression analysis guided 
by metabolic network structure, which lead to identification of genes commonly 
regulated due to connections on metabolites level. Thus, genome-scale metabolic 
modeling currently stands out as one of the most promising approaches to obtain an 
in silico prediction of cellular function based on interaction of all of the cellular 
components. 
Keywords 
Metabolic model, systems biology 
2.2 Introduction 
Systems biology is the integration of experimental and computational approaches in 
achieving its overall goal of explaining and predicting complex cellular behaviors of 
biological systems. It differs from traditional biology approaches in that it aims to 
study the interaction between the network components rather than the properties of 
the individual components themselves [1]. Using different ‘omics’ technologies a 
wealth of information is becoming available on the levels of many different cellular 
components and to some extent on the interaction between some of these 
components. Analysis and integration of these data will greatly benefit from the use 
of mathematical models, and cellular models are at the core of systems biology. We 
therefore see systems biology as an iterative process where a model is developed 
and continuously improved through comparison with experimental data and 
integration of new features (Figure 2-1).  
 
Figure 2-1. Iterative process of cellular model development.  
 
Mathematical models can vary in both complexity and approach, but in all cases the 
value of a mathematical model should be judged based on the objective of the 
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modeling exercise. Most common structures of models used for functional genomics 
and systems biology objectives are listed in Table 2-1. 
 
Table 2-1. Objectives and types of models commonly used in systems biology 
Objective Type of model 
Identification of significance Statistical models used to perform e.g. t-test or 
Anova test 
Grouping of information Statistical models used for clustering of data 
Mapping of interactions and development of 
predictive algorithms 
Data driven models like neural network or Hidden 
Markov models 
Quantitative analysis and dynamic simulation Kinetic models that describe the dynamics of the 
individual components in the sub-system 
Whole cell function described by function of a 
large fraction of the system components 
Metabolic models with added regulatory features 
 
Many different clustering methods and statistical tests have been developed to 
analyze ‘omics’ data, and these have been quite successful in structuring the 
information content. However, these mathematical methods (or models) are static of 
nature and they have no predictive power. Furthermore, even though they have 
proven valuable for data analysis they do not rely on the wealth of biochemical and 
molecular biology information gathered the last fifty years.  
Neural networks and Hidden Markov models are more advanced approaches to data 
analysis, and using such models it is possible to develop algorithms with predictive 
power. Thus it is possible to identify interactions between the different components in 
the system, even during dynamic processes as illustrated recently in a study of the 
cell cycle in yeast [2,3]. Despite the value of these models for pathway 
reconstruction, these models are data driven and can therefore not be used to 
simulate e.g. the effect of different environmental conditions on cellular growth. 
In order to simulate the dynamic response of biological systems to different stimuli or 
to different perturbations of the system, there are often applied kinetic models. These 
models are typically build from first principles, where the mass balances for the 
individual components are described by differential equations, and the kinetics of the 
different reactions and processes are described with more or less empirical rate 
equations. There are many examples of this type of models [4,5], but all models 
presented so far are for relatively small systems – at least in the perspective of a 
whole cell. Hence these models are basically not very useful for integration of omics 
data, and they are also not able to describe overall cellular function. In the long run it 
may, however, be possible to collect all the kinetics parameters and define rate 
equations for all reactions and processes in the cell, and hereby build a complete 
kinetic model for the cell.  
Even though there are many more or less empirical models that can simulate growth, 
these models are not really relevant in the context of systems biology. There is, 
however, one type of models that have shown a surprising ability to simulate growth 
of living cells – namely metabolic models, or often referred to as stoichiometric flux 
balance models [6-8]. These models rely on balancing of all intracellular metabolites 
in the metabolic network, which basically represents the core machinery of cellular 
function as it provides the building blocks and Gibbs free energy for cellular 
synthesis. The balancing of metabolites supplies a large number of constraints, and 
through the use of linear programming it is possible to find solutions that obey a 
specified objective function. Growth optimization has proven to be a generally 
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applicable objective function, and it has been demonstrated that even if cells do not 
obey this objective function [9,10], e.g. for Escherichia coli cells growing on glycerol, 
they will adapt to this if they are evolved over many generations [11].  
 
In this review we will discuss the process of metabolic model reconstruction and the 
recent advances in ‘omic’ data analysis guided by metabolic models. 
2.3 Metabolic models: reconstruction 
As mentioned above metabolic models currently represent the only attempt to 
construct mathematical models that include a large fraction of the components in the 
system and can simulate whole cellular behavior. There are a couple of reasons for 
why this may be the case: 
• the metabolism is very well established for many organisms, and the model 
therefore rely on much information of biochemistry and at the same time it 
integrates information from many different sources. 
• the concept of flux balancing is solid, and it is only for very short transients 
that the metabolite levels within the cells will change over time. 
• applying an objective function of optimizing growth is consistent with the 
extensive evolution of living cells to maximize their performance. 
 
Despite the advantages of metabolic models, these models do have some 
shortcomings, of which the most important is the lack of regulatory features. Thus, 
the models can not describe conditions that heavily rely on regulation of specific 
parts of the metabolic network. However, as metabolic models rely on simple mass 
balancing of metabolites and there are no fitted parameters, they are open-ended 
models, and new features can therefore easily be incorporated. Hence, these models 
can be continuously improved in the iterative cycle of model construction as 
illustrated in Figure 2-1. 
 
A very important step in generating metabolic models is the reconstruction of the 
metabolic network. Particularly it is important that the reconstruction process is done 
such that as much information as possible is build into the model. Hence the 
reconstruction involves several steps, and the process of genome-scale metabolic 
model reconstruction is illustrated in Figure 2-2. It usually starts with assigning 
reactions to the annotated genes in the genome sequence. Further the presence of 
various pathways in the cell is validated and the pathways are thoroughly curated 
using biochemical literature and publications. The next step is to identify the gaps in 
the metabolic network and try to fill them using directed search for the missing genes. 
The model can be validated against physiological data, ‘omic’ data, etc. as well as 
these data can be analyzed using the model. Addition of regulatory constrains 
improves model performance as it resolves the inconsistencies when regulation 
occurs on higher levels than fluxes level. Some parts of the reconstruction process 
(as the template model building, pathway presence evaluation, holes filling) can be 
automated using available software (e.g. Pathway Tools [12]), however scientific 
curation is still preferred for the final decisions. 
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Figure 2-2. The process of metabolic model reconstruction.  
  Information flow 
  Actions 
 
A number of stoichiometric reconstructions of metabolic networks have appeared 
representing all three domains of life: archaea, bacteria, and eukarya.  The sizes of 
these reconstructions range from tens to hundreds of reactions and genes; genome-
scale reconstructions are beginning to become more prevalent, which is enhanced by 
the recent abundance of sequencing data. These genome-scale reconstructions 
include reactions in central metabolic pathways, such as glycolysis, pentose 
phosphate pathway, and citric acid cycle, as well as reactions involving amino acid 
and nucleotide biosynthesis, cell wall synthesis, cofactor biosynthesis, and alternate 
carbon and nitrogen source utilization.  Table 2-2 shows the properties of various 
genome-scale reconstructions for different organisms.  The largest reconstructions to 
date are for Saccharomyces cerevisiae and E. coli, and for E. coli these 
reconstructions have been used to study this model organism for over a decade [13]. 
 
Table 2-2. Total organism ORFs, number of metabolic genes, number of reactions, 
number of metabolites. 
 
Organism ORFs Genes Metabolites Reactions Reference 
Escherichia coli 4,405 904 625 931 [13] 
Saccharomyces cerevisiae 6,183 750 646 1149 [14] 
Haemophilus influenzae 1,775 296 343 488 [23] 
Helicobacter pylori 1,632 291 340 388 [24] 
Plasmodium falciparum 5,342 737a 525 697 [25] 
Mannheimia succiniproducens 2,463 335 352 373 [26] 
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Methanococcus jannaschii 1,821 436a 510 609 [27] 
Streptomyces coelicolor 8,042 769 501 700 [30] 
Staphylococcus aureus 2,702 619 571 641 pers. comm. 
B.O. Palsson 
Mus musculus   872 1220 [28] 
a
 only the number of enzymes were reported. 
2.4 Metabolic models: a base for systems biology 
Metabolic networks provide a framework for the integrated analysis of different types 
of high-throughput data in this way serving the purpose of systems biology – 
understanding the cellular behavior as a whole. In the following section we discuss 
the recent achievements in the area – application of metabolic models for analysis of 
phenotype, gene expression data, metabolites concentrations as well as for analysis 
of the combination of several data types. 
2.4.1 Phenotype 
Genome-scale metabolic models have shown to be very useful for analysis of single 
deletion mutants at a large scale, and a couple of studies have appeared recently for 
analyzing mutant phenotypes for S. cerevisiae and E. coli.  The S. cerevisiae study 
looked at 4,154 cases of different mutant strains growth phenotypes in different 
media compositions [14]. The metabolic network reconstruction for this organism was 
used to accurately predict or explain 82.6% of the cases.  A combined metabolic and 
regulatory network reconstruction of E. coli was used to predict growth on various 
carbon and nitrogen sources for a range of metabolic and regulatory gene deletions 
[15]. An important development in this model was addition of regulatory constraints 
collected from the literature, which were incorporated as Boolean logic statements. A 
disadvantage of using Boolean logic statements for simulating regulation is the 
“switch” mechanism provided for signal transduction, compared with the more likely 
sigmoid function (or other type of shape) for activating the individual components in a 
real signal transduction pathway. The predictions obtained from using Boolean logic 
statements were, however, in good agreement with experimental data from high-
throughput phenotypic arrays. The stoichiometric network alone could correctly 
predict the phenotype in 65.2% of 13,750 cases, while the addition of regulatory 
effects improved the prediction rate to 78.7%.  
2.4.2 Gene expression 
The generation of gene expression data for a wide range of organisms and 
experimental conditions, provides a ready source of data for analysis within the 
context of network reconstructions.  Metabolic maps are widely used for visualization 
of expression data, putting the data into biochemical context for analysis. The 
expression data can for example be visualized by color gradients on metabolic maps 
(e.g. Pathway Tools Omics Viewer [12]).  A number of methods that rely on 
reconstructed metabolic networks have been developed that provide a more rigorous 
way of analyzing gene expression data. 
 
Ihmels et al. [16] used the reaction set for Saccharomyces cerevisiae derived from 
Kyoto Encyclopedia of Genes and Genomes (KEGG) and gene expression data for 
over 1,000 conditions from public repository for identifying correlations between 
expressions of the genes from the same metabolic pathway using signature 
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algorithms. They observed that enzymes involved in the same metabolic pathway 
were often co-expressed, and that the co-expressed enzymes were usually arranged 
in a linear pathway. The authors also found that at the branch points, the incoming 
branch is normally co-regulated with only one of the outcoming branches, which 
leads to linear metabolic flow through the network.  
Ihmels’ et al. work was based only on the connectivity between substrates and did 
not consider molecules involved in energy metabolism as well as reducing cofactors, 
which are known to be the most connected metabolites in the networks [17]. 
Incorporation of these compounds in the analysis might reveal less obvious enzyme 
interactions mediated by these common metabolites.  
 
Patil and Nielsen [18] applied a genome-scale metabolic model of S. cerevisiae [19] 
for the transcriptome analysis of several mutants in comparison to the wild type and 
for analysis of expression data from wild type strains grown on several different 
carbon sources. This computational approach was based on a graph-theoretical 
representation of the metabolic network and allowed identification of sub-networks 
with significantly correlated changes in gene expression as well as metabolites 
around which the most significant expression changes occurred. Because finding of 
high scoring sub-networks is a computationally extensive task, it was solved by using 
a simulated annealing algorithm. 
 
An analogical approach was reported previously for identifying highly scoring sub-
networks in a molecular interaction network [20]. In this study expression data was 
used from yeast mutants in the galactose assimilation pathway grown with and 
without galactose in combination with protein-protein and protein-DNA interactions 
obtained from publicly available databases. Many of the identified highly scoring sub-
networks coincided with the previously known regulatory circuits. 
 
The previously mentioned combined metabolic and regulatory networks 
reconstructed for E. coli were also used to demonstrate the iterative process of 
regulatory network reconstructions through the analysis of gene expression data [15]. 
The genome-scale network was used to generate predictions about gene expression 
in response to oxygen deprivation. When these predictions were inconsistent with the 
gene expression data, the regulatory constrains were modified. One can however 
discuss how suitable the prediction methodology is because in genome-scale 
networks multiple solutions normally exist. Besides taking into consideration that the 
initial regulatory network was obtained from the literature, the change of regulatory 
rules should only be viewed as a testable hypothesis about the involvement of 
different transcription factors in the regulation of metabolic genes.  
2.4.3 Metabolites concentrations 
Given that metabolic networks can be reconstructed at a genome-scale, an obvious 
data type that could be accounted for would be metabolite concentrations 
themselves.  To date, intracellular metabolite concentration measurements have 
been taken primarily for plants.  While the use of networks for analysis of such data is 
not as common as gene-expression data, the potential of such data will likely lead to 
the development of methods for analyzing it. 
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A significant progress towards this goal was made by Weckwerth et al. in a study of 
silent potato plant phenotype using metabolomics [21]. Over 1,000 compounds were 
quantitatively measured by GC/TOF MS in more than 30 samples for the wild type 
and mutant potato lines. The authors identified strong linear correlations (Pearson 
correlation coefficient more than 0.8) between metabolites concentrations and used 
these pair-wise correlations to represent the network topology for the wild type and 
mutant. The analysis of metabolites connectivity in the obtained networks indicated 
changes in carbohydrate and amino acids metabolism caused by silent mutation. 
2.4.4 Gene expression, proteome, interactome, phenotype 
Ideker et al. [22] used an integrated approach to study a pathway of galactose 
utilization (also see update). They started with reconstructing a network including 
enzymatic and transport reactions as well as protein-protein and protein-DNA 
interactions. The model was then used to make predictions about the behavior of the 
GAL mutants grown with and without galactose. Apparently the predictions were 
made ad hoc, which undermines the modeling aspect of this work and the 
applicability of the method for larger and/or less studied systems. The effects of the 
perturbation of the pathway by genetic modifications and environmental conditions 
were evaluated by transcriptome and proteome analyses. The work heavily relied on 
the visualization of the data. The genes with significantly changed expression profiles 
were overlaid on the physical interaction map and turned out to be highly connected. 
Clustering analysis of transcription data for several mutants strains allowed to confirm 
some initial hypothesis about the gene functions.  
2.5 Perspective 
The integrated analysis of ‘omic’ data is in its germination stage. However already 
the first results demonstrate how powerful the techniques can be and how much 
more information can be extracted from the same data when the analysis is 
supplemented with metabolic or (better and) regulatory networks. There’s a need for 
high quality metabolic and regulatory networks, which should preferably be presented 
in the same format. A challenging task is ahead of finding new computational and 
visualization methods, that integrate different data types. The tools should be 
presented in a user friendly format to allow numerous researches to gain more 
information from their experiments. In this context the development of systems 
biology markup language (SBML) is important. The field of systems biology will also 
benefit from having high quality network reconstructions.  It is important that these 
reconstructions represent the biological system of interest, as such there needs to be 
a balance between being able to rapidly generate these reconstructions and to curate 
them.  This curation can arise from the available literature for an organism as well as 
feedback or iterative improvements of the network reconstruction via analysis of high 
throughput data. 
2.6 Update 
In a recent study the impact of arsenic in S. cerevisiae was studied by mapping the 
gene expression and phenotypic sensitivity data onto metabolic and regulatory 
networks [29]. 
 CHAPTER 2 
 
 
32 
2.7 References 
1. Westerhoff HV, Palsson BO: The evolution of molecular biology into systems 
biology. Nat Biotechnol 2004, 22:1249-1252. 
2. de Lichtenberg U, Jensen LJ, Fausboll A, Jensen TS, Bork P, Brunak S: 
Comparison of computational methods for the identification of cell cycle 
regulated genes. Bioinformatics 2004. 
**3. de Lichtenberg U, Jensen LJ, Brunak S, Bork P: Dynamic complex formation 
during the yeast cell cycle. Science 2005, in press. 
The authors integrate microarray time-series data with the information on protein-
protein interactions to study periodically expressed genes in the yeast cell cycle. 
4. Pritchard L, Kell DB: Schemes of flux control in a model of Saccharomyces 
cerevisiae glycolysis. Eur J Biochem 2002, 269:3894-3904. 
5. Hoefnagel MH, Starrenburg MJ, Martens DE, Hugenholtz J, Kleerebezem M, Van 
S, II, Bongers R, Westerhoff HV, Snoep JL: Metabolic engineering of lactic acid 
bacteria, the combined approach: kinetic modelling, metabolic control and 
experimental analysis. Microbiology 2002, 148:1003-1013. 
6. Price ND, Papin JA, Schilling CH, Palsson BO: Genome-scale microbial in silico 
models: the constraints-based approach. Trends Biotechnol 2003, 21:162-169. 
7. Varma A, Palsson BO: Stoichiometric flux balance models quantitatively 
predict growth and metabolic by-product secretion in wild-type Escherichia 
coli W3110. Appl Environ Microbiol 1994, 60:3724-3731. 
8. Palsson B: Two-dimensional annotation of genomes. Nat Biotechnol 2004, 
22:1218-1219. 
9. Edwards JS, Palsson BO: The Escherichia coli MG1655 in silico metabolic 
genotype: Its definition, characteristics, and capabilities. Proceedings of the 
National Academy of Sciences 2000, 97:5528-5533. 
10. Forster J, Famili I, Palsson BO, Nielsen J: Large-scale evaluation of in silico 
gene deletions in Saccharomyces cerevisiae. Omics 2003, 7:193-202. 
**11. Ibarra RU, Edwards JS, Palsson BO: Escherichia coli K-12 undergoes 
adaptive evolution to achieve in silico predicted optimal growth. Nature 2002, 
420:186-189. 
The authors show, that under the growth selection pressure E. coli optimizes its 
growth on glycerol to achieve the optimal value predicted from the genome-scale 
stoichiometric model. 
12. Karp PD, Paley S, Romero P: The Pathway Tools software. Bioinformatics 
2002, 18:225-232. 
13. Reed JL, Palsson BO: Thirteen Years of Building Constraint-Based In Silico 
Models of Escherichia coli. J Bacteriol 2003, 185:2692-2699. 
14. Duarte NC, Herrgard MJ, Palsson B: Reconstruction and Validation of 
Saccharomyces cerevisiae iND750, a Fully Compartmentalized Genome-
Scale Metabolic Model. Genome Res 2004, 14:1298-1309. 
*15. Covert MW, Knight EM, Reed JL, Herrgard MJ, Palsson BO: Integrating high-
throughput and computational data elucidates bacterial networks. Nature 
2004, 429:92-96. 
This paper is the first attempt to incorporate regulatory rules into a stoichiometric 
genome-scale model. Addition of regulation into E. coli model improves the 
phenotype predictions for the large-scale phenotype arrays data. The model is 
also used to calculate the outcome of gene expression data under oxygen 
 From genomes to in silico cells via metabolic networks 
 
 
33 
limitation and to modify the regulatory constraints when the model leads to wrong 
predictions. 
**16. Ihmels J, Levy R, Barkai N: Principles of transcriptional control in the 
metabolic network of Saccharomyces cerevisiae. Nat Biotechnol 2004, 22:86-
92. 
The authors use large-scale gene expression data (over 1,000 profiles) along with 
the structure of the metabolic network derived from KEGG database to study how 
pathways are regulated on transcriptional level. 
17. Nielsen J: It is all about metabolic fluxes. J Bacteriol 2003, 185:7031-7035. 
**18. Patil K, Nielsen J: Uncovering transcriptional regulation of metabolism 
using metabolic network topology. Proc Natl Acad Sci U S A 2005, 102:2685-
2689. 
In this work gene expression data is analyzed in the context of the topology of  S. 
cerevisiae genome-scale metabolic network. This allows identification of 
transciptionally coupled metabolic genes sets that are not detectable by traditional 
statistical microarray data analyses. 
19. Forster J, Famili I, Fu PC, Palsson BO, Nielsen J: Genome-Scale 
Reconstruction of the Saccharomyces cerevisiae Metabolic Network. 
Genome Res 2003, 13:244-253. 
20. Ideker T, Ozier O, Schwikowski B, Siegel AF: Discovering regulatory and 
signalling circuits in molecular interaction networks. Bioinformatics 2002, 
18:233-240. 
*21. Weckwerth W, Loureiro ME, Wenzel K, Fiehn O: Differential metabolic 
networks unravel the effects of silent plant phenotypes. Proc Natl Acad Sci U 
S A 2004, 101:7809-7814. 
The linear correlations between metabolite concentrations are used to construct 
metabolite interactions maps for the wild type potato plant and its antisense 
mutant with a silent phenotype. Comparison of the topologies of these maps leads 
to hypotheses about the influence of the mutation on the cellular metabolism. 
22. Ideker T, Thorsson V, Ranish JA, Christmas R, Buhler J, Eng JK, Bumgarner R, 
Goodlett DR, Aebersold R, Hood L: Integrated genomic and proteomic 
analyses of a systematically perturbed metabolic network. Science 2001, 
292:929-934. 
23. Edwards JS, Palsson BO: Systems properties of the Haemophilus influenzae 
Rd metabolic genotype. Journal of Biological Chemistry 1999, 274:17410-17416. 
24. Schilling CH, Palsson BO: Assessment of the Metabolic Capabilities of 
Haemophilus influenzae Rd through a Genome-scale Pathway Analysis. 
Journal of Theoretical Biology 2000, 203:249-283. 
25. Yeh I, Hanekamp T, Tsoka S, Karp PD, Altman RB: Computational analysis of 
Plasmodium falciparum metabolism: organizing genomic information to 
facilitate drug discovery. Genome Res 2004, 14:917-924. 
26. Hong SH, Kim JS, Lee SY, In YH, Choi SS, Rih JK, Kim CH, Jeong H, Hur CG, 
Kim JJ: The genome sequence of the capnophilic rumen bacterium 
Mannheimia succiniciproducens. Nat Biotechnol 2004, 22:1275-1281. 
27. Tsoka S, Simon D, Ouzounis CA: Automated metabolic reconstruction for 
Methanococcus jannaschii. Archaea 2004, 1:223-229. 
28. Sheikh K, Forster J, Nielsen LK: Modeling Hybridoma Cell Metabolism Using a 
Generic Genome-Scale Metabolic Model of Mus musculus. Biotechnol Prog 
2005, in press. 
 CHAPTER 2 
 
 
34 
29. Haugen AC, Kelley R, Collins JB, Tucker CJ, Deng C, Afshari CA, Brown JM, 
Ideker T, Van Houten B: Integrating phenotypic and expression profiles to 
map arsenic-response networks. Genome Biol 2004, 5:R95. 
30. Borodina I, Krabben P, Nielsen J: Genome-scale analysis of Streptomyces 
coelicolor A3(2) metabolism. Genome Res 2005, in press. 
 
 35 
CHAPTER 3 
 
Genome-scale analysis of Streptomyces coelicolor A3(2) 
metabolism 
 
 
 
 
 
 
Irina Borodina1, Preben Krabben2, and Jens Nielsen1 
 
 
 
1
 Center for Microbial Biotechnology, BioCentrum-DTU, Building 223, DK-2800 Kgs. 
Lyngby, Denmark 
2 Department of Biochemical Engineering, University College London, Torrington 
Place, London, UK 
 
 
 
Personal communication with: 
Stephen Bentley (sdb@sanger.ac.uk), The Wellcome Trust Sanger Institute, Hinxton, 
Cambridge CB10 1SA, UK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Content of this chapter is published in: Genome Research, 2005, 15(6):820-829. 
 36 
 From genomes to in silico cells via metabolic networks 
 
37 
3.1 Abstract 
Streptomyces are filamentous soil bacteria that produce more than half of the known 
microbial antibiotics. We present the first genome-scale metabolic model of a 
representative of this group – S. coelicolor A3(2). The metabolism reconstruction was 
based on annotated genes, physiological and biochemical information. The 
stoichiometric model includes 819 biochemical conversions and 152 transport 
reactions, accounting for a total of 971 reactions. 700 of the reactions in the network 
are unique, while the rest are iso-reactions. The network comprises 500 metabolites. 
Seven hundred eleven open reading frames (ORFs) were included in the model, 
which corresponds to 13% of the ORFs with assigned function in the S. coelicolor 
A3(2) genome. In a comparative analysis with the S. avermitilis genome we showed 
that the metabolic genes are highly conserved between these species and therefore 
the model is suitable for use with other Streptomycetes. Flux balance analysis was 
applied for studies of the reconstructed metabolic network and to assess its 
metabolic capabilities for growth and polyketides production. The model predictions 
of wild type and mutants’ growth on different carbon and nitrogen sources agreed 
with the experimental data in most cases. We estimated the impact of each reaction 
knock-out on the growth of in silico strain on 62 carbon sources and 2 nitrogen 
sources; thereby identifying the “core” of the essential reactions. We also illustrated 
how reconstruction of a metabolic network at the genome level can be used to fill 
gaps in genome annotation.  
The supplemental material is available on  www.genome.org  
Keywords 
Streptomyces coelicolor, in silico, metabolic model.  
3.2 Introduction 
Streptomycetes are soil inhabiting Gram-positive bacteria belonging to the order of 
Actinomycetales (Garrity 2002). The genus is characterized by a high G+C content, 
large linear chromosomes (>8 Mb) and a complex life cycle, which involves 
morphological differentiation. Streptomycetes have attracted much attention due to 
their ability to make secondary metabolites that have a wide range of bio-activities 
and hereby may find use as antibiotics, immunosuppressants, anti-cancer agents, 
etc. It is estimated that Streptomyces spp. produce more than 50% of the total of 
11,900 known microbial antibiotics (Kieser et al. 2000). Streptomyces species also 
secrete a wide range of extracellular hydrolytic enzymes, which enable them to 
degrade lignocellulosic materials in soil, and many of these enzymes also have 
commercial interest.  
Streptomyces coelicolor A3(2) is by far the best genetically studied Streptomyces 
strain and has become a model organism for Streptomyces species (Hopwood 
1999). Release of the S. coelicolor A3(2) genome sequence (Bentley et al. 2002) has 
further expanded the knowledge of this organism and enabled large-scale analyses 
of transcriptome  (Huang et al. 2001; Bucca et al. 2003) and proteome (Hesketh et al. 
2002; Novotna et al. 2003). The rapidly growing amount of genome-wide data 
represents a valuable database for gaining more fundamental insight into the 
molecular mechanisms governing different processes in S. coelicolor A3(2), but 
particularly integration of these data through the use of mathematical models would 
enable extraction of more information from this database. In this context it has 
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recently been shown particularly valuable to use genome-scale models for the 
metabolism  (Ideker et al. 2001; Stelling et al. 2002; Kell 2004; Covert et al. 2004). 
At the present, metabolic networks have been reconstructed for several bacteria (e.g. 
Escherichia coli (Edwards et al. 2000b; Reed et al. 2003),) and for the yeast S. 
cerevisiae (Förster et al. 2003a; Duarte et al. 2004). The models have been 
successfully used to predict organism phenotype for a modified genotype (Edwards 
et al. 2000a; Förster et al. 2003b; Covert et al. 2004), and to predict cellular behavior 
under different physiological conditions (Edwards et al. 2001; Famili et al. 2003). 
Furthermore, these models may form the basis for the functional characterization  
(Papp et al. 2004), for extraction of information of coordinated transcriptional 
responses that can not be identified through classical statistical methods (Ihmels et 
al. 2004), and in design of improved strains for production of specific metabolites  
(Burgard et al. 2003).  
Here, the reconstructed metabolic network of S. coelicolor A3(2) is applied for 
detailed study of the organism’s metabolism. 
3.3 Results and discussion 
3.3.1 Reconstruction and characteristics of the metabolic network 
Reconstruction of high-quality and well annotated metabolic networks is laborious as 
information needs to be acquired from many different sources. The reconstruction 
can be facilitated by software, e.g., PathoLogic  (Karp et al. 2002), that assigns 
reactions to the annotated genes according to E.C. number or enzyme name. We 
used S. coelicolor A3(2) pathway database in KEGG 
(ftp://ftp.genome.ad.jp/pub/kegg/pathways/sco/) for extraction of the draft model. 
Automatically created models need to be manually curated using books, literature 
and other available information sources. The most problematic aspects are wrongly 
or insufficiently defined substrate specificity, reactions reversibility, protein 
complexes, cofactor specificity and the missing enzymes. Examples of these 
problems and the ways of dealing with them are listed in Table 3-1. 
 
Table 3-1. Typical problems arising from automatic metabolic networks 
reconstruction and examples of dealing with them.  
Problem Example 
1) Substrate specificity is 
insufficiently or wrongly 
defined. 
The ORF SCO4384 encodes an enoyl-CoA hydratase with assigned 
E.C. number 4.2.1.17 and the enzyme acts on a wide range of 3-
hydroxyacyl-CoA compounds. Judging from the neighbor ORF 
SCO4383, which encodes a 4-coumarate:coenzyme A ligase and is 
positioned in the same regulon, SCO4384 more likely catalyzes 
hydration of activated 4-coumarate and hence is involved in the 
secondary metabolism. 
2) Reversibility is not defined. Pyruvate carboxylase (E.C. 6.4.1.1) is shown in KEGG as acting in 
both directions even though it is known to be irreversible due to 
thermodynamic constraints prevailing in most cells, i.e. the 
carboxylation of pyruvate to oxaloacatate is associated with the 
cleavage of a high-energy phosphate bond in ATP resulting in the 
formation of AMP and pyrophosphate whereas the decarboxylation of 
oxaloacetate to pyruvate does not result in the formation of ATP. 
3) Enzyme subunits are shown 
as catalyzing a reaction 
independently though they are 
active only in a complex. 
The ORFs SCO0216-0219 form a four-subunit complex with a nitrate 
reductase activity, while in KEGG each of these ORFs is assigned the 
given function, basically indicating that each of these four ORFs 
encodes an isoenzyme. 
4) Cofactor requirements are 
often specific for the given 
Valine dehydrogenase E.C. 1.4.1.8 is given as NADP+-dependent in 
KEGG, however it was experimentally determined to use NAD+ as the 
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organism and have to be 
found elsewhere. 
preferred hydrogen acceptor (Navarrete et al. 1990). 
5) A number of reactions that are 
necessary for making a 
functional cell have not been 
assigned a corresponding 
ORF. 
Histidinol phosphatase E.C. 3.1.3.15 is an enzyme in the linear 
histidine biosynthesis pathway. It was included in the model even 
though the gene was not found in the genome of S. coelicolor A3(2). 
 
Modeling of S. coelicolor A3(2) is a challenging task due to the complexity of this 
filamentous bacteria. Its genome size of 8,667,507 base pairs is unusually large for 
bacteria sequenced to date. Out of 7,825 predicted open reading frames (ORFs), a 
function has been assigned to 5,492, which also includes broad definitions as 
“putative membrane protein”, “putative transmembrane transport protein” and similar 
(personal communication with Bentley S.D.). It is estimated that 965 proteins have a 
regulatory function, 819 proteins are secreted (these include numerous hydrolytic 
enzymes), 614 proteins participate in transport and twenty-two gene clusters are 
involved in secondary metabolites production (Bentley et al. 2002). Only 926 ORFs 
have an enzyme commission (E.C.) number assigned and out of these, 711 (77 %) 
were included in the model (Table 3-2, Appendix 3.1).  
 
Table 3-2. Comparison of the genome characteristics and the in silico metabolic 
networks of prokaryotic and eukaryotic species. 
1
 Escherichia coli K-12  (Reed et al. 2003) 
2
 Haemophilus influenzae Rd (Schilling et al. 2000) 
3
 Helicobacter pylori 26695 (Schilling et al. 2002) 
4
 Saccharomyces cerevisiae (Förster et al. 2003a) 
 
We considered the pathways, which were known to be operative in Streptomyces 
and/or for which most of the pathway specific enzymes were present. Genome-scale 
modeling is a dynamic process and we expect that the reaction list will be updated as 
new information is released. The total number of metabolic reactions included in the 
model is 971, of which 819 are metabolic conversions and the rest are transport 
reactions (Appendix 3.2). 89% of the metabolic conversion reactions have an ORF 
assigned; the other reactions were included based on physiological evidence. Only 
24% of the transport reactions have an assigned ORF, and this low percentage is 
due to the limited information on transport processes in this organism. The model 
Prokaryotes Eukaryotes 
 S. coelicolor 
A3(2) E. coli
1
 
H. 
influenzae2 H. pylori
3
 
S. 
cerevisiae4 
Genome characteristics 
Genome length (bp) 8,667,507 4,639,221 1,830,135 1,667,867 12,175,026 
G+C content 72% 51% 38% 39% 40% 
ORF 7,825 4,288 1,743 1,590 6,281 
   assigned function 5,492 2,656 1,011 1,091 4,379 
   no assigned function 2,333 1,632 732 499 1,902 
In silico metabolic network characteristics 
Total reactions (unique) 971 (700) 931 (931) 461 381 1175 (842) 
   biochemical conversions 819 767   826 
   Transport 152 164   349 
Reactions with ORF (% of total 
reactions) 764 (79%) 873 (94%) 412 (89%) 272 (71%) 1035 (88%) 
Metabolites 500 625 367 332 584 
ORF (% of ORFs with assigned 
function) 711 (13%) 904 (34%) 400 (40%) 290 (27%) 708 (16%) 
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includes biosynthesis of the polyketide antibiotic actinorhodin (ACT) and a non-
ribosomal peptide calcium-dependent antibiotic (CDA). The biosynthesis route of 
undecylprodigiosin (RED) is not yet completely elucidated (Thomas et al. 2002), 
therefore only the known steps for its biosynthesis are presented in the model. With 
the included reactions the total number of metabolites in the reconstructed network is 
500 (Appendix 3.3). 
3.3.2 Universality of the S. coelicolor A3(2) model 
We estimated the possibility of extrapolating the use of the S. coelicolor A3(2) 
metabolic network for other Streptomyces strains by comparing the genomes of S. 
coelicolor A3(2) and S. avermitilis (Appendix 3.4). In total 53% of the genes in S. 
coelicolor A3(2) are synteny conserved with S. avermitilis, i.e. their relative position in 
the genome has been retained throughout evolution of these two Streptomyces 
strains; 35% of the S. coelicolor A3(2) genes have orthologs, which position is not 
conserved in S. avermitilis; only 12% of the genes do not have an ortholog in S. 
avermitilis. Out of 711 ORFs included in the model 78% are synteny conserved with 
S. avermitilis, which shows that there is a much higher degree of synteny for 
metabolic genes than for the other genes. A further 22% of the ORF’s in the 
metabolic model are coding for isoenzymes of which at least 1 synteny conserved 
ORF is present in S. avermitilis. The high fraction of synteny conserved ORFs and 
isoenzymes in the model indicates that the S. coelicolor A3(2) metabolic network can 
be used as a starting point for a rapid reconstruction of the reaction networks for 
other Streptomyces species. 
3.3.3 Connectivity 
A frequency plot for all the metabolites in the metabolic networks of S. coelicolor 
A3(2), Saccharomyces cerevisiae (Förster et al. 2003a) and E. coli (Edwards et al. 
2000b) is shown in Figure 3-1. With the exception of proton, which is the most 
frequent metabolite in yeast due to proton-driven transport reactions, the most 
connected metabolites are involved in energy metabolism: ATP, ADP and phosphate. 
The reducing equivalent NADH is more common for the metabolic network of S. 
coelicolor A3(2), which also has the highest proportion of oxidoreductases. The 
higher occurrence of glutamate and α-ketoglutarate in S. coelicolor A3(2) reflects a 
higher frequency of the use of aminotransferases. Coenzyme A and acetyl-carrier 
protein occur more often in the S. coelicolor A3(2) model, which directly correlates 
with extensive propanoate, butanoate metabolism and the production of polyketide 
actinorhodin. 
 
Figure 3-1. Frequency of the most connected metabolites in the reconstructed 
metabolic networks of S. coelicolor A3(2), Saccharomyces cerevisiae (Förster et al. 
2003a) and E. coli (Edwards et al. 2000b). Frequency is calculated as the number of 
times a certain metabolite appears in the metabolic network divided by the sum of all 
metabolites occurrence. S. coelicolor A3(2) (), Saccharomyces cerevisiae (∆), E. coli 
(). Abbreviations: H – external proton, GLU – glutamate, PPI – pyrophosphate, COA 
– coenzyme A, AKG – α-ketoglutarate, PYR – pyruvate, ACCOA – acetyl-coenzyme 
A, ACP – acetyl-carrier protein. 
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3.3.4 Growth energetics 
Besides differences in some reactions and the preferred cofactors for some 
reactions, the core part of microbial metabolism, i.e. the central carbon metabolism 
(glycolysis, pentose phosphate pathway, and TCA cycle), biosynthesis of the 
biomass building blocks, is highly conserved. The biomass composition and the 
growth energetics are, however, unique properties of each organism. Here, the 
biomass composition was calculated based on the measurements performed in S. 
coelicolor A3(2) and related species (Appendix 3.5). The growth energetics is 
described by Stouthamer equation (1): 
 ATPxATPATP mYr +⋅= µ , (1) 
 which states that for a pseudo-steady state the rate of ATP production ATPr  is equal 
to the ATP consumption for growth µ⋅xATPY  and maintenance ATPm , where µ  is the 
specific growth rate and xATPY  is the ATP yield coefficient (Stouthamer et al. 1973). 
The main source of ATP in aerobically growing organisms is the oxidative 
phosphorylation. Streptomyces are known to use menaquinone as electron 
transporter in the membrane (Pandya et al. 1966; Yassin et al. 1988), even though 
surprisingly enough the genes for menaquinone synthesis were not found in the 
sequenced genomes of Streptomyces coelicolor A3(2) and Streptomyces avermitilis. 
The stoichiometry of the electron transport chain was assumed to be the same as 
recently described in the actinomycete Corynebacterium glutamicum (Bott et al. 
2003). The values of the ATP yield coefficient xATPY  and the maintenance flux ATPm  
were estimated from the chemostate cultivations data (Melzoch et al. 1997) as 
described in Methods (Figure 3-2, 3-3). 
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Figure 3-2. The ATP yield coefficient 
xATPY () and maintenance energy ATPm  () as a 
function of the maximal P/O ratio in Streptomyces coelicolor A3(2). 
 
Figure 3-3. Simulation of experimental chemostates data (Melzoch et al. 1997). 
Specific glucose uptake rate (experimental , model ----), specific carbon dioxide 
production rate (experimental , model ), specific oxygen uptake rate 
(experimental , model – – –), actinorhodin production rate (experimental o, model — 
– — – ). 
 
3.3.5 Reactions activity 
In order to investigate the topology of the metabolic network we created a list of 
unique reactions, and in this way eliminated the redundancy in the network resulting 
from the large number of isoenzymes (Appendix 3.7). This model was used for 
growth simulation in five different media: 1) glucose as C-source and nitrate as N- 
source, 2) mixture of carbohydrates, 3) mixture of organic acids and alcohols, 4) 
mixture of amino acids, and 5) mixture of nucleotides (Appendix 3.8). Except for the 
first scenario, non-limited ammonia uptake was allowed. Additionally, we simulated 
secondary metabolites production at slow growth rate on glucose and ammonia. The 
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analysis of the fluxes that computationally provided optimal growth rate or optimal 
antibiotics production rate at the given conditions (also considering alternative 
optimal solutions) showed that 88% of reactions were active under some or all of the 
tested conditions, 6% of reactions were inactive due to the formation of dead-ends 
(that means that one of reaction’s products or reactants can not be used or produced 
in the network (Figure 3-4)). In this way there was only a very small part (6%) of the 
non dead-end reactions that never got involved in the cellular metabolism, perhaps 
because the conditions that evoke these reactions’ activity have not been considered 
in the simulations. 
 
Figure 3-4. Activity of the reactions in the model of S. coelicolor A3(2). All the unique 
reactions in the model are divided into a number of categories based on their 
predicted activity under several growth conditions. The proportion of reactions for 
which the corresponding enzyme (-s) were detected on a 2D-gel is shown by dashed 
area. 
 
Interestingly, some of the enzymes that catalyze “dead-end” reactions in the model 
have been detected on 2D gels in S. coelicolor A3(2) grown on a minimal medium 
supplemented with casamino acids 
(http://dbkweb.ch.umist.ac.uk/StreptoBASE/s_coeli/referencegel/). One of the 
enzymes was putative mannose-1-phosphate guanyltransferase (SCO1388), which 
is known to be involved in mannosylation of proteins, a common protein modification 
for Actinomycetes. The reaction appears as a dead-end in the model because protein 
modifications are not included in the reactions list and therefore the GDP-activated 
mannose-1-phosphate is not used in any other reactions. Another enzyme is 2-
dehydro-3-deoxyphosphogluconate aldolase/4-hydroxy-2-oxoglutarate aldolase 
(SCO0852), which is either involved in Entner-Doudoroff (ED) pathway (this is 
unlikely as the characteristic ED pathway gene edd was not found in the genome 
sequence of Streptomyces coelicolor A3(2)) or is responsible for interconverting 4-
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hydroxy-α-ketoglutarate into glyoxylate and pyruvate. Experimental evidence has 
been obtained that the enzyme is important in regulation of glyoxylate levels in the 
cells of E. coli  (Cayrol et al. 1995). A hypothesis has been proposed that 4-hydroxy-
2-oxoglutarate aldolase action is coupled to α-ketoglutarate dehydrogenase complex 
and results in pyruvate-catalyzed oxidation of glyoxylate into malyl-CoA (Gupta et al. 
1984). We judge that it is important to include the reactions in the model even though 
the complete pathway is not known as dead-ends presence may give a hint to which 
enzymes one should look for in future annotation of the genome. 
3.3.6 Reactions dispensability 
We studied dispensability of the reactions in the network by making single reaction 
deletions and optimizing for the growth on 62 different carbon sources and 2 different 
inorganic nitrogen sources (ammonia and nitrate, only tested with glucose as carbon 
source). The approach differs from single gene deletion studies, because if 
isoenzymes are present, then their simultaneous knock-out will be simulated by 
deleting the reaction they catalyze. We find this approach more informative for 
studying the sensitivity of the metabolic network to perturbations. To quantify the 
effect of reaction deletion we defined reaction essentiality as the relative decrease in 
the specific growth rate with deletion of the reaction in comparison to the specific 
growth rate with the complete reaction set (2): 
 [ ]1....0)(
)(
1
max
max
=−=
∆
typewild
mutant
tyessentiali ireactionireaction µ
µ
, (2) 
i.e. the reaction essentiality is 1 for an essential reaction whereas it is 0 for a reaction 
that upon removal has no growth retarding effect. The reaction essentialities for the 
growth on glucose and ammonia are shown on Figure 3-5A, and Figure 3-5B 
illustrates the summed reactions essentialities for growth on the 63 different media 
(Appendix 3.9). Reactions with a summed reaction essentiality of 63 are required for 
growth under all the defined conditions, and hence are true essential reactions. The 
reactions that have a summed reaction essentiality lower than 63 are either 
necessary only under certain conditions or their deletion leads to growth retardation. 
The comparison of Figure 3-5A and Figure 3-5B shows that the choice of conditions 
is important for defining the dispensability of reactions. While during growth on 
glucose and ammonia 64% of the reactions could be eliminated without any 
consequences for the cellular growth, a number of these reactions turned out to be 
essential for growth on other carbon sources than glucose, and the number of non-
essential deletions were reduced from 64% to 39% when all the growth conditions 
were considered. The minimal metabolic net, necessary for the growth under all the 
conditions, consists of 146 reactions. Considering that 17 % of them have an 
isoenzyme, there are basically 121 metabolic genes that are truly essential (e.g. 
essential on the complete medium), which corresponds to 12% of the original 
metabolic network. 
Essential and non-essential reactions were found to have almost equal occurrence of 
isoenzymes (17 and 15% respectively), whereas a higher fraction of the growth-
retarding or conditionally essential reactions were catalyzed by isoenzymes (26%). 
This undermines a hypothesis that isoenzymes exist to increase the robustness of 
the metabolic network to mutations.  
 
 From genomes to in silico cells via metabolic networks 
 
45 
Figure 3-5. Essentiality of the reactions in the model of S. coelicolor A3(2) during 
growth on glucose (A) and during growth under 63 various conditions (B). All the 
reactions were sorted into three categories: essential reactions, conditionally 
essential reactions and non-essential reactions depending on their influence on 
biomass synthesis. The percentage of reactions with isoenzymes among all the 
reactions in the given category is shown. 
 
3.3.7 Metabolic capabilities of the network 
3.3.7.1 Degradation of C- and N-sources 
In most of cases the model correctly predicted growth capability on various C- and N-
sources for S. coelicolor A3(2) wild type and mutant (Table 3-3). There was a 
disagreement on usage of aspartate and glutamine as the sole C-source, which was 
possible according to the model, but has not been observed experimentally. It is 
known than S. coelicolor A3(2) can grow on asparagine, which is presumably 
degraded via asparatate. In this case, it may be regulatory events that do not allow 
asparatate utilization rather than the lack of metabolic capacity. S. coelicolor A3(2) 
can use glutamine as the sole N-source, but not as C-source, while glutamate can be 
used as both. There’s evidence that glutamate is decarboxylated into γ-
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aminobutanoate upon the uptake (Inbar et al. 1991). Therefore, if glutamine is 
deaminated by glutaminase intracellularly, the formed glutamate can not further be 
degraded. In this way glutamine would only provide nitrogen for growth, but not 
carbon units. 
 
The deletions of trpC1 and trpD1 in S. coelicolor A3(2) result in auxotrophy for 
tryptophan, because the genes with analogical functions – trpC2 and trpD2 – are 
located in the calcium-dependent antibiotic biosynthetic cluster and apparently can 
be used exclusively in the secondary metabolism (Hu et al. 1999b). 
The described inconsistencies can be resolved in future by expanding the model to 
include regulatory constraints. 
 
Table 3-3. Comparison of experimentally determined and in silico predicted growth 
phenotypes. + stands for growth, - for no growth. 
1
 The data are for Streptomyces lividans 
3.3.7.2 Biomass yield 
The biomass yields of in silico S. coelicolor A3(2) on various carbon sources were 
similar to that of in silico yeast (Förster et al. 2003a) (Figure 3-6A). The energy 
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Strain Substrate/phenotype Literature 
C-source 
wt 
glycerol, L-arabinose, D-arabitol, D-ribose, D-
xylose, L-xylitol, D-fructose, D-galactose, D-
gluconate, D-glucose, D-mannitol, D-
mannose, L-rhamnose, salicin, cellobiose, 
lactose, maltose, melibiose, trehalose, 
acetate, citrate, lactate, malate, pyruvate, 
succinate, tartrate, propanoate, alanine, 
asparagine, glutamate, glycine, histidine, 
isoleucine, leucine, lysine, methionine, 
proline, serine, threonine, tryptophan, valine 
 (Hodgson 1980; Zhang et 
al. 1996c) 
∆msdA propanoate  (Zhang et al. 1996b) 
+ + 
∆glnA no glutamine auxotrophy  (Fink et al. 1999) 
wt succrose, arginine, methionine, phenylalanine 
 (Hodgson 1980) 
∆msdA valine  (Zhang et al. 1996a) 
∆hisA trp- his-  (Barona-Gomez et al. 2003) 
∆malE maltose  (van Wezel et al. 1997) 
∆argG arg-  (Flett et al. 1987) 
- - 
∆metF met-  (Blanco et al. 1998)1 
wt aspartate, glutamine  (Hodgson 1980) 
- + 
∆trpC1∆trpD1 trp-  (Hu et al. 1999a) 
N-source 
+ + wt aspartate, asparagine, glutamate, glutamine, isoleucine, leucine, lysine, praline, valine 
 (Hodgson 1980) 
- - ∆vdh valine, isoleucine, leucine  (Tang et al. 1993) 
+ - wt methionine, phenylalanine  (Hodgson 1980) 
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requirements were considered for the simulations. The exception was growth on C-2 
compounds like acetate and ethanol where S. coelicolor A3(2) was more efficient at 
utilizing these substrates. This is due to the action of the acetate kinase (encoded by 
ackA) and the phosphate acetyltransferase (encoded by pta), which catalyze the 
conversion of acetate into acetyl-phosphate and further into acetyl-CoA at the 
expense of only one high-energy phosphate bond hydrolysis in ATP. In eukaryotes 
these enzymes are not present and acetate is activated by acetyl-CoA synthase 
(encoded by acs) with the co-current hydrolysis of ATP to AMP, which is energetically 
more costly. Comparison of the growth capabilities of in silico S. coelicolor and in 
silico E. coli  (Edwards et al. 2000b) showed that the S. coelicolor had higher 
biomass yields, which was primarily due to higher maintenance energy requirements 
in E. coli (Figure 3-6B). 
 
Figure 3-6. Maximal simulated biomass yield of S. coelicolor A3(2) as compared to 
S. cerevisiae (Förster et al. 2003a) (A) and E. coli  (Edwards et al. 2000b) (B) on 
different carbon sources (g/g substrate). All the calculations were made for substrate 
uptake rate of 6 C-mmol/g DW/h. The maintenance energy requirement was 
considered. 
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3.3.7.3 Anaerobic growth 
The inability of Streptomyces to grow anaerobically has been a puzzle for quite some 
time (Hodgson 2000). Generally the microbes are capable of growing anaerobically, 
as they may obtain their Gibbs free energy by substrate-level phosphorylation 
resulting in fermentative metabolism. The presence of lactate dehydrogenase in the 
sequenced genome of S. coelicolor A3(2) indicates that the organism should be 
capable of having a fully operational fermentative metabolism with lactate as a key 
fermentation product. Indeed, excretion of lactate has been observed for S. griseus 
grown under microaerophilic conditions (Hockenhull et al. 1954). Two reasons were 
suggested to explain the anaerobic Streptomyces paradox: either the organisms are 
sensitive to the fermentation products or/and there are some essential reactions that 
require oxygen.  
We analyzed the problem from the perspective of the reconstructed metabolic 
network and did not find any essential reactions that exclusively use oxygen. It 
seems that the essential dehydroorotate dehydrogenase E.C. 1.3.3.1 (SCO1482) 
required for pyrimidines biosynthesis and L-aspartate oxidase E.C. 1.4.3.16 
(SCO3382) participating in nicotinamide nucleotides biosynthesis can both use 
oxygen and menaquinone as electron acceptors. Anaerobic growth can simply 
require that the produced menaquinol can be re-oxidized by the reverse action of 
succinate dehydrogenase. When glucose uptake rate was set to the maximal 
experimentally observed value (2.2 mmol/g DW/h) (Melzoch et al. 1997) and oxygen 
uptake rate was fixed to zero, the maximum specific growth rate was predicted to be 
0.022 h-1 and 0.056 h-1 with ammonia and nitrate as nitrogen source respectively. 
The growth however implied conservation of a proton potential over the membrane, 
i.e. the protons exported during secretion of succinate are used for uptake of 
glucose. This is an unlikely situation in vivo and then substrate uptake might be the 
limiting factor for growth without oxygen. Glucose is transported into the S. coelicolor 
A3(2) by proton symport and the proton gradient is created primary in the respiratory 
process. Meanwhile, facultative anaerobes like yeast and E. coli use respectively 
facilitated diffusion and the PTS transport system, which remain active under 
anaerobic conditions.  
3.3.7.4 Actinorhodin production 
Several recent publications are dedicated to expressing bacterial and fungal 
polyketide synthase (PKS) genes in heterologous hosts. (Kealey et al. 1998; 
Kennedy et al. 2003; Kinoshita et al. 2003). As an example we addressed the issue 
of metabolic capabilities of yeast and S. coelicolor A3(2) to produce reducing 
cofactors and the most common polyketides precursors (Figure 3-7).  
The capabilities of the metabolic networks of yeast and S. coelicolor A3(2) to produce 
acetyl-CoA, malonyl-CoA and reducing equivalents NADH and NADPH turned out to 
be very similar. However Streptomyces have a clear advantage in the form of more 
extensive polyols metabolism, which allows them to make such typical building 
blocks for polyketides production as methylmalonyl-CoA, propionyl-CoA and 
butanoyl-CoA. Development of heterologous production of certain polyketides from 
E. coli or yeast is tedious as it requires not only addition of PKS genes, but also the 
genes necessary for biosynthesis of precursors. 
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Figure 3-7. Predicted polyketides production capabilities of S. coelicolor A3(2) and 
Saccharomyces cerevisiae (Förster et al. 2003a) (in mol/mol glucose). All the 
calculations were made for glucose uptake rate of 1 mmol/g DW/h. 
 
3.3.8 Filling the gaps in genome annotation 
We assumed that the following processes had to be included in order to produce a 
“viable” model cell: 
• transport reactions (nutrients and oxygen uptake, metabolites excretion); 
• biosynthesis of the 12 biomass precursors; 
• biosynthesis of each biomass component (amino acids, vitamins, co-factors, 
etc.); 
• degradation of the experimentally utilizable substrates. 
If any of these conditions were not fulfilled, a missing reaction (-s) was added 
according to the pathway structure (organism specific or general if the former was not 
available). 205 reactions without assigned ORFs were added to the model: 79 
enzymatic reactions, 117 transport reactions, 5 spontaneous and 4 artificial reactions 
like maintenance, biomass assembly (Appendix 3.10). Out of the 79 enzymatic 
reactions, 27 were identified as being essential for growth on glucose and salts. In 
the context of functional genomics the reconstructed metabolic network hence serves 
as physiological evidence for the presence of these genes and allows directed 
search for the ORFs with the necessary function. Each of these 27 reactions was 
subsequently analyzed on an individual basis. The genome was searched for genes 
with specific protein motifs (http://www.sanger.ac.uk/Software/Pfam/) and the 
obtained hits were evaluated using the functions of the neighboring genes and their 
possible organization in an operon. The previously described Bayesian method  
(Green et al. 2004) has essentially the same logics, but it does not account for the 
protein motifs and uses homology search instead, besides, it requires model 
implementation in Pathway Tools  (Karp et al. 2002). 
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3.3.8.1 Phospholipids biosynthesis  
One of the enzymes missing in the phospholipids biosynthesis is cardiolipin 
synthase. No homologues of bacterial cardiopin synthase, which catalyzes the 
condensation of two phosphatidylglycerols into cardiolipin and glycerol were found in 
the genome of S. coelicolor A3(2). Presumably the cardiolipin synthesis occurs in the 
same way as in eukaryotes in reaction of phosphatidylglycerol with CDP-glycerol 
accompanied by formation of CMP. In this case the enzyme should possess a CDP-
alcohol phosphatidyltransferase domain. With Pfam motif search 8 ORFs were found 
to contain such a domain in the S. coelicolor A3(2) genome. Three of these ORFs 
(SCO1527, SCO1389 and SCO5753) were synteny conserved with M. tuberculosis 
enzymes coding for phosphatidylinositol synthase (pgsA), cardiolipin synthase 
(pgsA2), and phosphatidylglycerol synthase (pgsA3) respectively  (Jackson et al. 
2000). Once a link has been established between gene and enzymatic function, it is 
possible to transfer the knowledge between different species by homology and 
synteny information, and we hereby predict that SCO5753 encodes 
phosphatididylglycerol synthase, SCO1527 – a phosphotidylinositol synthase and 
SCO1389 – a cardiolipin synthase. 
3.3.8.2 Polyprenoids biosynthesis 
The annotation of the polyprenoid biosynthesis was re-examined because 5 essential 
genes were found to be missing in the KEGG database, i.e. (E)-4-hydroxy-3-
methylbut-2-enyl diphosphate reductase (IspH/LytB), pentaprenyl diphosphate 
synthase, hexaprenyl diphosphate synthase, octaprenyl diphosphate synthase, and 
nonaprenyl diphosphate synthase. The enzymes involved in the polyprenoid 
biosynthesis all have a prenyltransferase domain IPR001441. S. coelicolor A3(2) 
contains 7 genes with a polyprenyltransferase domain, i.e. SCO0185, SCO0565, 
SCO0568, SCO2509, SCO3858, SCO4583, SCO5250, and SCO6763. Two of the 
genes, SCO2509 and SCO3858, are synteny conserved with M. tuberculosis and 
must therefore have an important function. Furthermore SCO0185, SCO4583, 
SCO5250, and SCO6763 are synteny conserved with S. avermitilis. These 6 
conserved genes are likely to be involved in general polyprenoid biosynthesis. The 
SCO0185 (crtB) is involved in biosynthesis of a secondary carotenoid metabolite  
(Lee et al. 2001), which is probably connected to the response to UV-radiation. This 
indicates that SCO0185 might not be true synteny conserved between S. coelicolor 
A3(2) and S. avermitilis but is a results of a transfer of a gene cluster. The SCO6763 
is placed in another secondary metabolite gene cluster responsible for hopanoid 
biosynthesis, which is thought to be involved in the stress response in aerial mycelia 
by decreasing the water permeability of the plasma-membrane  (Poralla et al. 2000). 
The last four unaccounted genes must be the genes that are responsible for 
polyprenoid biosynthesis for general purposes, i.e. plasma membrane electron 
carrier and transmembrane sugar carrier. The homologue of SCO3858 (Rv1086) has 
been biochemically characterized in M. tuberculosis as an omega,E,Z-farnesyl 
diphosphate synthase  (Schulbach et al. 2000). 
3.4 CONCLUSIONS 
We have reconstructed the metabolic network of S. coelicolor A3(2). Besides 
resulting in improved annotation of several genes and suggestions for annotation of 
other genes, the reconstructed network may be used as a model of the metabolism in 
Streptomyces. Earlier attempts to model Streptomyces spp. (Roubos 2002; Bruheim 
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et al. 2002; Avignone et al. 2002) show that there is a demand for a high quality 
metabolic model of Streptomyces both in academic and industrial research. The 
model presented in this paper has been reconstructed based on the up-to-date 
knowledge about Streptomyces and can readily (or with small adjustments for 
species specificity) be used for simulations. We therefore expect that the model will 
be a useful tool for genome-wide analysis of the transcriptome and the proteome as 
well as for designing strategies for improvement of antibiotics yields in Streptomyces. 
3.5 Methods 
3.5.1 Reconstruction process 
For reconstruction of S. coelicolor A3(2) metabolic network we used the annotated 
genome databases (KEGG PATHWAY database: http://www.genome.ad.jp/dbget-
bin/get_htext?S.coelicolor.kegg+-f+T+w+C and The Wellcome Trust Sanger Institute 
database: http://www.sanger.ac.uk/Projects/S_coelicolor/scheme.shtml), metabolic 
databases (KEGG Ligand database http://www.genome.ad.jp/kegg/ligand.html, 
ExPASy Biochemical Pathways http://www.expasy.org/cgi-bin/search-biochem-index, 
ExPASy Enzyme Database http://www.expasy.org/enzyme, Swiss-Prot database 
http://www.expasy.org/sprot/sprot-top.html), biochemistry books (Ingraham et al. 
1983; Stanier et al. 1986; Michal 1999), reviews (Hodgson 2000) and journal 
publications. The reconstruction process was started by downloading the S. 
coelicolor pathway database from KEGG ftp server 
(ftp://ftp.genome.ad.jp/pub/kegg/pathways/sco/) and the reactions corresponding to 
the given E.C. numbers/enzyme names were written using metabolic databases 
indicated above. Water, intracellular protons and hydroxyl ions were not included in 
the model, assuming that different non-enzymatic processes also use these 
substrates and therefore they don’t need to be balanced in the set of enzymatic 
reactions. The functions of the included genes were compared to the functional 
assignments in The Wellcome Trust Sanger Institute database and when possible 
confirmed by information from the literature. In case the reaction was necessary to 
produce a viable in silico cell, but the corresponding gene was not in present in the 
annotated genome, the reaction was included in the model without genomic 
evidence. Unless the information of irreversibility of a reaction was available it was 
set as reversible. A list of the reactions with corresponding references is available as 
the supplementary material (Appendix 3.2). The biomass equation was made based 
on the macromolecular composition of S. coelicolor A3(2) (Shahab et al. 1996) and 
related species and is also available as the supplementary material (Appendix 3.5).  
3.5.2 Modeling 
Flux balance analysis (FBA) was used for quantification of metabolic fluxes  (Varma 
et al. 1994; Schilling et al. 1999). The reactions set composed a stoichiometric matrix 
S  with dimensions nm× , where m  was the number of metabolites and n  was the 
number of reactions. Assuming pseudo-steady state over intracellular metabolites 
concentrations the metabolic model could be defined by the following matrix 
equation:  
 0=⋅ vS , (2)   
where v  represented all the metabolic fluxes. 
As the number of metabolic fluxes exceeded the number of mass balance 
constraints, there existed a set of feasible metabolic fluxes distributions. A solution 
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was found using linear programming by introducing an optimization problem: 
MAXIMIZE vcZ ⋅= , where c  was a row vector showing the influence of individual 
fluxes on the objective function. Additional constraints were imposed on fluxes: 
iii bva ≤≤ , indicating the reaction irreversibility ( ∞<≤ iv0 ) or measured flux. The 
transport fluxes for phosphate, sulfate, ammonia and oxygen were not restrained 
( ∞<≤∞− iv ). The uptake rates of metabolites that were not available in the medium 
were set to zero ( 0=iv ). The excretion of the major metabolic products (carbon 
dioxide, pyruvate, acetate, etc.) was allowed ( ∞<≤ iv0 ).  
For simulations of growth the flux to biomass was set to a certain value and the 
substrate uptake rate was minimized. For simulation of antibiotic production, the 
substrate uptake rate was constrained and the flux towards the antibiotic was 
maximized.  
In order to find fluxes that were active during alternative optimal solutions, the 
following algorithm was used: 
• substrate uptake rates were constrained and the biomass growth rate was 
maximized; 
• the growth rate was fixed to the found maximal value, thus an additional 
constrain was introduced; 
• by changing vector c  each reaction in the network was maximized and then 
minimized, if the flux through the reaction was different from zero in at least 
one of these optimizations, the reaction was considered to be active in 
alternative optimal solutions.  
The calculations were performed using the commercially available linear 
programming package LINDO (Lindo Systems Inc., Chicago). The algorithm for 
finding fluxes that are active during alternative optimal solutions was implemented in 
Matlab (The MathWorks Inc., Natick), but LINDO package was used as the solver for 
the linear programming problems. 
3.5.3 Estimation of energetic parameters 
Knowing one of the energetic parameters (P/O ratio, xATPY  or ATPm ) allows calculation 
of the other two parameters from continuous cultivations data. Because none of the 
parameters was known, they were estimated for P/O ratios in the range of 0.5 to 2 
(Figure 3-2).  
The xATPY is composed of three parts: 
• ATP costs for the synthesis of biomass building blocks (amino acids, 
nucleotides, etc.), which was accounted for through reactions stoichiometry; 
• ATP costs for polymerization of monomers into biological polymers (proteins, 
DNA, etc.), which was assumed to be the same as for E. coli (Ingraham et al. 
1983) and was included in the reactions of macromolecules biosynthesis; 
• and ATP costs for growth associated maintenance entenancgrowth_maixATPY _ , added to 
the growth equation. 
The last composite nanceaintemgrowthxATPY __  as well as maintenance ATP ( ATPm ) were not 
known and were estimated from the experimental chemostate data (Melzoch et al. 
1997).  
 From genomes to in silico cells via metabolic networks 
 
53 
Normally the glucose uptake rate glucq , carbon dioxide production rate 2COq  and 
oxygen uptake rate 
2Oq are linearly dependent on the specific growth rate (Figure 3-
3). The ceaintenanmgrowthxATPY __  and ATPm  were set up to arbitrary values and the 
simulations were run for each of the experimentally investigated dilution rate by fixing 
the specific growth rate and actinorhodin production rate to the experimental values 
and performing linear optimization for glucose uptake rate minimization (Appendix 
3.6). The obtained glucq , 2COq  and 2Oq dependence on dilution rate was compared to 
the experimental. The ceenanowth_maintgrxATPY _  and ATPm  were changed until a good 
prediction was obtained. For the further simulations the maximal P/O ratio was fixed 
to 1.5 and 
xATPY  and ATPm  were set to the corresponding values. 
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4.1 Abstract 
Common scab is a widespread disease of potatoes and other root and tubers crops, 
causing serious economical losses worldwide. Scab is caused by phytopathogenic 
Streptomyces species, of which S. scabies is the most common. Based on the 
recently released genome sequence of S. scabies we reconstructed a genome-scale 
metabolic network.  
For making the network we used two approaches: one was a partly automated 
reconstruction using software package Pathway Tools, another was reconstruction 
by homology based on S. coelicolor  A3(2) model [1]. 
Using Pathway Tools we could quickly generate a template model and predict protein 
complexes, transcriptional units, and transporters as well as identify 462 enzymes 
that are necessary for cellular function, but haven’t been annotated (so called 
pathway holes). Using the prediction tools in-built in Pathway Tools we found the 
coding genes for 72 of the pathway holes.  
By comparing the genomes of S. scabies, S. coelicolor and S. avermitilis, we 
reconstructed a stoichiometric model of S. scabies. In comparison to S. coelicolor, it 
lacked isocitrate lyase, but included thaxtomin biosynthesis pathway. We show that 
this model can be used to simulate for example which enzymes are essential for 
thaxtomin biosynthesis and for cells viability at different conditions. 
 
Supplementary material: the Pathway Tool model of S. scabies is supplied in 
Appendix 4.1 and the bioopt format of the model is given in Appendix 4.2. 
Keywords 
Streptomyces scabies, metabolic model, in silico 
4.2 Introduction 
Common scab of potatoes is caused by several Streptomyces species [2, 3] and 
occurs in most of potato cultivation areas. It can also appear on other tubers as 
beets, turnip, radish, carrots, etc. Scab is characterized by formation of lesions widely 
ranging in size, color and texture. Appearance of lesions is a large economical 
problem, because the market value of contaminated tubers decreases significantly. 
The main organism causing potato scab is Streptomyces scabies, which has recently 
been sequenced in collaboration between Welcome Trust Sanger Institute (UK) and 
Cornell University (USA). The sequence was made publicly available 
(ftp://ftp.sanger.ac.uk/pub/pathogens/ssc/) while the annotation is currently ongoing.  
The availability of genomic sequence allows us to better understand pathogenicity 
mechanism of S. scabies and to identify the targets for fighting this pathogen. To 
achieve this aim, functional genomics, connecting the sequences of the genes to 
their function, is of the utmost importance. Metabolic models have previously proven 
to be useful in complementing the manual genome annotation process [4]. They 
allow fast identification of missing enzymes to ensure the complete functionality of 
the organism [1]; they also allow predictions of lethal or non-pathogenic phenotypes, 
helping to find cure against pathogens [5]. 
Here we report reconstruction of S. scabies metabolic model and its application for 
studying organism physiology. 
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4.3 Results and discussion 
4.3.1 Automated reconstruction using genome annotation data 
The complete genome sequence of 10,148,695 bp was initially automatically 
annotated using Glimmer 3.02 [6] (http://www.cbcb.umd.edu/software/glimmer). 9178 
open reading frames were predicted, of which 9,106 encode proteins and 72 – 
transport RNAs. Of all the protein-coding ORFs, 1,759 were annotated as 
hypothetical proteins and further 1,971 did not match with any other proteins 
sequence in the database, meaning that 5,376 genes had some function annotated. 
The output file from Glimmer 3.02 was converted into gene bank format file and used 
as an input into Pathway Tools version 10.5 (SRI International, USA). Pathway Tools 
uses an advanced algorithm to assign reactions to the genes, based on E.C. 
numbers and gene names from the annotation. The initial model, consisting of a 
thousand enzymatic reactions and 714 metabolites, was quite large considering that 
E.C. numbers were available only for 18 genes and most of the functions were found 
by unambiguous enzyme name matching (Table 4-1). Furthermore 1,297 proteins 
were predicted to be metabolic enzymes, but exact function could not be assigned to 
them because of ambiguity problem, non-standard enzyme names or other issues. It 
is possible to go through the list of these enzymes and assign their function manually 
later.  
After creating the initial database we predicted protein complexes using a feature 
from Pathway Tools. The proteins that have the same function, have subunit 
indication in their name and are positioned adjacent to each other on the 
chromosome are grouped into protein complexes. We identified 43 protein 
complexes, which included NAD(P) transhydrogenase, urease, DNA gyrase, ATP 
synthase, acetolactate synthase and others. 
Our next step was to predict transcriptional units. The program works by first finding 
adjacent genes that are transcribed in the same direction (directon). If a single gene 
is surrounded by genes that are transcribed in a different direction, it is automatically 
assigned as a transcriptional unit, because it would need its own promoter. In case of 
a longer directon, the genes in it are analyzed for their function, for belonging to the 
same pathway, for being parts of a protein complex, for base pair distances between 
them and then if the estimated score is higher than a threshold, they are assigned to 
be part of an operon. In our case the program predicted 6,798 transcriptional units, of 
which 1,446 were operons and the rest 5,352 were single genes. The lengths of the 
operons are shown on a histogram (Figure 4-1). The longer the operons, the less 
abundant they are in the genome. 
 
Table 4-1. Statistics of the S. scabies pathway genome database at different steps of 
reconstruction in Pathway Tools. 
 Initial Create protein complexes Transcription Units Transport 
Pathways 226 226 226 230 
Enzymatic reactions 1000 1005 1005 1026 
Transport reactions 2 2 3 63 
Polypeptides 9113 9113 9113 9113 
Protein complexes 1 44 44 50 
Enzymes 678 711 711 784 
Transporters 10 10 10 149 
Compounds 714 721 721 747 
Transcription units 0 0 6798 6796 
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Figure 4-1. Histogram shows frequency of operons with a specific number of genes 
in them.  
 
 
A special program module - transporter identification parser - was used to predict 
transport proteins and their substrates, 146 high confidence transporters were 
predicted (Table 4-1). 
As the final step, we searched if all metabolic pathways were complete using 
“pathway hole filler” [7]. From the genes that already have been included in the 
model, the estimation is made whether a certain pathway is present in the organism. 
For example, the presence of an enzyme which is unique for a pathway gives a 
higher score to this pathway existence. The enzymes, which are necessary for the 
pathway to work, but absent from the model are found. In case of S. scabies 462 
pathway holes were detected (Appendix 4.3). The sequences for the corresponding 
enzymes were found in the genomes of S. coelicolor and S. avermitilis and were 
BLASTed against S. scabies genome to identify the candidates for filling in the holes. 
72 candidate enzymes with reliability value of at least 0.9 were found (Appendix 4.4). 
Among these enzymes were GDP diphosphokinase (E.C. 2.7.6.5) and ppGpp 
diphosphatase (E.C. 3.1.7.2), which are responsible for maintaining the suitable 
levels of global regulator metabolite ppGpp. Both enzymatic functions were assigned 
to a single open reading frame SCAB07497, which is also consistent with 
observations in other Streptomycetes, where these activities are combined in one 
enzyme [8]. 
We exported the reactions from the database and formatted the file so it could be 
used as an input for stoichiometric modeling. However, the problems associated with 
automatic database reconstruction (see chapter 3) were numerous and multiple 
manual corrections needed to be done before the model could be used for 
simulations. We evaluated it as being inexpedient to make all the corrections at this 
stage, where we only had an automatic draft annotation of the genome to start with. 
4.3.2 Reconstruction using homologous search to S. coelicolor genes 
Because of the problems encountered above we decided to use a shortcut for 
construction of a stoichiometric model, namely by using the previously described S. 
coelicolor model as a template. Each gene of S. coelicolor [1] was BLASTed against 
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S. scabies open reading frames. The same procedure was repeated using S. 
avermitilis genes. There are a large number of genes, which function is conserved 
across all three Streptomyces species. For some of these genes also the position on 
the chromosomes is conserved, these synteny conserved genes lie on the diagonals 
of the plots (Figure 4-2). 
 
Figure 4-2. Global comparison of genes in S. coelicolor, S. avermitilis and S. 
scabies. The dots mark the position of homologous genes on the chromosome of 
different species. 
 
 
625 genes from the S. coelicolor model [1] were homologous across all three 
species. For 62 genes either no homologue was found in S. scabies when BLASTing 
with S. avermitilis genes (BLASTing with S. coelicolor found a homologue) or the 
closest homologue was different from that found by BLASTing with S. coelicolor 
genes. For 6 more genes homologues were only found when searching with S. 
avermitilis sequences. Eventually there were 18 S. coelicolor genes, which did not 
have a homologue in the S. scabies genome (Figure 4-3, Table 4-2). 
Some of these 18 genes performed the same function as other genes that were 
found in S. scabies. The rest of the genes, which function could not be compensated, 
are shown in Table 4-2. These reactions were excluded from the S. coelicolor model 
to provide a draft model of S. scabies. Among these reactions were secondary 
metabolic reactions leading to actinorhodin, prodigiosins and calcium-dependent 
antibiotics. The secondary metabolites clusters often are species-specific, therefore it 
is not surprising they are not present in S. scabies, which is not known to produce 
pigmented antibiotics. 
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Figure 4-3. Statistics over metabolic genes homology across the three species. SCO 
– S. coelicolor, SAV – S. avermitilis, SCAB – S. scabies. 
 
Table 4-2. Reactions from the S. coelicolor model, which were NOT included in the 
S. scabies model due to the absence of close homologous enzyme, which could 
catalyze the reaction. 
S. coelicolor 
A3(2) ORFs 
without 
homologues in 
S. scabies 
genome 
Function E.C.# Reactions 
Essentiality 
under 63 
conditions 
[1] 
SCO5078 actinorhodin biosynthesis  C16H16O5 + 0.5 O2 + NAD -> 
C16H14O6_2 + NADH 
0 
SCO5081 actinorhodin biosynthesis  C16H16O5 + 0.5 O2 + NAD -> 
C16H14O6_2 + NADH; 
C32H26O12 + O2 -> ACT 
0 
SCO5077 
(SAV2084) 
actinorhodin biosynthesis  C16H16O5 + 0.5 O2 + NAD -> 
C16H14O6_2 + NADH 
0 
SCO5079 
(SAV0140) 
actinorhodin biosynthesis  C16H16O5 + 0.5 O2 + NAD -> 
C16H14O6_2 + NADH 
0 
SCO5089 
(SAV2373) 
actinorhodin polyketide 
synthase acyl-carrier protein  
2.3.1.- 8 MALCOA -> C16H17O8 + 8 
COA + 8 CO2 
0 
SCO5090 
(SAV2383) 
actinorhodin polyketide 
synthase  bifunctional 
cyclase/dehydratase  
 C16H20O9 -> C16H16O7 0 
SCO5889 PCP - peptidyl carrier protein  PRO-AMP -> PRO-PCP + AMP 0 
SCO7311 lysine decarboxylase 4.1.1.18 LYS -> CADA + CO2 2 
SCO3215 Glutamate-3-
methyltransferase 
 GLU + MTHF -> THF + NRP1 0 
SCO0982 
(SAV2043) 
isocitrate lyase 4.1.3.1 ICIT -> GLX + SUCC 6 
SCO2144 
(SAV6487) 
D-glycerate transport via 
sodium symport 
 DGLYCERATExt + Naxt -> 
DGLYCERATE + Na 
1 
SCO3029 
(SAV5047) 
L-lactate transport via proton 
symport/putative L-lactate 
permease  
 LLACxt + H <-> LLAC 1 
SCO0985 
(SAV2046) 
5-
methyltetrahydropteroyltriglut
amate-homocysteine S-
methyltransferase 
2.1.1.14 HCYS + MTHPTGLU <-> 
THPTGLU + MET 
0 
SCO6075 
(SAV1247) 
3'-5'-cyclic nucleotide 
phosphodiesterase 
3.1.4.17 cAMP -> AMP; 
cGMP -> GMP 
0 
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Surprising was the absence of isocitrate lyase and cyclic nucleotide 
phosphodiesterase. Possibly these enzymes have quite different sequences in S. 
coelicolor and S. avermitilis. Isocitrate lyase, which lyses isocitrate into glyoxylate 
and malate, is the principal enzyme in glyoxylate shunt, a pathway that is responsible 
for generation of C4 metabolites from C2 compounds during growth on acetate, fatty 
acids or similar. There are, however, several other organisms that can grow on 
acetate in spite of the lack of isocitrate lyase activity, among them Rhodobacter spp. 
[9, 10], α-proteobacteria and S. collinus [11]. While several alternative routes from 
acetate-CoA to glyoxylate have been proposed, they haven’t been explicitly proven. 
Cyclic nucleotide phosphodiesterase hydrolyses cyclic AMP and GMP into their 
normal form and hence regulates their level in the cell. cAMP and cGMP are 
important signaling molecules, they modulate DNA-binding of a transcription factor 
cAMP receptor protein [12]. Both adenylate cyclase, which is responsible for 
biosynthesis of cyclic nucleotides, and cAMP receptor proteins have homologues in 
S. scabies, SCAB03456 and SCAB04132 respectively. Deletion of either of these 
genes in S. coelicolor causes defects in germination and growth delay and affects 
sporulation [13]. As it is very unlikely that cyclic nucleotide phosphodiesterase is 
missing, we searched the S. scabies annotation and indeed we found a calcineurin-
like phosphoesterase (SCAB02697), which is most likely to perform this function. The 
S. coelicolor phosphodiesterase is also calcineurin-like according to its Pfam domain 
(http://pir.georgetown.edu/pirwww/index.shtml). 
4.3.3 Reconstruction of thaxtomins biosynthesis 
The pathogenicity of scab-causing Streptomyces species has so far been mainly 
attributed to production of phytotoxins thaxtomins. All Streptomyces species that are 
capable of causing scab can make thaxtomins [3]. Deletion of thaxtomins 
biosynthetic genes from pathogenic Streptomyces makes them incapable of 
colonizing tubers [14]. Thaxtomins are dipeptides, consisting of phenylalanine and 
nitrated tryptophan [15, 16] (Figure 4-4). Thaxtomins inhibit cellulose biosynthesis in 
expanding plant tissues, stimulate calcium ion spiking and cause cellular death [3]. 
Arabidopsis mutant resistant to thaxtomin was isolated; it had a mutation in txr1 
gene, which apparently is a regulator of thaxtomin transport. The resistant plant had 
reduced uptake rate of thaxtomin. [17] 
Another Streptomyces gene nec1 is also connected to pathogenicity. It was initially 
discovered by expression of S. scabies cosmid library in non-pathogenic S. lividans 
species [18]. The clones carrying nec1 gene became capable of causing necrosis of 
potato slices. The gene is conserved between several parasitic Streptomyces 
species [19, 20]. Nec1 gene encodes a secreted protein, however, the exact 
mechanism of this protein action is so far unknown [3].  
Thaxtomin genes and necrosis factor gene are located on a mobilizable 
pathogenicity island (PAI), which also often includes other supposedly virulence 
genes as cytokinin biosynthetic genes and saponinase [3]. The island transfers easily 
between Streptomyces species by conjugation, but it’s not always that adoption of 
this island confers pathogenicity phenotype [21]. 
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Figure 4-4. Principal route for biosynthesis of thaxtomins A, B and C. 
 
 
The pathway is not present in MetaCyc database and hence was not included in the 
S. scabies model during automatic reconstruction. It was not annotated during the 
automatic genome annotation either. We used similarity search to the pathogenicity 
island of S. turgidiscabies (AY707079–AY707081) [21] to find thaxtomin biosynthetic 
genes in S. scabies. At least four genes are known to be directly involved in 
thaxtomin biosynthesis txtA, txtB, txtC and nos. Homologues of each of these genes 
were found in S. scabies with zero E-values (Figure 4-5). The sequence alignments 
of each gene are shown in Appendix 4.5.  
 
Figure 4-5. Position of the putative thaxtomins biosynthetic genes on the 
chromosome of S. scabies. 
 
 
 
The genes txtC, txtA and txtB are located adjacent to each other and are surrounded 
by transposases from up- and downstream. Two other genes are present in the same 
transposable element – a putative regulatory protein of AraC family and an MBth-like 
protein which was originally found in Mycobacterium tuberculosis, where it functions 
as salicylate synthase and is involved in mycobactin biosynthesis [22, 23], and later 
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was also found in some secondary metabolic genes clusters in Actinomycetes [24]. 
araC gene is positioned in opposite direction than the other genes and is most likely 
transcribed from a separate promoter. Nitric oxide synthase gene nos is positioned 
close to the transposon element, next to a putative cytochrome P450 hydroxylase, an 
enzyme likely involved in the secondary metabolism.  
 
All the thaxtomins that have been isolated so far from infected plant tissues have 4-
nitrotryptophyl in their structures. The nitration of tryptophan has been shown to 
occur in many Streptomyces species by the action of nitric oxide synthase (NOS). 
[25]. Bacterial nitric oxide synthase NOS performs formation of nitric oxide from 
arginine. Nitric oxide reacts with with tryptophan, generating 4-nitro-tryptophan. The 
positional targeting of nitration to the 4th position is achieved by complex formation 
between NOS and an unusual tryptoptophanyl-tRNA synthetase (TrpRS II), at least 
in Deinococcus radiodurans [26-29]. The trpSII gene is present in both S. coelicolor 
(SCO4839) and S. avermitilis (SAV3417) genomes, and we also detected a 
homologue in S. scabies (SCAB03561). TrpRS II charges tRNATrp with 4-nitro-
tryptophan. Another amino acid, which composes the thaxtomin dipeptide, is 
tryptophan. It is also attached to a specific tRNA. Both amino acid precursors are 
methylated, most probably by S-adenosylmethionine (SAM), because txtA and txtB 
carry SAM-dependent N-methyltransferase domains [14]. The methylated precursors 
are joined by two peptide bonds into thaxtomin D by TxtA and TxtB. The P450 
cytochrome TxtC hydroxylates thaxtomin D into thaxtomin B and further into 
thaxtomin A [30], most probably using ferredoxin as electron donor. The reactions 
that lead to thaxtomins biosynthesis are highlighted in Table 4-3. All these reactions 
were included in the model. 
4.3.3 Simulations 
Simulations were performed using linear programming software package LINDO API 
(LINDO Systems Inc., USA). An in-house program Bioopt was used as an interface to 
communicate the model stoichiometric matrix, flux limits and the optimization criteria 
to LINDO. 
We simulated single gene deletions and searched for the ones that eliminate 
thaxtomin A biosynthesis. 38 reactions were found for growth on minimal medium 
(data not shown). However, in real situation the parasite might be capable of getting 
amino acids from the plant host, therefore we then simulated gene deletions during 
growth on glucose and all twenty amino acids. Besides the reactions from thaxtomin 
pathway, only 6 other reactions were found that can eliminate thaxtomin 
biosynthesis. Five of these reactions are involved in S-adenosinemethionine 
metabolism and are catalyzed by methionine adenosyltransferase, 
adenosylhomocysteinase, methionine synthase, 5,10-methylenetetrahydrofolate 
reductase and flavin reductase. The last reaction, catalyzed by ribose-phosphate 
diphosphokinase was involved in nucleotides biosynthesis. Unfortunately, all of these 
enzymes also have analogues in plants (we looked at Arabidopsis thaliana) and 
hence are not suitable targets for management of S. scabies infections.  
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Table 4-3. Enzymes necessary for thaxtomins biosynthesis in S. scabies according 
to computer simulations. The highlighted enzymes are specific for thaxtomin 
pathway. 
 
Medium with amino 
acids Enzyme Gene Reaction 
Thaxtomins Growth 
tryptophanyl-tRNA synthase SCAB03561 
(trpSII) 
4-nitro-TRP + ATP + 
tRNA_trp -> 4-nitro-
TRP-tRNA_trp + PPI + 
AMP 
0% 100% 
nitric oxide synthetase SCAB03185 
(nos) 
ARG + 2 O2 + 1.5 
NADPH -> CITR + NO 
+ 1.5 NADP 
0% 100% 
nitric oxide synthetase SCAB03185 
(nos) 
NO + O2 + 0.5 NADH + 
TRP -> 4-nitro-TRP + 
0.5 NAD 
0% 100% 
phenylalanyl-tRNA synthase SCAB07402 
(alpha subunit) 
AND SCAB07403 
(beta subunit) 
PHE + ATP + 
tRNA_phe -> PHE-
tRNA_phe + PPI + 
AMP 
0% 100% 
SAM-dependent 
methyltransferase 
SCAB03179 
(txtA) AND 
SCAB03180 
(txtB) 
PHE-tRNA + SAM -> N-
methyl-PHE-tRNA + 
SAH 
0% 100% 
SAM-dependent 
methyltransferase 
SCAB03179 
(txtA) AND 
SCAB03180 
(txtB) 
4-nitro-TRP-tRNA + 
SAM -> N-methyl-4-
nitro-TRP-tRNA + SAH 
0% 100% 
non-ribosomal protein 
synthesis 
SCAB03179 
(txtA) AND 
SCAB03180 
(txtB) 
N-methyl-PHE-tRNA + 
N-methyl-4-nitro-TRP-
tRNA -> 
THAXTOMIN_D + 2 
tRNA 
0% 100% 
P450 cytochrome 
hydroxylase 
SCAB03177 
(txtC) 
THAXTOMIN_D + 
FERO + O2 -> FERI + 
THAXTOMIN_B 
0% 100% 
P450 cytochrome 
hydroxylase 
SCAB03177 
(txtC) 
THAXTOMIN_B + 
FERO + O2 -> FERI + 
THAXTOMIN_A 
0% 100% 
flavin reductase SCAB08267 OR 
SCAB05029 
FAD + NADH <-> 
FADH2 + NAD 
0% 0% 
methionine 
adenosyltransferase 
SCAB07532 MET + ATP -> PPI + PI 
+ SAM 
0% 0% 
ribose-phosphate 
diphosphokinase 
SCAB05417 OR 
SCAB00918 
R5P + ATP <-> PRPP 
+ AMP 
0% 0% 
adenosylhomocysteinase SCAB05519 SAH -> HCYS + ADN 0% 0% 
methionine synthase SCAB07333 HCYS + MTHF <-> 
THF + MET 
1% 69% 
5,10-
methylenetetrahydrofolate 
reductase (FADH2) 
SCAB06780 METTHF + FADH2 -> 
MTHF + FAD 
1% 69% 
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4.4 Conclusions 
In this work we performed fast reconstruction of the metabolic network of a plant 
parasite – Streptomyces scabies. We used two methods: automatic reconstruction of 
a template model using Pathway Tools and manual adaptation of an already 
available S. coelicolor A3(2) metabolic network [1].  
Pathway Tools is useful for fast automated reconstruction of the sequenced 
organisms. It uses the genome annotation to assign reactions to genes, naturally, the 
higher the quality of the annotation, the better the model. The software has many 
nice features, as predictors of proteins complexes, transporters and transcriptional 
units. One of the most useful features is pathway hole finder, which allows 
identification of enzymes that have been missed during annotation for one or another 
reason. The software is useful for storing various information about enzymes in an 
easily accessible form. It allows quick publication of the model on the World Wide 
Web and has navigation options that would allow the users to browse the network. 
The pathway genome database reconstructed in Pathway Tools can be readily used 
for interpretation of –omic data. There’s, however, one disadvantage: in our hands 
the construction of stoichiometric model from the Pathway Tools database was very 
tedious and time consuming. More features should be added to the program if it 
should be suitable for mathematical simulations. 
Reconstruction of basic S. scabies model from the previously made S. coelicolor 
model was fast. A great advantage was that the reconstruction was based on 
homology and hence did not depend on the genome annotation. Most of the genes in 
S. coelicolor model had homologues in S. scabies and hence most of reactions were 
common for these two species. We had to remove a few reactions (actinorhodin and 
calcium-dependent antibiotics biosynthesis and isocitrate lyase) and we added 
biosynthesis of thaxtomins. The model was used to simulate which reactions were 
essential for thaxtomin production in environment, which contains amino acids. S-
adenosinemethionine metabolism was found essential for thaxtomin biosynthesis. 
In conclusion, the choice of the metabolic model reconstruction technique depends 
on the purpose the model will have to fulfill. For data storage and distribution, and -
omic data interpretation reconstruction in Pathway Tools is a good option. For 
mathematical simulations, building up on the available models of related organisms 
can be more time efficient. 
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5.1 Abstract 
Streptomycetes are exploited for production of a wide range of secondary 
metabolites and there is much interest in enhancing the level of production of these 
metabolites. Secondary metabolites are synthesized in dedicated biosynthetic routes, 
but precursors and co-factors are derived from the primary metabolism. High level 
production of antibiotics in Streptomycetes therefore requires engineering of the 
primary metabolism. Here we demonstrate this by targeting a key enzyme in 
glycolysis, phosphofructokinase, leading to improved antibiotic production in 
Streptomyces coelicolor A3(2). Deletion of pfkA2 (SCO5426), one of three annotated 
pfkA homologues in S. coelicolor A3(2), resulted in a higher production of the 
pigmented antibiotics actinorhodin and undecylprodigiosin. The pfkA2 deletion 
strain had an increased carbon flux through the pentose phosphate pathway, as 
measured by 13C metabolic flux analysis, establishing the ATP-dependent Pfk as a 
key player in determining the carbon flux distribution. The increased pentose 
phosphate pathway flux appeared largely due to accumulation of glucose-6-
phosphate and fructose-6-phosphate, as experimentally observed in the mutant 
strain. Through genome-scale metabolic model simulations we predicted that 
decreased phosphofructokinase activity leads to increase in pentose phosphate 
pathway flux and in flux to pigmented antibiotics and pyruvate supposedly through 
increased production of NADPH and acetyl-CoA. Integrated analysis of gene 
expression data using the genome-scale metabolic model further revealed 
transcriptional changes in redox co-factors - dependent enzymes as well as in 
pentose phosphate pathway enzymes and enzymes involved in storage 
carbohydrates biosynthesis. 
5.2 Introduction 
Streptomyces are well known for their production of biologically active secondary 
metabolites, with almost two-thirds of all known natural antibiotics being produced by 
Streptomyces. The best genetically characterized strain is S. coelicolor A3(2), which 
produces pigmented antibiotics and has become the preferred model organism in 
Streptomyces research. 
Secondary metabolites are generally synthesized in dedicated biosynthetic 
pathways, but these are linked to the primary metabolism through the use of specific 
precursors and various cofactors. Although still largely unclear, the link between 
primary and secondary metabolism has been repeatedly observed (1-3). Thus, 
deletion of the glyceraldehyde-3-phosphate (G3P) dehydrogenase encoding gene 
gap1 improved clavulanic acid production in S. clavuligerus due to increased supply 
of precursor G3P (4). Furthermore, overexpression of acetyl-CoA carboxylase acc in 
S. coelicolor improved the yield of actinorhodin, which uses the ACC product, 
malonyl-CoA, as a precursor for actinorhodin biosynthesis (5). In another study 
deletion of important tricarboxylic acid cycle genes, such as citrate synthase (citA) or 
aconitase (acoA) in S. coelicolor, resulted in glutamate auxotrophy, overproduction of 
organic acids, as well as changes in secondary metabolite production and 
morphological differentiation (6,7). Polyphosphate kinase ppk gene inactivation in S. 
lividans was also shown to have effect on secondary metabolite production as it 
resulted in accumulation of polyphosphates and activation of actinorhodin production, 
which is normally silenced in this species (8-10). 
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In order to further evaluate the link between primary and secondary metabolism we 
decided to study the effect of phosphofructokinase (Pfk) on secondary metabolism in 
S. coelicolor. Pfk is a highly regulated enzyme in the conserved Embden-Meyerhof-
Parnas glycolysis pathway (EMP) catalyzing the phosphoryl transfer to the 1st 
position of the substrate fructose-6-phosphate. This enzyme is most commonly 
dependent on ATP as the source of the phosphoryl group and is allosterically 
regulated by a number of effectors. The reaction catalyzed by ATP-dependent Pfks is 
irreversible and therefore the six-carbon sugars are confined to the subsequent 
glycolytic reactions. This positions Pfk as a committed step for the EMP pathway at 
glucose-6-phosphate (G6P) branching node. Besides going to EMP pathway the 
G6P can enter pentose phosphate pathway or serve as precursor for carbohydrate 
polymers biosynthesis. Alteration of phosphofructokinase activity might influence the 
flux distribution at the G6P node and hence it is a high profile target for altering 
metabolic fluxes in the cell. 
The full genome sequence of S. coelicolor A3(2) (11) revealed the presence of three 
highly homologous pfkA genes (SCO2119, SCO5426 and SCO1214) with 56-72% 
identity and 69-82% similarity at the amino acid level. This number of copies is large 
when compared to closely related, less developmentally complex actinomycetes like 
Mycobacterium tuberculosis (12,13) and Corynebacterium glutamicum (14), which 
both contain only one pfkA gene. The biological reason for the presence of multiple 
copies of primary metabolic genes such as pfk is not known, and there is little 
information available about the regulation of primary metabolic isoenzymes in S. 
coelicolor. It is for instance not known whether expression of various isoenzymes is 
dependent on the developmental phase of a colony, or whether isoenzymes convey 
different kinetics. 
Previously, a S. coelicolor Pfk enzyme had been purified and characterized as 
described by Alves et al. (15). This ATP-dependent, allosterically controlled enzyme 
was linked to the pfkA1 gene (SCO2119). Studying the original N-terminal sequence 
of the protein purified in that study, however, revealed that the N-terminal sequence 
does not exactly fit the predicted PfkA1 N-terminus but has an identical match to the 
PfkA2 (SCO5426) enzyme N-terminus (Table 5-1). In this paper, we also report that 
PfkA2 is the only isoenzyme with detectable Pfk activity in S. coelicolor extracts (see 
below), which further confirms that the enzyme studied by Alves et al. is indeed 
PfkA2 (15) (pers. comm.). 
 
Table 5-1. Alignment of N-terminal sequences of all three S. coelicolor PFK 
isoenzymes and the N-terminal sequence of the previously purified S. coelicolor PFK 
as determined by Alves (15). 
PFKA1 MKVGVLTGGGDCPGLNAVIRAVVRKGVQEYGYDFTGFRDGWRGPLEGDTVPLDIPAVRGI 
N terminus   MRIGVLTAGGDXPGLNAVIXSVVXXAVDENNXGXXV------------------------ 
PFKA2        MRIGVLTAGGDCPGLNAVIRSVVHRAVDNYGDEVIGFEDGYAGLLDGRYRALDLNAVSGI 
PFKA3        MRIGVLTSGGDCPGLNAVIRSVVHRAVVDHGDEVIGFRDGWKGLLECDYLKLDLDAVGGI 
             *  **** *** *******  **   *            
Changing the flux distribution at the principal glucose-6-phosphate (G6P) node by 
modulating Pfk expression might be a tool to influence antibiotic production through 
increasing cofactor availability. Thus, shifting the flux towards the pentose phosphate 
pathway (PPP) may increase the NADPH production. Since the biosynthetic 
pathways for many polyketides require NADPH, this may result in enhanced 
biosynthesis of antibiotics. 
To evaluate whether PfkA2 in fact is controlling the flux distribution and whether there 
is a direct link between the fluxes in the primary metabolism and secondary 
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metabolism, we studied the effect of pfkA2 deletion on intracellular carbon fluxes, 
metabolite levels, gene expression, and secondary metabolite production in S. 
coelicolor. 
5.3 Experimental procedures 
5.3.1 Alignment 
Construction of the alignment of N-terminal sequences of all three PFK isoenzymes 
and the N-terminus as determined by Alves et al. (15) was done using ClustalX. 
5.3.2 Strains 
The S. coelicolor M145 (SCP1-, SCP2-) strain used for construction of the pfkA 
single gene deletions was kindly supplied by Matthias Redenbach. The ordered 
cosmid library made from this strain (16) was used in the S. coelicolor genome 
sequencing project (11). Later genotyping of the strain indicated a possible 
duplication of 20 genes (SCO4672-4695) mostly coding for proteins of unknown 
function. No gene was found underrepresented in this strain. The reference strain 
used for metabolic flux analysis was S. coelicolor M145, which was a gift from 
Mervyn Bibb, John Innes Centre, UK. To ensure that the unintended duplication in 
the Redenbach parental strain did not influence the observed phenotype, we also 
have deleted pfkA2 in the reference M145 strain. No morphological differences 
between M145 and the Redenbach strain, or between the pfkA2 mutants thereof, 
were observed on plates or in liquid complex medium. Ten genes from the duplicated 
region, most of them assigned as hypothetical proteins, were found to be 
overexpressed in the Redenbach ∆pfkA2 mutant as compared to the reference 
M145. 
The single gene deletion mutants ∆pfkA1, ∆pfkA2 and ∆pfkA3 were constructed by 
lambda-mediated recombination in E. coli according to the REDIRECT protocol (17). 
The REDIRECT strategy is based on replacement of a chromosomal sequence within 
an S. coelicolor cosmid (16) by a selectable marker. This marker is PCR generated 
using primers with 39 nt homology extensions. These homology extensions are 
designed to match the immediate flanking regions of the genes targeted allowing 
stable in frame, full length gene replacements.  
The pfkA1 gene was fully replaced with a viomycin resistance cassette, which was 
amplified from plasmid pIJ780. The pfkA2 and pfkA3 genes were replaced by an 
apramycin resistance cassette generated by PCR from plasmid pIJ773. The primers 
used in this process are listed in Table 5-2. The strains were maintained on master 
plates of mannitol soy flour (MS) agar (18) containing 50 µg/ml apramycin/viomycin 
for the mutants. The cells from the master plates were streaked onto fresh MS plates, 
from which spores were harvested to make dense spore plates. The dense spore 
plates provided inocula for further studies. 
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Table 5-2. Nucleotide sequence of primers used for 	RED–mediated deletion of the 
pfkA genes. The universal 5’ and 3’ ends of the disruption cassette are underlined. 
REDIRECT primers sequence (5’ – 3’) 
PfkA1 forward GGCCTCAACCACCCACCCTGGCAAAGGGG 
TTGTGCGATGATTCCGGGGATCCGTCGACC 
PfkA1   reverse ACCGCCGTCGCCGGTCAGCGGCCGTTCCG 
CCGGACGTCATGTAGGCTGGAGCTGCTTC 
PfkA2 forward TCACCGGTGTCAACAGCGAGCAGGAGACA 
CAGCACGATGATTCCGGGGATCCGTCGACC 
PfkA2   reverse TGGACGGCGGTCGAGAGGCACCCCTAGAG 
GGGAGGCCTATGTAGGCTGGAGCTGCTTC 
PfkA3 forward CCGGACCCGTGCCACGTTGAGAAGGTATTT 
CGGGCTATGATTCCGGGGATCCGTCGACC 
PfkA3   reverse GCGAATCACCTCAAGGCCCGAGCTCCGACC 
GGCAGGTCATGTAGGCTGGAGCTGCTTC 
5.3.3 Batch cultivations for metabolic flux analysis and transcription analysis 
Batch cultivations were performed in fermenters with 1 L working volume (Applicon, 
USA) at 30ºC, pH 6.8-7.0, 800 rpm agitation rate, and a 1 vvm aeration rate. The 
fermentors were equipped with a cooled condenser to avoid evaporation from the 
medium. pH was controlled by automatic addition of 1 N NaOH. The aeration rate 
was adjusted after every sampling to compensate for working volume reduction. The 
concentrations of CO2 and O2 were monitored by an acoustic gas analyzer (1311, 
Bruël & Kjær, Denmark). 
The defined minimal medium was limited in phosphate and contained 3 mM 
NaH2PO4, 100 mM NH4Cl, 10 mM KCl, 2 mM Na2SO4, 2 mM citric acid as chelating 
agent, 1.25 mM MgCl2, 0.25 mM CaCl2, as well as per liter: 20 g glucose, 5 ml trace 
elements solution (20 mM FeCl3, 10 mM CuCl2, 50 mM ZnCl2, 10 mM MnCl2, 0.02 
mM Na2MoO4, 20 mM CoCl2, 10 mM H3BO4), 1 ml vitamins solution (0.05 g biotin, 1 
g Ca-pantothenate, 1 g nicotinic acid, 25 g myo-inositol, 1 g thiamine-HCl, 1 g 
pyridoxine-HCl and 0.2 g para-aminobenzoic acid per liter), and 100 µl organic 
antifoam 204 (Sigma-Aldrich, USA). All components, except glucose and vitamins, 
were added to the MilliQ water (Millipore, USA) in the fermenter and autoclaved at 
121ºC for 40 min. Glucose and vitamins were added after autoclaving and pH 
adjustment by sterile filtration. 30% of the added glucose for the labeled cultivations 
consisted of 1-13C-glucose (Omicron Biochemicals Inc., USA). 
The inoculum for each fermenter was prepared as follows: spores from one dense 
spore plate were harvested with 2 ml 20% sterile glycerol, filtered through glass fiber 
wool to get rid of mycelial fragments and inoculated into a 500 ml volume baffled 
shake flask with 50 ml 2xYT medium (18) and 30 glass beads (ø3 mm). The culture 
was incubated at 30°C and 150 rpm agitation for 12 h, centrifuged at 3,000 g for 5 
min, resuspended in 3-5 ml of residual liquid and immediately inoculated into a 
fermenter.  
5.3.4 Analysis of biomass dry weight 
Throughout cultivation 12 ml samples were taken. Of these samples 8 ml was filtered 
through pre-dried Supor®-450 membrane filters (0.45 µm pore, Pall Corporation, 
USA). The filtrate was collected in a pre-cooled tube and kept at -20ºC until 
extracellular metabolite analysis. The cells were washed twice with 0.9% sodium 
chloride, dried in a microwave oven at 150 W for 20 min after which the dry weight of 
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the biomass was calculated. The remaining 4 ml of the sample was divided into 2x2 
ml portions and kept at -20ºC for antibiotic analysis. 
5.3.5 Shake flasks cultivations for analysis of antibiotics, intracellular sugar 
phosphates and carbohydrates 
The defined mineral medium for the shake flasks cultivation was the same as 
described for the batch cultivations, but contained 40 g per liter of glucose instead of 
20 g per liter, and was supplemented with 50 mM 2-(N-morpholino)ethanesulfonic 
acid for buffering purposes. The pH of the medium was adjusted to 6.8 before 
autoclaving. 
The cultivations were performed in 500 ml baffled shake flasks with 50 ml defined 
medium and 30 glass beads (ø3 mm). The cultures were kept at 30ºC on a shaking 
table with an agitation speed of 150 rpm. 
The inoculum for shake flasks was prepared in the same way as for the fermenters, 
except for the centrifugation step. Preculture (2.5 ml) was added directly to each 
shake flask (5% v/v). 
5.3.6 Shake flask cultivations for antibiotic phenotyping in complex medium 
Streptomyces strains used were grown under standard conditions in 200 ml R2YE 
medium (18). The 1 L flasks were inoculated with 106 spores per ml of medium. 
Spores were pregerminated for 15 min at 50°C in TY medium (18) and spun down 
(15 min, 16,100xg). Most of the supernatant was removed before inoculation. The 
cultures were grown in 1 L shake flasks equipped with stainless steel spirals at 30°C 
while shaken at 200 rpm. 
5.3.7 Actinorhodin and undecylprodigiosin quantifications 
To extract actinorhodin, 2 ml 3 N KOH was added to a 2 ml sample, vortexed and left 
shaking overnight at +2ºC. The suspensions were centrifuged at 4,000xg for 10 min 
and the absorbance of the supernatant was measured at 640 nm. The actinorhodin 
concentration was calculated based on an extinction coefficient of 25,320 M-1cm-1 
(19). Undecylprodigiosin was extracted in the same manner but with methanol 
acidified to pH 1.5 with HCl in a tube with ø0.25-0.5 mm glass beads. The extinction 
coefficient of undecylprodigiosin used was 100,500 M-1cm-1 at 530 nm (20). 
5.3.8 Analysis of extracellular metabolites 
A range of extracellular metabolites including glucose were analyzed by HPLC using 
an Aminex HPX-87H column (Bio-Rad Laboratories, USA). The operating 
temperature was 60°C. Separation was achieved using 5 mM H2SO4 at a flow rate of 
0.6 ml/min. The HPLC was equipped with a Waters 410 differential refractometer 
(Millipore, USA) and a tunable absorbance detector set at 210 nm (Waters 486, 
Millipore, USA). Glucose, glycerol, succinate, and ethanol were quantified using a 
refractometer whereas acetate and pyruvate were quantified by UV absorbance. A 
calibration curve was made using 6 different metabolite concentrations. 
5.3.9 Analysis of intracellular sugar phosphates concentration 
Cells from triplicate shake flask cultures were quenched in cold methanol and then 
extracted with chlorophorm (pH 7), according to a slightly modified method from de 
Koning and van Dam (21). Cell culture (10 ml) was used to determine biomass dry 
weight in order to calculate the sugar phosphate portion per g dry weight. Cell 
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suspension (5 ml) was sprayed into 20 ml 60% (v/v) methanol buffered with 12.5 mM 
tricine (pH 7.4) and kept in a -40ºC ethanol bath. The cells were centrifuged for 5 min 
at 4,000xg at -20 ºC. The supernatant was collected and kept at -80ºC until further 
analysis. Pure methanol (2.5 ml) was added to the cell pellet, after which the tube 
was immersed in liquid nitrogen and stored at -80ºC. The extraction was performed 
by shaking the tubes at -20ºC overnight at 300 rev/min after addition of 5 ml 
chlorophorm, 2 ml of buffer (3 mM tricine, 3 mM EDTA, pH 7.0), and glass beads 
ø0.25-0.5 mm. The mixture was centrifuged at 1,200xg for 12 min at -20ºC and the 
upper phase was collected. Pure methanol (2 ml) was added to the remaining 
chlorophorm and cells, vortexed, separated by centrifugation, and pooled with the 
first portion of the extract. The extract and the quenching liquid were freeze-dried and 
the solid matter was redissolved in 1 ml MilliQ water.  
Glucose-6-phosphate (G6P) and fructose-6-phosphate (F6P) were analyzed in an 
enzymatic assay with G6P-dehydrogenase (G6P-DH) and phosphoglucose 
isomerase (Pgi) by fluorimetric measurement of NADPH formation on Perkin Elmer 
Luminescence spectrometer LS50B set at 340 nm for excitation and 456 nm for 
emission. The reaction was carried out at room temperature in 250 mM 
triethanolamine buffer with 0.025 mM NADP+. The sample was added to the buffer 
and the baseline absorbance was measured after which 1 unit of G6P-DH was added 
per ml. The increase in absorbance was measured after 5-7 min. The increase in 
absorbance, and thus NADPH, is proportional to the conversion of G6P. The 
additional increase in absorbance after addition of Pgi corresponds to the amount of 
F6P converted.  
G6P and F6P amounts were calculated from the calibration curves, which were linear 
in the 0 to 10.5 nM range. The samples fell within the range of the calibration curve. 
Some of the samples were measured a few times to determine the measurement 
error, which was not higher than 5%.  
5.3.10 Measurement of carbohydrates content 
The samples for measurement of carbohydrate content were collected during the 
stationary phase when the triplicate shake flask cultures became red indicating 
undecylprodigiosin production. Sample (5-10 ml) was centrifuged at 10,000xg for 10 
min, washed twice with distilled water and freeze-dried. 5 mg of dried sample was 
then dispersed in 1 ml distilled water. To this mixture 2 ml of 0.5% anthrone in 70% 
sulfuric acid was added (22). The sample was boiled in a water bath for 20 min, 
cooled to room temperature, and absorbance was measured at 625 nm and 
compared to a glucose standard curve. 
5.3.11 Measurement of amino acids labeling and estimation of metabolic fluxes 
For the labeled cultivations additional samples of 5-10 ml were withdrawn. The 
biomass was centrifuged at 10,000xg for 5 min, washed twice with cold 0.9% NaCl 
and kept at -20ºC until further analysis. The biomass was hydrolyzed with 6 N HCl at 
105ºC and then derivatized as described in Christensen et al. (23). The labeling of 
amino acid fragments was measured by GC-MS (23). The labeling of each fragment 
was expressed as summed fractional labeling (SFL) determined by the formula:  
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where in is the peak intensity of mass isotopomer with n 13C atoms. The data was 
corrected for natural isotope abundance before usage (23).  
The labeling data together with growth parameters and cellular composition were 
used to calculate fluxes by an algorithm from Wiechert (24) implemented in an in-
house software package based on Matlab (The MathWorks Inc., USA). The cellular 
composition was taken from Borodina et al. (25), except for protein composition, 
which was specifically determined for S. coelicolor cultivations on a defined mineral 
medium (26) (Appendix 5.1). 
5.3.12 Diamide sensitivity assays 
Diamide sensitivity assays were performed as described previously (3,27). Halo 
surfaces were determined after 48 h of incubation at 30°C. 
5.3.13 Sampling for microarray analysis and RNA isolation 
The samples for gene expression analysis were taken during the exponential growth 
phase, when the carbon dioxide concentration in the outlet gas was 0.1%, 
corresponding to approximately 2 g/L of dry weight biomass. Samples of 20 ml were 
withdrawn quickly and sprayed into 50 ml falcon tubes filled with crushed ice resulting 
in almost immediate cooling down to 0-2 ºC. The mixture was shaken and centrifuged 
at 4,000 g for 1 min. The supernatant was decanted, the cells were immersed in 
liquid nitrogen and then stored at -80ºC until RNA extraction. The total time spent on 
the sampling procedure did not exceed two minutes. 
Total RNA extraction was performed with an RNeasy kit (QIAGEN GmbH, Germany) 
using a FastPrep FP120 (3x40”, Qbiogene Inc., USA) for breaking the cells. After the 
removal of cellular debris additional steps were performed: two rounds of 
phenol:chlorophorm:isoamylalcohol (pH 8) extraction and 1 round of chlorophorm 
extraction. The rest of the procedure was according to the manufacturer’s 
instructions. The total RNA was subjected to DNase digestion and then concentrated 
from the reaction solution using an RNeasy CleanUp kit (QIAGEN GmbH, Germany). 
The quality of RNA was assessed on a Bioanalyzer (Agilent, USA) to ensure that no 
degradation of 23S RNA of 16S RNA had occurred. 
5.3.14 Microarray analysis 
The arrays were spotted oligonucleotide arrays (University of Surrey fabricated 
oligonucleotide (50 mer) microarrays), containing duplicate spots of probes for 7337 S. 
coelicolor genes. Each probe was 50 nucleotide bases long and was designed for 
minimal cross-hybridization with other genes.  
The RNA samples were labeled and hybridized to the arrays according to the 
procedure described on http://www.surrey.ac.uk/SBMS/Fgenomics/Microarrays. The 
design included three biological replicates for the reference strain and two biological 
replicates for the ∆pfkA2 mutant as well as dye swaps. Only two biological replicates 
were analyzed in case of ∆pfkA2 because one of the RNA preparations did not pass 
the quality control. We applied loop design (28), where samples were compared 
directly to each other without a common reference (Appendix 5.2). 
5.3.15 Array image analysis and data normalization 
The arrays were scanned using an Affymetrix 428 laser scanner (Affymetrix Inc., 
USA). Image analyses were carried out using BlueFuse software (BlueGnome 
Limited, UK), which allows automatic grid alignment, spot boundary detection, 
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background substraction, and signal intensities estimation. The quality of the spots 
was scored 0 or 1 (0 for bad quality, 1 for good) depending on spots radius, 
circularity, uniformity, and grid offset. The raw data can be found in Gene Expression 
Omnibus (http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE7686. 
For the data analysis we used MAANOVA program 
(http://www.jax.org/staff/churchill/labsite/software/Rmaanova) implemented in R statistical 
package (http://www.r-project.org). The raw signal intensities from two spots 
corresponding to each gene were log2 transformed, normalized within arrays using 
regional lowess method, which is a combination of intensity-based and special 
lowess methods (29). The normalized data was fitted into ANOVA model. The 
ANOVA model was a fixed effect linear model with variance terms due to array, dye 
and strain effects (30). The differentially expressed genes were found by permutation 
test (30). Only genes that had at least one quality spot per each array were 
considered. 
5.3.16 Identifying reporter metabolites and significantly co-regulated metabolic 
Subnetworks 
An algorithm by Patil et al. (31) and a S. coelicolor genome-scale metabolic model 
(25) were used for identifying reporter metabolites and transcriptionally co-regulated 
metabolic subnetworks. 
5.3.17 Metabolic modeling 
A genome-scale metabolic model of S. coelicolor A3(2) containing 700 unique 
reactions was used for metabolic modeling (25). For calculating fluxes in the wild 
type strain the glucose uptake rate was set to the experimental value and the fluxes 
through NADP+-dependent glucose-6-phosphate 1-dehydrogenase (G6P-DH), 
phosphofructokinase, isocitrate dehydrogenase, and through the reactions leading 
from pyruvate to acetyl-CoA, were constrained to the values determined from 13C 
metabolic flux analysis (MFA) for the wild type strain. The flux distribution was 
obtained by linear optimization for growth using the LINDO program (Lindo Systems 
Inc., USA). To simulate the fluxes in the mutants the flux through 
phosphofructokinase was set to decreasing values and the new flux distribution was 
found by using the MOMA approach (32) using in-house developed software (33). 
5.3.18 Reverse Transcriptase-PCR 
RNA for RT-PCR was isolated according to van Keulen et al. (34) in which the usage 
of Tri®Reagent (Sigma) is combined with the usage of the SV total RNA isolation kit 
of Promega. RNA (5 
g) was mixed with 0.5 
l of 10x hexanucleotide mix (Roche), 
RNase-free DNaseI (Promega) and MilliQ until a final volume of 12 
l. This mixture 
was then heated to 70°C for 10 min after which 4 
l 5x first strand buffer for 
SuperScriptII (Invitrogen), 2 
l 0.1 M DTT, and 1 
l 10mM dNTP mix (Roche) were 
added. This mix was incubated for 10 min at 25°C before adding 1 
l RNaseOut (10 
U/
l, Invitrogen) and 1 
l SuperScript™II Reverse Transcriptase (200 U/
l, 
Invitrogen). During the incubation period at 42°C (1 h) cDNA is made of the total RNA 
batch. 
The PCR on cDNA template was performed with the primers listed in Table 5-3. The 
internal fragments amplified are in the range of 520-530 bp. The PCR mix contained 
10-100 ng cDNA, 1 pmol/
l of both forward and reverse primer, 2.5 mM MgCl2, 5% 
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dimethylsulfoxide (DMSO) and 1 U of Taq polymerase (Sigma). The annealing 
temperature was 56.5°C and 40 cycles were applied. 
Table 5-3. Nucleotide sequences of primers used for amplifying internal pfkA 
fragments in RT-PCR. 
 
RT primer Sequence (5’ – 3’) 
RT PFK1 forward GACGGCATCCGGCGCATCAA 
RT PFK1 reverse TCTGCTTGGCCAGCCATTCG 
RT PFK2 forward GCGAGGCCTGCGAGAACGCG 
RT PFK2 reverse AGCGCGGTGCCGATGCCCTG 
RT PFK3 forward GGACGGCGTGGAGCGGGCCC 
RT PFK3 reverse AGCTGGCGGGCGATCCCGGC 
 
Restriction analysis on the RT-PCR products was performed following standard 
procedures in order to determine the authenticity of the products. High similarity of 
the pfkA genes causes cross annealing of the primers producing aspecific RT-PCR 
products. To verify identity of pfkA1, pfkA2, or pfkA3 specific products, the PCR 
product was cut, respectively with SacII, BglI, or HaeII (Figures 5-1 and 5-2). As a 
control, a restriction was performed with any two of the aforementioned restriction 
enzymes. The RT-PCR products obtained were purified and concentrated prior to 
digestion using a Sigma GenEluteTM PCR Clean-Up Kit. 
 
Figure 5-1. Schematic representation of the restriction digestion procedure used for 
confirming pfkA products in Reverse Transcriptase-PCR. Presence of recognition 
sites in the pfkA internal fragments for any of the three restriction endonucleases 
mentioned at the left of the scheme is symbolized with an X. 
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Figure 5-2. A. RT-PCR data on S. coelicolor A3(2) reference strain cDNA template, 
created from total mRNA isolated. From left to right RT-PCR products are shown that 
were obtained using pfkA1, pfkA2, pfkA3, and 16S primers. B. Restriction fragments 
of PCR products obtained by RT-PCR. Lane 1 represents pfkA2 specific PCR 
product amplified from the S. coelicolor A3(2) reference strain cDNA pool of which 
any false positive signals have been removed by restriction digestion (see figure 5-1). 
Lane 2 shows confirmed positive pfkA3 signal obtained from reference strain cDNA. 
Lane 3 is pfkA3 product obtained from pfkA2 cDNA and confirmed by restriction 
analysis. M is the marker. 
 
A.       B. 
  
5.3.19 Preparation of extracts and enzyme activity assays 
Cells used for activity assays were harvested after 67 h of growth in 200 ml defined 
medium in a 1 L flask equipped with a stainless steel spiral. Cells were harvested by 
centrifugation and resuspended in buffer containing 50 mM TES [N-
tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid] (pH 7.2), 5 mM MgCl2, 5 mM 
2-mercaptoethanol, 50 mM (NH4)2SO4, and 0.1 mM phenylmethylsulfonyl fluoride 
(buffer A), and disrupted by sonication until >90% of the cells were lysed. 
Pfk activity assays were based on the consumption of NADH in a coupled assay, 
according to Alves et al. (1997) (15). G6P-DH (EC 1.1.1.49) assays were based on 
the production of NADPH and performed according to the protocol of Lessie and 
Vander Wyk and modified by Butler et al. (3). Both the consumption of NADH and the 
production of NADPH were measured spectrophotometrically at 340 nm. Protein 
concentrations were determined using the Bio-Rad protein assay reagent and a BSA 
based standard curve. 
5.4 Results 
5.4.1 Deletion of phosphofructokinase isoenzymes influences antibiotic 
production 
The S. coelicolor reference strain as well as its isogenic mutants ∆pfkA, ∆pfkA2 and 
∆pfkA3, were grown in complex (R2YE) media in shake flasks and the pigmented 
antibiotics actinorhodin (ACT) and undecylprodigiosin (RED) were quantified in the 
course of several days (Figure 5-3). 
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Figure 5-3. Quantification of undecylprodigiosin (Red, A) and actinorhodin (Act, B) in 
R2YE grown pfkA deletion cultures. Concentrations of Red and Act produced were 
determined after 28, 48, and 64.5 hours of growth in shake flasks corresponding to 
exponential, early stationary and late stationary phases. 
 
 
Morphology of the pfkA single deletion mutants did not differ from that of the parent 
strains, neither in liquid media nor on solid media. When grown in R2YE liquid 
medium the ∆pfkA2 mutant had a 2-6 fold increased antibiotic production compared 
to the reference strain. This was in contrast with the pfkA1 and pfkA3 single deletion 
mutants, which produced ACT and RED in quantities comparable to that of the 
reference strain. The ACT and RED overproduction by the pfkA2 deletion strain was 
most pronounced after 64.5 h of growth when the culture entered the stationary 
phase. The ACT and RED overproduction phenotype in ∆pfkA2 was also observed in 
defined medium (Figure 5-4). Because of its antibiotic overproduction characteristics, 
the ∆pfkA2 strain was selected for more detailed analysis. 
 
Figure 5-4. Antibiotics production by reference and ∆pfkA2 mutant strains during 
growth in shake flasks in defined medium. The error bars indicate standard deviation 
between biological triplicates. 
 
5.4.2 Deletion of pfkA2 influences biomass yield 
The reference M145 strain and the ∆pfkA2 mutant were grown in phosphate-limited 
defined mineral medium with glucose as the only carbon source in well-controlled 
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fermenters to estimate growth parameters (Table 5-4). The maximal specific growth 
rates were not significantly different when accounting for the standard deviation 
(0.09±0.02 h-1 and 0.11±0.01 h-1), however, the mutant had a lower biomass yield on 
glucose (0.31±0.02 against 0.39±0.02 g [dry weight]/g glucose). The mutant strain 
was also characterized by a slightly larger specific carbon dioxide production, 54±7 
mmol CO2/g (dry weight) compared to 44±7 mmol CO2/g (dry weight) in the reference 
strain (93% confidence level). HPLC analysis of the fermentation broth of the ∆pfkA2 
cultures revealed the presence of small amounts of acetate, which was not found in 
the reference cultivations. 
 
Table 5-4. Growth parameters of reference and ∆pfkA2 mutant strains as determined 
in controlled fermentations in defined medium. The values for the reference strain are 
average values from three cultivations and the values for the mutant are averaged 
from duplicate cultivations.  
Growth parameters M145** M145∆pfkA2*** 
Maximal specific growth rate, µmax, h-1 0.11±0.01 0.09±0.02 
Biomass yield on glucose, YSX, g (dry weight)·g glucose-1 0.39±0.02 0.31±0.02 
Specific glucose uptake rate, rs, mmol glucose·g (dry weight)-1·h-1 1.57 1.61 
CO2 yield on glucose, YSC, mmol CO2·g (dry weight)-1 44 ±7 54 ±7 
Carbon balance closure* 94±9% 84±4% 
* Assuming 5% ash content in the biomass and average biomass composition CH1.81O0.58N0.2S0.004P0.01 
** Average values and standard deviations calculated from 4 independent cultivations 
*** Average values and standard deviations calculated from 3 independent cultivations 
5.4.3 The ∆pfkA2 strain accumulates glucose-6-phosphate 
We speculated that limited phosphofructokinase capacity in the ∆pfkA2 strain 
resulted in intracellular accumulation of the substrate for this enzyme - fructose-6-
phosphate. As the isomerisation between F6P and G6P is generally close to 
equilibrium, we expected to see elevated levels of G6P as well. Both strains were 
grown in triplicate shake flasks and the samples for intracellular sugar phosphate 
analysis were taken 24 h after inoculation. At this point the biomass concentration 
was about 2 g/L and the cells were in the exponential growth phase. Cold methanol 
quenching was applied. Because previous reports on actinomycetes (35) suggest 
leakage caused by cold shock, we measured the sugar phosphates both in extracts 
of biomass and in the quenching liquid. Indeed, we found that 94-97% of the 
metabolites had leaked out of the cells during the quenching with cold methanol. The 
method was, however, still suitable for our assay, because G6P and F6P do not 
freely diffuse across membranes and are normally not found outside cells; all sugar 
phosphates in the quenching liquid should therefore be of intracellular origin. 
Glucose-6-phosphate concentration was higher in the mutant (6.9±0.2 µmol/g [dry 
weight]) than in the reference strain (5.2±0.4 µmol/g [dry weight]). Fructose-6-
phopshate concentration was also higher at 90% confidence level: 1.9±0.4 µmol/g 
[dry weight] for the mutant and 1.4±0.4 µmol/g [dry weight] for the reference strain. 
The ratio between F6P- and G6P concentrations was 1:3.6 in both strains. The 
results were consistent with data in yeast, where deletions of one or two subunits of 
phosphofructokinase also resulted in accumulation of intracellular hexose 
monophosphates (36, 37). Another reported effect in yeast is the accumulation of 
storage carbohydrates glycogen and trehalose (37), carbohydrates that are also 
produced by S. coelicolor (38-40). We could not detect glycogen in the late stationary 
phase of the liquid cultures of either the reference or the mutant strain (data not 
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shown). The total carbohydrate content in stationary phase cultures was not 
significantly different between the two strains: 13±3% of dry weight for the reference 
strain and 15±2% for the mutant. 
5.4.4 The ∆pfkA2 strain has an increased flux through the pentose phosphate 
pathway 
Fermentations with the M145 and ∆pfkA2 strains were performed with 30% 1-13C-
labeled glucose as the carbon source. Samples for biomass measurements were 
taken during cultivations and the labeling of proteinogenic amino acids was 
measured using gas chromatography coupled to mass spectrometry (GC-MS). 
Labeling of most of the amino acids fragments followed first order kinetics according 
to the equation: SFL=SFL0+(SFL-SFL0)×(1-e-µt) (Figure 5-5, Appendix 5.3), where 
SFL0 stands for initial labeling of the fragment and SFL describes the steady state 
labeling after all the unlabeled proteins from the inoculum cells had been substituted 
by proteins synthesized from labeled glucose. 
 
Figure 5-5. SFL values of leucine, alanine, aspartate, valine and isoleucine 
fragments as a function of time in the S. coelicolor A3(2) reference strain (the number 
next to the amino acid abbreviation is m/z value). The labeling of the amino acids 
fragments follows first order kinetics. Fermentations with the S. coelicolor A3(2) 
reference strain and the ∆pfkA2 strain were performed with 30% 1-13C-glucose as 
carbon source. Samples for biomass measurements were taken during cultivations 
and the labeling of proteinogenic amino acids was measured using gas 
chromatography coupled to mass spectrometry (GC-MS). 
 
Labeling of most of the fragments had reached steady state by the end of the 
exponential phase. There were no clear changes in the labeling of amino acids after 
the end of the exponential growth phase, implying that flux distribution in the 
stationary phase was similar to that of the exponential phase. SFL values together 
with growth parameters were used to calculate the intracellular fluxes (Figure 5-6, 
Appendix 5.3).  
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The label distribution in the amino acids reflects the pathways by which amino acid 
precursors were synthesized. Labeling of alanine and valine gives information about 
the glycolytic pathway, which leads to the formation of pyruvate. With an active 
Entner-Doudoroff (ED) pathway present, half of the pyruvate made from 1-13C-
glucose would be labeled at the carboxylic group (1st position). The percentage of 
labeling of that atom was around 3% (deduced from fragments Ala158, Ala116, 
Ala99) and close to the natural labeling of 1.1% (Appendix 5.3). Also the 1st and 2nd 
atoms of phosphoenolpyruvate (fragment Phe143) were slightly labeled. Therefore 
we conclude that the label in pyruvate was not supplied by an ED pathway, but was 
the result of scrambling in the PP pathway and/or activity of phosphoenolpyruvate 
carboxykinase or malic enzyme, feeding label from the TCA cycle. In the oxidative 
branch of the pentose phosphate pathway the 1st carbon atom of glucose does not 
get incorporated in pyruvate but is oxidized, producing carbon dioxide. In case of 
glucose labeled in the C1 position, the label will be lost and all pyruvate resulting from 
this pathway will be non-labeled. The higher the flux through the PP pathway, the 
fewer 13C heavy isotopes will get incorporated into pyruvate and into TCA cycle 
intermediates. In the reference S. coelicolor strain the labeling of pyruvate 2nd and 3rd 
carbon atoms at the end of cultivation (Ala99, Ala116) reached 16.4-16.6%, which is 
close to the theoretical maximum if all pyruvate is generated through the EMP 
pathway, meaning that the pentose phosphate flux was very low. For the mutant 
strain the corresponding labeling value was 14.2-14.5%, indicating higher PP flux. 
The labeling of pyruvate and TCA cycle intermediates (oxaloacetate and α-
ketoglutarate) was lower in the ∆pfkA2 strain, which also indicates a higher flux 
through the PP pathway in the mutant. The labeling of acetyl-CoA 2nd carbon atom as 
calculated from fragment Leu158 was lower than the labeling of the 3rd carbon atom 
than pyruvate. It means that not all acetyl-CoA is coming directly from pyruvate, but 
some can be supplied through other pathways that have lower labeling. It could be 
phosphoketolase pathway. Phosphoketolase Xpk (E.C. 4.1.2.9) catalyzes the 
cleavage of xylulose-5-phosphate into glyceraldehyde-3-phosphate and acetyl-
phosphate as well as cleavage of fructose-6-phosphate into erythrose-4-phosphate 
and acetyl-phosphate. The activity of this enzyme has been measured mostly during 
growth on pentoses in Bifidobacteria (36,37), several Lactobacillus species (38,39), 
Saccharomyces cerevisiae (40) and others. BLASTing with Xpk protein sequence of 
Bifidobacterium adolescentis against the whole genome of S. coelicolor A3(2) gave a 
hit to a probable phosphoketolase SCO0617 with 49% identity. In the initial genome 
annotation this protein was noted as hypothetical (11). 
For flux calculations we included the EMP and PP glycolytic pathways, 
phosphoketolase reactions and the tricarboxylic acid cycle. The anaplerotic 
glyoxylate shunt was considered to be inactive on glucose (41), so only pyruvate- 
and PEP carboxylases were included. It is not possible to discriminate between these 
two reactions with high confidence when the 1st carbon of pyruvate is not labeled, 
hence the summed anaplerotic flux is shown in Figure 5-6. We did not account for 
acetate secretion since only small amounts below 0.1 g/l were detected in the late 
broth samples of the mutant strain. 
For S. coelicolor M145, 7% of the imported glucose went into the oxidative branch of 
the pentose phosphate (PP) pathway (Appendix 5.4). This pathway is involved in 
generation of precursors for nucleotide biosynthesis (ribose-5-phosphate) and 
aromatic amino acids (erythrose-4-phosphate). Because there was no back-flux from 
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the PP pathway into glycolysis, the main role of the PP pathway was generation of 
biomass precursors. 
In the ∆pfkA2 mutant strain as much as 50% of the imported glucose was shunted 
towards the pentose phosphate pathway. As the amount of precursors generated in 
this case exceeded the demand, most of the carbon entering the PP pathway was 
further shuffled through phosphoketolase into glyceraldehyde-3-phosphate and 
acetyl-phosphate. The oxidation of glucose-6-phosphate into ribulose-5-phosphate 
usually leads to production of two NADPH molecules. In S. coelicolor the cofactor 
specificity of two glucose-6-phosphate-1-dehydrogenases (zwf1 and 2, SCO6661 
and SCO1937 respectively) and of 6-phosphogluconate dehydrogenase (zwf3, 
SCO0975) has been determined (5). Both enzymes are NADP+-dependent which 
means that there was an increased NADPH production in the mutant strain. By the 
action of phosphate acetyltransferase acetyl-phosphate can be converted into acetyl-
CoA, which further enters TCA cycle, fatty acid metabolism, secondary metabolism, 
etc. Acetyl-phosphate can also be hydrolyzed by acylphosphatase into acetate. 
The flux through the TCA cycle and through the anaplerotic pathways did not differ 
much between the reference and the mutant strains. 
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Figure 5-6. Changes in intracellular fluxes in the ∆pfkA2 mutant strain compared to 
the S. coelicolor A3(2) reference strain. The standard deviation of flux estimation did 
not exceed 5%. All fluxes are expressed in mmol/g(dry weight)/h. The enzymes that 
are part of significantly co-regulated metabolic subnetwork are highlighted. The 
whole subnetwork can be found in Appendix 5.6. Genes up-regulated in the mutant 
are shown in red and down-regulated in green. The reaction catalyzed by 
phosphoketolase and leading from fructose-6-phosphate into erythrose-4-phosphate 
and acetyl-phosphate is not shown to avoid crowdiness of the figure. The flux 
through it was 0.02 for the reference strain and 0.00 for the mutant strain. 
 
5.4.5 The ∆pfkA2 strain produces more NADPH 
To test whether the increased flux through the PP pathway in the mutant led to 
NADPH overproduction, we examined the diamide sensitivity of the strains. The test 
was previously used for a study of zwf1/zwf2 negative S. lividans strains (3). Diamide 
oxidizes sulphide groups in proteins and thiols causing formation of toxic disulfide 
bridges. This oxidative stress is neutralized by thioredoxin reductase (27), which 
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requires NADPH as electron donor. The more NADPH is available in the cells, the 
more resistant the strain should be to diamide. The test showed a slightly reduced 
sensitivity of the mutant strain to diamide (at P>90%). The halo surface surrounding 
the 0.5 M diamide impregnated disc, measured 962.2 ± 27.5 mm2 for the wild type 
versus 916.9 ± 15.5 mm2 for the deletion strain. 
5.4.6 Reverse transcriptase-PCR 
High similarity of the three pfkA genes prevents discrimination between their 
transcripts on microarrays. This was also evident from our array studies, showing no 
significant change in pfkA2 expression for the pfkA2 deletion strain, indicating cross-
hybridization by pfkA1 and/or pfkA3 mRNA (Appendix 5.5). A combination of RT-PCR 
with restriction digestion, however, does allow detection and discrimination of mRNA 
of a single pfkA. RT-PCR revealed the presence of pfkA2 and pfkA3 mRNA in M145 
grown on mineral medium (Figure 5-2). The cells were harvested in the exponential 
growth phase. This finding is in accordance to that of Hesketh et al. (42) who 
detected PfkA2 and PfkA3 protein spots on 2D-gels of S. coelicolor grown under 
comparable conditions (SMM phosphate limited mineral medium). As anticipated, 
only the presence of pfkA3 mRNA was detected in mRNA isolated from the pfkA2 
deletion strain harvested at the same time-point. The authenticity of the RT-PCR 
products was confirmed by restriction analysis, to exclude products formed due to 
cross-annealing of the primers. 
5.4.7 Phosphofructokinase (Pfk) and glucose-6-phosphate 1-dehydrogenase 
(G6P-DH) activity assays 
In order to study differences in G6P-DH and Pfk activities, enzyme assays were 
performed on S. coelicolor crude extracts. G6P-DH assays did not reveal significant 
differences in activity between pfkA2 deletion mutants and their parent strain (166 ± 
37 
mol/min/mg protein). Despite many attempts, no residual Pfk activity could be 
detected in pfkA2 deletion mutants. Various assay conditions have been tested, 
aiming to detect even minute Pfk activities that might account for the remaining EMP 
carbon flow as detected by 13C metabolic flux analysis, but with no success. 
5.4.8 Deletion of pfkA2 causes transcriptional changes in regulatory and 
membrane proteins as well as in fatty acids metabolism 
The effect of the pfkA2 deletion on gene expression was studied by comparison of 
RNA of the S. coelicolor A3(2) reference- and mutant strains using spotted DNA 
microarrays. RNA was isolated from cultures in the mid exponential growth phase. 
The 588 genes that had a p-value below 0.05 in permutation test and for which there 
was at least one quality spot per each array were considered to be differentially 
expressed (Appendix 5.5). The genes were sorted into functional categories 
according to a protein classification scheme proposed by the Sanger Institute 
(http://www.sanger.ac.uk/Projects/S_coelicolor/scheme.shtml). Functional categories that 
were most influenced by the genetic change were determined by hypergeometric 
distribution and included fatty acids metabolism, regulatory genes and membrane 
proteins (Table 5-5).  
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Table 5-5. Genes that are significantly (p<0.05) up- or down-regulated (dark shading) 
in the pfkA2 mutant in comparison to the S. coelicolor A3(2) reference strain. The 
genes are sorted by functional categories and for each category the p-value from 
hypergeometric distribution is shown. 
 
Functional category 
Differentially 
expressed    
Total number 
in genome p-value* 
Transcriptional regulators and other regulatory proteins 
48 460 
0.01 
Degradation of fatty acids 9 58 0.02 
Gram positive membrane 72 826 0.09 
Ribosomal proteins, synthesis, modification 6 62 0.20 
Secondary metabolism 24 276 0.21 
Gram positive peptidoglycan, teichoic acid 4 40 0.23 
Cell division 3 20 0.27 
Sensor kinase 7 86 0.33 
Degradation of proteins, peptides, glycoproteins 10 126 0.36 
Degradation of carbon compounds 7 90 0.38 
Cations transport 3 39 0.39 
Transposon/insertion element-related functions 4 58 0.46 
Non-classified 42 559 0.49 
Response regulators and sigma factors 12 167 0.51 
Gram positive exported lipoprotein 32 438 0.55 
Fatty acid and phosphatidic acid biosynthesis 3 53 0.60 
Transport/binding proteins 36 518 0.69 
Macromolecule synthesis, modification 16 247 0.70 
Degradation of polysaccharides 5 92 0.71 
Electron transport 3 70 0.79 
Detoxification 2 88 0.97 
Others 62 1017 - 
Unknown function 178 2336 - 
Total 588 7726   
*p-value of having the detected or higher number of genes from a particular functional category among 
the differentially expressed genes. Calculated according to: , where N are the 
total genes analyzed on chip; K are differentially expressed genes; M are the genes from a particular 
functional category present on the chip and x is the number of differentially expressed genes that 
belong to that functional category. Small p-values indicate functional categories that were most 
affected by the mutation. 
 
Of around 460 transcriptional regulators and regulatory proteins that were annotated 
in the S. coelicolor genome 46 changed their expression significantly in the ∆pfkA2 
mutant. As the exact role and binding sites are not known for most of the 
transcriptional regulators it is difficult to say what influence their changed expression 
has on the cells. One of them is, however, a better studied A-factor receptor 
homologue, CprB (SCO6071) (43). In contrast to another A-factor receptor 
homologue, CprA (SCO6312), which acts as a positive regulator of secondary 
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metabolism and sporulation, CprB seems to have an opposite role (44). Deletion of 
CprB caused increased actinorhodin production and earlier sporulation (44). This 
gene was down-regulated in ∆pfkA2 mutant. Another gene with a better studied 
function was recX gene (SCO5770), which was slightly higher expressed in the 
mutant. recX is positioned downstream recombinase recA and is most probably 
involved in its downregulation (45-48). recX transcripts were previously detected in S. 
lividans only under DNA damaging conditions (49). 
Fatty acids are building blocks of phospholipids and glycolipids used in the cellular 
membranes as well as of triacylglycerols, which serve as energy storage molecules 
(50-52). Triacylglycerols were found in the post-exponential phase biomass of 
several Streptomyces species and were hypothesized to serve as a C2 source for 
polyketides formation (50). Biosynthesis of fatty acids can as well serve as a sink for 
NADPH, which is used during chain elongation. Subsequent degradation of fatty 
acids would provide ATP and NADH/FADH2, the latter also coupled to ATP 
production through the electron transport chain. In our data set we saw significant 
overexpression of acyl-CoA dehydrogenases (SCO3051, SCO4681, SCO1701) as 
well as lipases/esterases (SCO4746, SCO3644). 
Interestingly, the phosphofructokinase genes display a trend of increased 
expression. Because of the high homology between the isoenzymes, it is not 
possible to distinguish the species on the array. However, since pfkA2 has been 
completely deleted from the mutant, the mRNA must be of pfkA1 and/or pfkA3 origin, 
that in a reaction to the loss of pfkA2 increase in expression. Because mRNA of 
pfkA1 could not be detected with RT-PCR the mRNA must be the result of pfkA3 
transcription. 
5.4.9 Metabolic subnetworks with changed gene expression 
Of the 588 genes with altered expression only a minor part can be directly linked to 
the primary metabolism or to the antibiotic production.  Studying metabolic 
subnetworks might in this case prove to be a useful tool for interpreting the effect of 
the pfkA2 deletion on gene expression. Metabolic genes are interconnected through 
common metabolites. To avoid potentially harmful accumulation of metabolites, the 
activities of the enzymes that produce and consume those metabolites have to be 
coordinated. In bacteria, genes that belong to a linear metabolic pathway often are 
positioned in one operon to ensure their coordinated expression. When an enzyme is 
deleted or over-expressed, the cells will seek to maintain metabolic status quo by 
changing the activities of connected enzymes, either at the transcriptional level or at 
the protein level.  
To further analyze the transcriptional response to the deletion of pfkA2 we identified 
metabolites around which the most significant changes in expression occurred (Table 
5-6). For this purpose we used a genome-scale metabolic model to define 
connections between metabolites and the enzymes that have these metabolites as 
substrates or products (31). The significance of the gene expression test, expressed 
as p-values from the permutation test, were used for each metabolic gene included in 
the model. 
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Table 5-6. Top 20 reporter metabolites* around which the most significant changes in 
expression occurred in the ∆pfkA2 mutant strain compared to the S. coelicolor A3(2) 
reference strain, identified using an algorithm by Patil et al. (31) and an S. coelicolor 
genome-scale metabolic model (25), to define connections between metabolites and 
the enzymes that have these metabolites as substrates or products. 
 
Metabolite Processes 
Number of 
neighbors p-value 
D-Glucose 1-phosphate Storage carbohydrates 2 0.00 
D-Galactose 1-phosphate Storage carbohydrates 2 0.07 
UTP 
Pyrimidines/Storage 
carbohydrates/Peptidoglycan 5 0.02 
N6-(1,2-Dicarboxyethyl)-AMP ATP biosynthesis 2 0.05 
NADH Reducing cofactor 49 0.04 
D-Ribose 5-phosphate Pentose phosphate pathway 9 0.08 
2,3,4,5-Tetrahydrodipicolinate Amino acids metabolism 2 0.04 
L-Lysine Amino acids metabolism 3 0.07 
3-Phosphonooxypyruvate Amino acids metabolism 2 0.00 
L-Homoserine Amino acids metabolism 2 0.00 
L-Histidine Amino acids metabolism 3 0.02 
L-Aspartate Amino acids metabolism 12 0.03 
L-Aspartate 4-semialdehyde Amino acids metabolism 4 0.03 
2-Dehydro-3-deoxy-D-arabino-
heptonate 7-phosphate  Amino acids metabolism 2 0.07 
Acetaldehyde Pyruvate metabolism 7 0.01 
Ethanol Pyruvate metabolism 3 0.02 
Propionyl-phosphate Propanoate metabolism 2 0.02 
Propanoate Propanoate metabolism 4 0.04 
Methylmalonate semialdehyde Propanoate metabolism 7 0.08 
Oxaloacetate TCA cycle/Anaplerotic reactions 11 0.03 
 
Among the high scoring reporter metabolites were glucose-1-phoshate and 
galactose-1-phosphate, precursors for storage carbohydrates, which indicates 
transcriptional changes in this route. Increased accumulation of storage 
carbohydrates was observed in yeast with knocked-out phosphofructokinase (53), 
though we could not detect that in S. coelicolor (see above). Another top scoring 
reporter metabolite is the reducing co-factor NADH. This cofactor participates in 62 
reactions in the model and the low p-value indicates that transcriptional changes 
occurred in many of the neighboring enzymes. Some other reporter metabolites were 
from amino acid biosynthesis and degradation pathways. Amino acid biosynthesis 
leads to oxidation of NADPH into NADP+ and can be connected to the altered level of 
this co-factor. There were changes in pyruvate and propanoate metabolism, which 
supply precursors for polyketide compounds. The presence of oxaloacetate among 
reporter metabolites can indicate both transcriptional changes in the TCA cycle and 
anaplerotic reactions. Remarkably, significant transcriptional changes occurred 
around ribose-5-phosphate, a key metabolite of the pentose phosphate pathway and 
nucleotide precursor. 
The enzymes can be represented in the form of a network, where the 
enzymes act as nodes and the shared substrates make the edges. In this metabolic 
network significantly regulated sub-networks can be found (31). Genes linked to the 
most significant sub-networks are highlighted in Figure 5-6. The sub-network 
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included citrate synthase citA, which is homologous to the principal isoenzyme in the 
S. coelicolor strain MT1110 (7). The strain with deletion of this enzyme becomes 
auxotrophic for glutamate and shows severe acidification of medium with acetate, 
pyruvate and other organic acids (7). CitA (SCO2736) was up-regulated in our 
mutant strain (p=0.08). Another up-regulated enzyme, which is also part of the most 
significantly regulated subnetwork was acetate kinase (SCO5424). The analysis 
indicates some transcriptional changes around the acetyl-CoA node, which is also 
consistent with the low acetate secretion by the mutant strain. The subnetwork also 
included RNA synthesis, which is primarily catalyzed by alpha- (SCO4729), beta- 
(SCO4654) and omega- (SCO1478) RNA polymerase subunits. In the mutant, alpha-
, beta- and omega-chains of RNA polymerase were downregulated, the former two at 
a 95%- and the latter at an 85% significance level. 
5.4.10 Metabolic modeling 
For the purpose of metabolic engineering it is a great advantage to be able to predict 
which genetic changes will lead to a desired phenotype. Genome-scale metabolic 
models have been used recently for making such predictions (54,55). We were 
interested to see what phenotype the existing S. coelicolor genome-scale metabolic 
model would suggest for decreased phosphofructokinase activity. 
The model contains 700 unique reactions, many of which are reversible, hence the 
degree of freedom is very high and the model can therefore not be used to obtain 
precise estimates of the intracellular fluxes without the addition of some constraints. 
By including a few constraints from the 13C MFA calculations (restrictions of the PP 
flux, the TCA flux, and the EMP flux), the model could predict the specific growth rate 
to be 0.1 h-1 when the specific glucose uptake rate was set at 1.57 mmol/g (dry 
weight)/h. This is very close to the actual value (Table 5-4) and hence we assumed 
that the predicted fluxes were a good reflection of the actual fluxes in the cell.  
Using the obtained wild type flux distribution we predicted how the fluxes would 
change with a decrease in the EMP flux. We assumed that the cells will undergo as 
few flux changes as possible to adjust to the new conditions, hence we chose a 
minimization of flux adjustment (MOMA) approach for the simulations (32). 
First, the model predicted excretion of compounds, which were not detected 
experimentally and are not earlier reported to be produced during S. coelicolor 
fermentations, e.g. acetate, acetaldehyde, ethanol, formate, and proline. When the 
secretion of these compounds was constrained to zero, the model predicted 
pyruvate, actinorhodin, and calcium-dependent antibiotic as fermentation products 
(Figure 5-7). The decrease of flux through phosphofructokinase correlated with 
decreased specific growth rate and an increased flux through the PP pathway, the 
latter was also observed experimentally. 
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Figure 5-7. Influence of decreased flux through phosphofructokinase on growth rate 
(), pentose phosphate flux () and TCA cycle flux () [A] and on pyruvate excretion 
(), actinorhodin () flux and calcium-dependent antibiotic flux () [B]. 
 
 
 
5.5 Discussion 
In this study the effects of the deletion of pfkA2 (SCO5426) on cellular processes in 
S. coelicolor were studied. The most obvious effect of this deletion was an increase 
in production of the pigmented antibiotics actinorhodin (ACT) and undecylprodigiosin 
(RED) on both mineral and rich media without a significant decrease in specific 
growth rate.  
A direct link between primary- and secondary metabolism in Streptomycetes has 
been demonstrated before. In Streptomyces lividans, a close relative of S. coelicolor, 
deletion of 1 of 2 zwf genes led to an increase in ACT and RED production with an 
unaltered specific growth rate (3). The zwf gene products, glucose-6-phosphate 
dehydrogenase (G6P-DH), catalyze the first reaction of the pentose phosphate 
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pathway. The authors explained their results by increased carbon availability for 
antibiotics biosynthesis pathway when less carbon was oxidized to carbon dioxide in 
pentose phosphate pathway. Another group performed metabolic flux analysis on the 
physiological data from S. lividans chemostats and also hypothesized that decreased 
flux through the PP pathway would result in increased antibiotic production (56). This 
hypothesis was tested in S. coelicolor by Ryu et al (5), who partially blocked the flow 
into the PPP by deleting zwf and increased actinorhodin precursor availability by 
overexpressing acetyl-CoA carboxylase. Deleting the main Zwf activity (zwf2), 
however, caused an enhanced mycelial growth and a decreased specific ACT 
production rate. These results were in contradiction to the ones obtained for S. 
lividans (3). In both S. lividans and S. coelicolor the deletion of a zwf gene did lead to 
a decrease in G6P-DH specific activity. However, it should be noted that in vivo 
fluxes do not obligatory correlate with the in vitro measured enzymatic activity, 
therefore it is not clear how the flux through PPP was influenced in these studies. 
The current study focused not on decreasing C-flow through the PPP but on 
decreasing flux through glycolysis. Glycolysis is not completely blocked in the pfkA2 
mutant, as demonstrated by the metabolic flux analyses, despite our inability to find 
remaining Pfk activity in pfkA2 cell extracts. The remaining Pfk activity is most likely 
provided by PfkA3, of which mRNA could be traced using Reverse Transcriptase 
PCR. Failure to detect this PfkA3 activity may be due to enzyme instability during 
extract preparation, or requirement for specific assay conditions that we have not 
been able to identify. This reduction in Pfk activity in the mutant led to an 
accumulation of F6P and G6P. This result is consistent with data in yeast, where 
deletions of one or two subunits of phosphofructokinase also resulted in 
accumulation of intracellular hexose monophosphates (57). Our studies show that 
accumulation of G6P in S. coelicolor A3(2) results in an increased flow of carbon 
through the PPP, which is consistent with the increased CO2 production by the 
pfkA2 mutant strain. Also a flux through xylulose-5-phosphate phosphoketolase 
was predicted in the pfkA2 mutant, but not in the reference strain. This enzyme is 
usually active during growth on pentoses, which give plenty of xylulose-5-phosphate 
that the cells have to deal with. Apparently, similar effect was achieved by increasing 
the glucose conversion through the pentose phosphate pathway. Through the 
labeling pattern talks for the presence of phosphoketolase activity, it should 
additionally be proven in enzymatic essays. It is interesting to note that over-
expression of PPP enzymes would not necessarily lead to higher PPP flux. The 
higher affinity of phosphofructokinase to fructose-6-phosphate may cause it to be the 
flux controlling for the PPP flow. The final result of over-expressing PP pathway 
related enzymes might therefore only cause a minor increase in the PPP flux. Our 
study indicates that due to the tight regulation in the central carbon metabolism, it 
may be better to constrain fluxes in the metabolic network through deletion of specific 
flux controlling genes rather than by over-expression of genes. 
We suggest that the stimulating effect of the increased PPP flux on antibiotic 
production is at least partly due to an increase in supply of NADPH as demonstrated 
by diamide sensitivity tests. NADPH is the reducing agent used in the process of 
making secondary metabolites and the PPP is one of the most important NADPH 
producing pathways. A role for NADPH in increase of antibiotic production has also 
been suggested before (1). Another effect could be increased production of acetyl-
CoA, which serves as the basic precursor for polyketides, due to high flux thorough 
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the phosphoketolase pathway. The later hypothesis, however, needs more 
verification. 
The various observations made can be explained in terms of metabolite overflow. 
Accumulation of primary metabolites can be potentially harmful to an organism. 
Excess metabolites can be disposed of through the production of waste products, 
possibly the original function of the relatively ancient secondary metabolic pathways. 
The major evolutionary driving force for secondary metabolite synthesis, however, 
may soon have become that of fitness increase due to their bioactivity (58). 
Nevertheless, the overflow concept still gives a foundation for speculation on the link 
between primary- and secondary metabolism. In light of this hypothesis any gross 
metabolic imbalance that cannot be dealt with by tweaking primary metabolic 
pathways would stimulate production of secondary metabolites. 
We also show that the experimentally observed effects of decreased 
phosphofructokinase activity can be predicted using a genome-scale metabolic 
model. This implies that the model can be used for design of strains with further 
improved antibiotic production. 
Gene expression analysis, which revealed numerous changes in the expression of 
regulatory proteins in the mutant, indicate that increase of antibiotics production also 
might be influenced by some regulatory events, e.g. that pfkA2 deletion caused 
higher expression of the antibiotics biosynthetic clusters. As we did not analyze 
genes expression in the stationary phase, we can not confirm or decline this 
hypothesis, however, we could see that the indirect negative regulator of actinorhodin 
biosynthesis CprB was down-regulated in the mutant in the exponential growth 
phase.  
Transcriptional data yet also showed changes in the expression of metabolic genes. 
The total number of genes that were found significantly differentially expressed was 
relatively low, less than 10% of the genome. This could be expected considering that 
the mutation did not have a drastic effect on cellular physiology and morphological 
development. Interpretation of gene expression data is even further complicated by 
the inferior annotation of S. coelicolor genes as compared to more studied model 
organisms like E. coli or the yeast Saccharomyces cerevisiae. Integrated data 
analysis methods have proven useful for interpretation of –omic data. For studying 
transcriptional changes in metabolic genes particularly supplementing the expression 
data analysis with the knowledge of metabolic network has an advantage (31). We 
identified transcriptional changes in the carbohydrate storage metabolism, as well as 
in enzymes connected to reducing co-factor NADH, PP pathway and nucleotides 
metabolism intermediate ribose-5-phosphate and tricarboxylic cycle intermediates 
oxaloacetate and acetyl-CoA. These findings confirm that changes have occurred in 
the central carbon metabolism and resulted in higher antibiotics biosynthesis.  
In future work it will be of interest to study whether the mutant with deletion of pfkA2 
can be useful for production of other NADPH- and/or acetyl-CoA-requiring antibiotics. 
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6.1 Abstract 
In industrial processes antibiotic-producing Streptomyces are usually grown in batch 
cultivations on complex medium, containing amino acids and peptides as nitrogen 
source. Exhaustion of nitrogen source elicits ppGpp-mediated stringent response, 
which is known to cause growth cessation and induction of antibiotics biosynthesis 
genes in the model Streptomyces – S. coelicolor A3(2). 
We compared growth, amino acids consumption and gene expression in S. coelicolor 
and its congenic ∆relA relaxed mutant grown in liquid cultures on nitrogen-limited 
medium in order to elucidate the global role of ppGpp.  
Deletion of relA gene caused the mutant to grow with a higher specific growth rate 
but with a lower biomass yield on glucose and amino acids. Amino acids in both 
reference and mutant strains were taken up simultaneously and the uptake rates 
were proportional to the extracellular concentrations of amino acids, pointing that the 
main uptake routes were through non-specific amino acids transporters. The largest 
transcriptional changes occurred at the peak of ppGpp concentration between the 
end of the exponential and the early stationary phase in the reference strain, while 
the transcriptional changes in the mutant strain at the corresponding physiological 
stages were moderate. The ppGpp-regulated genes included ribosome constituents, 
secondary metabolic genes, and also cellular membrane constituents and numerous 
regulatory genes. The upregulated genes were overrepresented on the arms of the 
chromosome, while downregulated genes were more common on the core of the 
chromosome around the origin of replication. Analysis of significantly co-regulated 
metabolic networks identified transcriptional changes in energy metabolism in the 
stringent strain in the transition phase. The corresponding changes were not found in 
the relaxed mutant. 
KEYWORDS 
Stringent response, Streptomyces coelicolor, gene expression 
ABBREVIATIONS 
ppGpp guanosine 3 ,´5 -´bispyrophosphate 
pppGpp guanosine 3 -´diphosphate, 5 -´triphosphate 
RNAP  RNA polymerase 
SHX  serine hydroxamate 
6.2 Introduction 
Under the conditions of nutrient starvation microorganisms can elicit a stringent 
response characterized by slow-down of growth, reduction of stable RNAs synthesis 
as well as changes in the morphology, pathogenicity or secondary metabolites 
production [Sands et al, 1952]. The response is mediated by guanosine 3 ,´5 -´
bispyrophosphate (ppGpp), synthesized by stringent factor (p)ppGpp synthase RelA, 
which catalyses ppGpp synthesis either directly from GDP and ATP or from GTP and 
ATP through guanosine 3 -´diphosphate, 5 -´triphosphate (pppGpp) [Cashel et al, 
1969]. The enzyme is associated with the ribosomal complex and apparently gets 
activated when free tRNA is encountered at the A-site of 50S ribosome [Haseltine et 
al, 1973]. The presence of free tRNA can be a consequence of nitrogen or carbon 
starvation, but can as well be provoked by sudden oxygen depletion, which leads to 
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reduced ATP synthesis and hence abolishment of the ATP-dependent 
transamination of free tRNAs. 
At growth-favorable conditions constant low levels of ppGpp and pppGpp are 
maintained by the combined action of a synthase and a hydrolase, which in E. coli 
are coded by respectively relA and spoT and in actinomycetes are typically fused in 
one gene.  
 
The presence of ppGpp-mediated stringent response was demonstrated in several 
Streptomyces spp. and its influence on morphological differentiation and secondary 
metabolites formation was shown [Oki et al, 1975; An et al, 1978; Riesenberg et al, 
1984; Ochi et al, 1986]. Specifically, the relC relaxed mutants, which had a mutation 
in the ribosome, preventing the binding of uncharged amino acids and hence 
activation of the stringent factor, were deficient in antibiotics production.  
 
In S. coelicolor a decrease in transcription from the four promoters of the rrnD gene 
set coding ribosomal RNA was measured when stringent response was induced by 
addition of serine hydroxamate, which acts as a competitive inhibitor of seryl-tRNA 
synthase [Strauch et al, 1991]. Strauch et al. have also shown that when S. coelicolor 
A3(2) is grown in a nitrogen-limited medium, the accumulation of ppGpp peaks at the 
end of exponential phase and precedes entry into stationary phase and antibiotics 
biosynthesis. They detected that this time point also correlated with the appearance 
of transcripts of an early gene in the actinorhodin biosynthetic cluster - actIII. 
Chakraburtty et al. continued the work on stringent response in S. coelicolor A3(2). 
They isolated and sequenced and then tried to disrupt the relA gene. Deletion of a C-
terminal fragment did not result in a ppGpp-deficient strain [Chakraburtty et al, 1996], 
however, the deletion of a bigger N-terminal region on the relA gene gave a mutant 
that did not synthesize ppGpp under any of the conditions tested [Chakraburtty et al, 
1997]. It is most likely that the C-terminal region of relA is responsible for the 
ribosome binding, while N-terminal region has the catalytic activity and on deletion of 
the C-terminal region the protein still can function in the cells in a ribosome-
independent manner like the stringent factor in S. marookaensis [Oki et al, 1975; 
Muta et al, 1992]. The mutant showed relaxed phenotype where transcription from 
the rrnD promoters did not decrease significantly at the nutritional shift-down. On the 
nitrogen-limited medium the mutant was deficient in morphological differentiation as 
well as antibiotics (undecylprodigiosin and actinorhodin) production. On phosphate-
limited medium the mutant sporulated and produced antibiotics normally, meaning 
that phosphate-limitation is regulated in a different, relA-independent manner 
[Chakraburtty et al, 1997].  
 
In order to study the direct ppGpp effect on antibiotics genes, the relA gene and its 
truncated versions were placed under the control of a thiostrepton-inducible promoter 
(tipAp) [Hesketh et al, 2001]. Addition of thiostrepton to the exponentially growing 
cultures lead to the accumulation of intracellular ppGpp and induced the pathway 
specific activator for actinorhodin production (actII-ORF4), but not the activator for 
undecylprodigiosin (redD). The growth was not influenced by relA induction and the 
production of undecylprodigiosin started upon the entry into stationary phase as in 
the wild type. It was also previously described by Takano and co-workers that 
provoking the ppGpp formation by nutritional shift-down or by serine hydroxamate 
addition does not lead to redD induction [Takano et al, 1992]. Apparently the 
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presence of ppGpp is not sufficient to activate the transcription of redD, which might 
be additionally controlled by some other regulatory genes or γ-butyrolactones, shown 
to appear in the S. coelicolor A3(2) culture broth during the transition phase [Aigle et 
al, 2000].  
 
Over the past ten years the evidence has been accumulated that ppGpp physically 
interacts with RNA polymerase (RNAP) in E. coli [Reddy et al, 1995]. The binding site 
is constituted of three RNAP subunits: β, β  ´and σ70 [Hernandez et al, 1995; Chatterji 
et al, 1998; Zhou et al, 1998; Toulokhonov et al, 2001; Cashel et al, 2003]. It’s been 
explicitly proven by Jishage et al. that ppGpp modulates the competition of different 
σ-factors for the core RNA polymerase [Jishage et al, 2002]. The accumulation of 
ppGpp leads to dissociation of the core RNAP from stringent promoters as rrn and 
the increased concentration of free cores allows promoters with lower affinity for σ70 
and promoters that use alternative σ-factors to recruit the polymerase and thus start 
the transcription of the controlled regulon. One type of the regulon that are positively 
regulated by ppGpp is amino acids biosynthesis clusters, proven by the fact that 
ppGpp0 E. coli strains are polyauxotrophic [Xiao et al, 1991]. The transcription from 
alternative promoters controlled by σS and σ32 in E. coli also positively correlates with 
ppGpp presence and is drastically reduced in ppGpp0 cells. The mechanism 
discovered in E. coli is probably universal for all the organisms that exhibit stringent 
response. For Streptomyces spp., which have unusually high amount of σ-factors (65 
in S. coelicolor and 62 in S. avermitilis) [Bentley et al, 2002; Omura et al, 2001], the 
ppGpp can play a very important global regulatory role changing the expression of 
whole regulons under the control of these different σ-factors. 
 
In addition to controlling gene expression through direct interaction with RNAP, the 
ppGpp has other effects on the cell due to consumption of ATP and GTP for its 
biosynthesis. ATP is the principal energy carrier in the cell, while GTP is used for 
polypeptide chain elongation during protein biosynthesis. The depletion of these 
compounds would lead to immediate arrest of protein biosynthesis as well as most of 
the other growth-associated metabolic processes. In Streptomyces coelicolor A3(2) a 
five-fold decrease in the intracellular concentration of GTP was observed 7.5 min 
after nutritional shift-down, while the level of ATP remained essentially unchanged 
[Chakraburtty et al, 1997]. The ∆relA mutant responded to the shift-down by increase 
in GTP concentration. The absence of effect on ATP level is surprising, but the 
authors continued observing the nucleotides levels only 15 min after the nutritional 
shift-down and because some carry-over of the nutrients is highly likely, the 
measurements perhaps should have been made for a longer time before conclusions 
on ATP concentration changes can be made. In another work, where the stringent 
response was induced by serine hydroxamate, more profound changes in nucleotide 
concentrations have been observed: 20 min after SHX addition GTP and UTP levels 
decreased to 20-25% and ATP and CTP to 50% of the initial values [Strauch et al, 
1991]. 
6.3 Materials and methods 
6.3.1 Chemicals 
All chemicals were of chemical purity degree or higher, purchased from Merck (NJ, 
USA) or Sigma-Aldrich Co. (MO, USA). Casamino acids were from Difco (Becton, 
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Dickenson and Company, USA). (The 13C6-labeled glucose was from Omicron 
Biochemicals Inc. (IN, USA).  
6.3.2 Strain and culture conditions 
We used Streptomyces coelicolor A3(2) plasmidless strain M600 (SCP1-, SCP2-) and 
its congenic ∆relA mutant M570 [Chakraburtty et al, 1997]. The spores were obtained 
on soya flour-mannitol agar plates as described in [Kieser et al, 2000] and stored in 
20% glycerol. An equivalent of 1.2·1011 spores were pregerminated for 8 hours at 
150 rpm in 50 ml of 2xYT in 500 ml shake flasks with baffles and with added 30 glass 
balls of Ø3 mm. The germinated spores were harvested by centrifugation for 5 min at 
4,000xg, washed with fermentation medium and used for inoculation of 1L-working 
volume fermentor (Applicon Dependable Instruments, Holland). The medium 
contained: 10 mM NaH2PO4, 20 mM NH4Cl, 10 mM KCl, 2 mM Na2SO4, 2 mM citric 
acid as chelating agent, 1.25 mM MgCl2, 0.05 mM CaCl2, as well as per liter: 15 g 
glucose, 5 ml trace elements solution (20 mM FeCl3, 1 mM CuCl2, 5 mM ZnCl2, 10 
mM MnCl2, 0.02 mM Na2MoO4, 2 mM CoCl2, 1 mM H3BO4), 2 g Difco casamino acids 
(Becton, Dickenson and Company, USA) and 100 µl organic antifoam 204 (Sigma-
Aldrich, USA). For labeled substrate cultivations 20% of glucose was fully labeled 
with C13 isotope – 13C6-glucose.  
Fermentors were autoclaved with water and antifoam at 121ºC for 40 min and all 
other components were subsequently added by sterile filtration in the form of stock 
solutions. The aeration rate was 1 volume per volume per minute. For carbon 
labeling experiments the inlet air was bubbled through a 2 N NaOH solution in order 
to remove atmospheric carbon dioxide, however this was done only after the cultures 
started growing and the carbon dioxide percentage in the outlet air was about 0.06%. 
The pH of the medium was kept at 6.8-7.0 by automatic addition of 0.1 N NaOH and 
the temperature was kept at 30°C throughout the cultivation. 
6.3.3 Biomass dry weight 
8-10 ml of culture broth was filtered through a 0.45-µm pore size pre-dried filter 
(Supor-450, Pall Corporation, Ann Arbor, USA). The filtrate was collected and used 
for metabolites analysis on HPLC and for analysis of antibiotics. The biomass on the 
filter was washed twice with distilled water; the filter with biomass was then dried in a 
microwave oven at 170 W for 20 min, cooled down in a desiccator for 15 min and the 
mass gain was measured. 
6.3.4 Analysis of glucose, amino acids and extracellular metabolites 
Glucose and several extracellular primary metabolites were analyzed by HPLC with 
an Aminex HPX-87H column (Bio-Rad Laboratories, Hercules, CA, USA) operating at 
60°C. The compounds were eluted with 5 mM H2SO4 at a flow rate of 0.6 mlmin-1. 
Glucose, ethanol, glycerol and succinate were quantified using a differential 
refractometer (Waters 410; Millipore, Bedford, MA, USA) whereas acetate and 
pyruvate were quantified using a tunable absorbance detector set at 210 nm (Waters 
486; Millipore, Bedford, MA, USA).  
For analysis of amino acids, a filtered sample was concentrated by freeze-drying and 
injected into HPLC. After separation on ion-exchange column, the amino acids were 
oxidized, derivatized with orto-phthalaldehyde and detected by amperometric 
detector. The procedure is described in details in [Barkholt et al, 1989]. 
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For analysis of the blue actinorhodin pigment we added 2 ml of 3N KOH to 2 ml of 
whole broth and extracted with shaking at 4°C overnight. Then we centrifuged the 
mixture at 5,000xg for 15 min and measured the absorbance of supernatant at 640 
nm. The concentration was calculated using extinction coefficient of 25,320 M-1cm-1. 
The extraction of red prodigiosin pigments was performed according to the same 
procedure except that we used 2 ml of methanol buffered with HCl to pH 1.5 for 
extraction. The absorbance was measured at 530 nm and extinction coefficient was 
100,500 M-1cm-1. 
6.3.5 ppGpp analysis 
For analysis of ppGpp 50 ml of sample was quickly withdrawn from fermentor, added 
to the tube with a bit of crashed ice, mixed and centrifuged for 4,000xg for 1 min. The 
supernatant was decanted and the pellet was frozen in liquid nitrogen and kept at -
80°C until further analysis. 4 ml of 1M formic acid was added to the pellet, the sample 
was vortexed and sonicated in ice-cold water bath for 10 min. The extraction was 
continued for 2 hours on a rotating mixer in a cold room (4°C). The sample was 
filtered through nitrocellulose membrane with pore size 0.45 µm, the filtrate was 
collected, frozen in liquid nitrogen and freeze-dried. The dry matter was dissolved in 
200 µl of MilliQ water and stored at -20°C. The quantification of ppGpp was carried 
out by HPLC with Partisil 10-SAX column (Whatman, UK) as described in [Takahashi 
et al, 2004]. 
6.3.6 GC-MS analysis 
From the labeled substrate cultivations samples of 10-20 ml were taken for the 
analysis of cell mass labeling. Samples were centrifuged at 4000 rpm for 2 min, 
washed twice with 0.9% NaCl and stored at -20°C until further analysis. 
15 mg of wet cell mass was hydrolyzed with 6M HCl at 105 ºC for 24 hours to release 
free amino acids from protein molecules. The hydrolysate was centrifuged at 
15,000xg to remove the cell debris, divided into two aliquots and dried at 105°C. The 
crude hydrolysates were subjected to derivatization that rendered them volatile: 
amino acids were converted to N-ethoxycarbonyl amino acid ethyl esters and N-(N,N-
dimethylaminomethylene) amino acid methyl esters and glucose to glucose 
pentaacetate [Christensen et al, 1999]. Analysis was made by gas chromatography 
coupled with mass spectrometry as previously described [Christensen et al, 1999]. 
The signal intensities were corrected for occurrence of natural isotopes in the atoms 
of the derivative part and in oxygen and nitrogen atoms of the amino acids. The 
corrected intensities were used for calculating the summed fractional labeling (SFL) 
of a fragment according to the formula: 
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, where ij is the peak 
intensity of mass isotopomer mj and n is the number of carbon atoms in the fragment. 
The SFL value shows the amount of 13C atoms per 100 fragments. 
In order to compare the labeling states of two metabolites with different numbers of 
carbon atoms carbon normalized labeling (CNL) was calculated as: 


 = , 
where SFL is the summed fractional labeling of all the carbons in the fragment and n 
is the number of carbon atoms in the fragment. 
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6.3.7 RNA isolation and gene expression analysis 
The samples of 20 ml were withdrawn quickly and sprayed into 50 ml falcon tubes 
filled with crushed ice resulting in almost immediate cooling down to 0-2 ºC. The 
mixture was shaken and centrifuged at 4,000xg for 1 min. The supernatant was 
decanted, the cells were immersed in liquid nitrogen and then stored at -80ºC until 
RNA extraction. The total time spent on the sampling procedure did not exceed two 
min. 
Total RNA extraction was performed with RNeasy kit (QIAGEN GmbH, Germany) 
using 3x40s cycles on FastPrep FP120 (Qbiogene Inc., USA) for breaking the cells. 
After separation of cellular debris, additional steps were added: two rounds of 
phenol:chlorophorm:isoamylalcohol (pH8) extraction and 1 round of chlorophorm 
extraction. The rest of the procedure was according to the manufacture’s instructions. 
The total RNA was subjected to DNase digestion and then concentrated from the 
reaction solution using RNeasy CleanUp kit (QIAGEN GmbH, Germany). The quality 
of RNA was assessed on Bioanalyzer (Agilent, USA) to make sure there was no 
contamination with DNA and no degradation of RNA occurred. The RNA samples 
were labeled and hybridized to the arrays according to the procedure described on 
http://www.surrey.ac.uk/SBMS/Fgenomics/Microarrays. The arrays were spotted 
oligonucleotide arrays, containing duplicate spots of probes for 7337 S. coelicolor 
genes. Each probe was 50 nucleotide bases long and was designed for minimal 
cross-hybridization with other genes. To maximize the usage of arrays we applied 
look design [Vinciotti et al, 2005] with using a genomic DNA as a common reference 
(Appendix 6.1). The arrays were scanned with Affymetrix 428 laser scanner 
(Affymetrix Inc., USA). Image analyses was made using BlueFuse software 
(BlueGnome Limited, UK), which allows automatic grid alignment, spots boundaries 
detection, background substraction and signal intensities estimation. The spots 
quality was scored to 0 or 1 depending on their radius, circularity, uniformity and grid 
offset. For normalization and data analysis we used maanova package [Cui et al, 
2003] implemented in R statistical programming environment (http://www.r-
project.org). Maanova stands for microarray analysis of variance and is well suited for 
experimental designs with multiple factors. The intensities for duplicate spots were 
averaged, log transformed and normalized within array using glowess [Kerr et al, 
2000]. Further on the intensities were fit an ANOVA model according to [Cui et al, 
2003]. ANOVA model is fit in two stages, the first stage is the normalization model: 
yijkgr = µ + Ai + Dj + ADij + rijkgr (1) 
The term µ captures the overall mean. The other terms capture the overall effect of 
array (A), dyes (D) and labeling reactions (AD). The residual of the first stage is then 
used as the input for the second stage. The second stage models gene-specific 
effects: 
rijkr = G + AGi + DGj + VGk + ijkr (2) 
Here G captures the average effect of the gene. AG captures the array by gene 
variation. DG captures the dye by gene variation. VG captures the effects for the 
experimental varieties. To compare two conditions we used permutation test [Kerr et 
al, 2000], also implemented in maanova. Consensus clustering was done using a 
macluster function in maanova package with 1000 permutations at 0.6 significance. 
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6.4 Results 
6.4.1 ppGpp slows down the growth rate and leads to more efficient nutrient 
utilization 
S. coelicolor strain M600 and its congenic ∆relA mutant were grown in well-controlled 
fermentors in mineral medium supplemented with casamino acids. Because ppGpp 
response is best induced by starvation for amino acids, we used growth-limiting 
concentrations of nitrogen, half of nitrogen was inorganic ammonium chloride and 
half was coming from casamino acids. Ammonium and amino acids were consumed 
by the cells concurrently, though amino acids were exhausted before ammonium 
(data not shown). No overflow metabolism, signified by secretion of primary 
metabolites as pyruvate, acetate or similar, was observed in any cultivation. 
The strain with deleted relA gene grew faster than the reference strain both in the 
first and the second exponential growth phases (Figure 6-1, Table 6-1). It also 
consumed more glucose and amino acids for synthesis of a unit of biomass, which 
resulted in a lower biomass concentration at the end of the growth phase in the 
mutant cultivation in comparison to the reference. 
The intracellular concentration of ppGpp reached maximum around the end of the 1st 
exponential growth phase of M600 and that was also the time when pigmented 
prodigiosins could be detected in the medium (Figure 9-1). Actinorhodin pigments 
were first detected in the stationary phase. As expected, the M570 did not produce 
ppGpp at any time of cultivation. The onset of RED production in M570 was delayed, 
it appeared first in the stationary phase. The transcription of RED biosynthetic cluster 
activator redD reached the maximum at the 2nd point in M600 and only at the 3rd 
point in M570. 
  
Figure 6-1. Fermentation profiles of S. coelicolor reference (A) and ∆relA (B) in batch 
cultivations in N-limited minimal medium supplemented with casamino acids,  
glucose - , biomass dry weight - , total amino acids - , ppGpp - . The arrows 
show time points when samples for mRNA were taken. Error bars show standard 
deviations calculated from biological triplicates. Times of onset of undecylprodigiosin 
and actinorhodin production are indicated by RED and ACT signs correspondingly. 
         
      A 
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Table 6-1. Physiological parameters of S. coelicolor reference strain (M600) and its 
∆relA mutant (M570) 
 
M600 M570 Parametersc 
Phase 1a Phase 2b Phase 1a Phase 2b 
Maximal specific growth rate, µmax, h-1 0.30±0.02 0.19±0.04 0.35±0.03 0.13±0.02 
Specific glucose uptake, Yxs, (g 
glucose)·(g dry weight) 0.83 1.50±0.29 1.32 1.58±0.31 
Specific amino acids uptake, Yxaa, (g 
amino acids)·(g dry weight) 0.93 0.14 1.24 0.35 
a
 Exponential growth on amino acids, ammonium and glucose 
b
 Exponential growth on ammonium and glucose 
c
 The numbers are average values between four biological replicates (three non-labeled and one 
labeled cultivation), standard deviations are also shown. Where standard deviation is not shown, the 
numbers were only measured in labeled cultivations. 
6.4.2 Amino acids uptake and biosynthesis are weakly regulated 
All amino acids were uptaken simultaneously; there was no multiphasal growth on 
preferred amino acids. The specific consumption of amino acids correlated linearly 
with their initial concentration in the cultivation medium (Figure 6-2A), pointing to the 
presence of amino acids-nonspecific transport complexes. 
 
Figure 6-2. Correlation between specific uptake rate of amino acids and their initial 
concentration in the medium (A). Correlation between specific uptake rate of amino 
acids and amino acids content in the biomass (B).   – M600 data,  – M570 data. 
The data about content in the biomass was calculated based on protein composition 
[Davidson, 1992] and protein and peptidoglycan content [Borodina et al, 2005] at 
dilution rate 0.3h-1. 
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The specific uptake rates of amino acids were also proportional to the content of a 
specific amino acid in the biomass, with the exception of alanine and glycine (Figure 
6-2B). Alanine and glycine are used in the biosynthesis of peptidoglycan, which 
explains their high abundance in Streptomyces biomass.  
The specific consumption of most of the amino acids exceeded the content of amino 
acids per unit of biomass several fold (Table 6-2). This shows that the uptaken amino 
acids were used not only as building blocks for protein biosynthesis but also as a 
source of energy and precursors, because larger part of them was degraded. 
Consumption of aspartate, glutamate and arginine was 50-60% higher in the mutant 
than in the reference strain. 
 
Table 6-2. Content of amino acids in the biomass and their specific uptake. 
Specific uptake, mmol/g DW 
Amino acid 
Content in the 
biomass, 
mmol/g DW M600 M570 
Aspartate/Asparagine 0.25 2.87 3.99 
Threonine 0.15 0.99 0.76 
Serine 0.14 2.27 2.13 
Glutamate/Glutamine 0.40 7.81 10.79 
Proline 0.13 3.46 3.11 
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Glycine 0.78 1.06 0.92 
Alanine 0.72 1.78 2.05 
Cysteine 0.05 0.04 0.00 
Valine 0.25 2.18 1.88 
Metionine 0.07 0.43 0.40 
Isoleucine 0.15 0.78 0.68 
Leucine 0.23 1.94 2.27 
Tyrosine 0.05 0.08 0.03 
Phenylalanine 0.07 0.63 0.45 
Histidine 0.04 0.37 0.28 
Lysine 0.16 1.22 0.77 
Arginine 0.11 0.68 1.06 
 
To further study amino acids consumption we analyzed the labeling of proteinogenic 
amino acids from the cultivation on 20% 6C13-labelled glucose. We took several 
biomass samples in the course of cultivation, both in the exponential and stationary 
phases, hydrolyzed the proteins and analyzed the labeling of the proteinogenic 
amino acids on GC-MS. 
The labeling of amino acids was constant in the exponential phase of cultivation 
(Figure 6-3); after exhaustion of amino acids in the medium the labeling began to 
increase indicating biosynthesis from labeled glucose and then the labeling almost 
reached a new plato.  
 
Figure 6-3. Dynamics of label incorporation into proteinogenic amino acids (the 
patterns for both strains were similar, here strain 570 is shown).  
 
A few amino acids (leucine, isoleucine, proline, valine) were only naturally labeled 
(Table 6-3), meaning that these amino acids were not synthesized when there was 
sufficient supply from the medium. The first reaction in proline biosynthesis is 
catalyzed by glutamate-5-kinase, which is encoded by gene proB (SCO2587). This 
gene is significantly downregulated in the early time points of cultivation both in the 
reference and in the mutant strain (Figure 6-4). Under different experimental 
conditions it was found that proline genes are constitutively expressed and are 
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stimulated during growth on proline [Hood et al, 1992], hence their regulation is 
conditional.  
The precursor for biosynthesis of branched chain amino acids valine and leucine is 2-
acetolactate and for isoleucine it is 2-aceto-2-hydroxy-butanoate, both of these 
precursors are made by the action of acetolactate synthase. The latter consists of 
small and large subunits ilvN (SCO5513) and ilvB (SCO5512). Open reading frame 
SCO2769 was annotated as putative acetolactate synthase. While the expression of 
SCO2769 increases in the time course of cultivation, the expression of ilvB and ilvN  
decreases and is higher in the reference than in the mutant strain. The expression of 
these two genes correlates very well, they make an operon, which is transcribed from 
promoter upstream ilvB. The expression from ilvB promoter was shown to decrease 
in the presence of the three branched amino acids [Craster et al, 1999]. From our 
results we can conclude that the expression of ilvBN decreased at the appearance of 
ppGpp, but there was no repression of genes by casamino acids. The synthesis of 
branched amino acids could have been inhibited on the enzymatic level: it’s known 
that the small subunit of acetolactate synthase has a binding site for valine, which 
inhibits the enzyme [Kopecky et al, 1999; Bauerle et al, 1964].   
LeuA and leuB genes, both involved in leucine synthesis were dowregulated during 
the growth on amino acids. So was threonine ammonium lyase (SCO4962), which is 
needed for biosynthesis of 2-oxobutanoate, isoleucine precursor. 
 
Figure 6-4. Expression of enzymatic genes involved in biosynthesis of proline and 
branched amino acids. 
 
Interconversions between glyceraldehyde-3-phosphate and glycine, serine and 
threonine lead to high labeling of these amino acids. 
High labeling in alanine, glutamate and aspartate reflect participation of these amino 
acids in transamination reactions, which equilibrate the labeling in the intracellular 
pools of amino acids and their precursors: pyruvate, alpha-ketoglutarate and 
oxaloacetate correspondingly. 
Weak labeling of phenylalanine and lysine indicate that the control of their synthesis 
is not very tight and their presence in the medium does not stop the biosynthesis 
from the labeled precursors completely. Aspartate kinase, the first enzyme in lysine 
biosynthesis, has been shown to be under lysine-sensing riboswitch control in B. 
subtilis [Mandal et al, 2003] and in E. coli [Patte et al, 1998]. In B. subtilis truncated 
versions of aspartate kinase mRNA are made in the presence of lysine [Mandal et al, 
2003].  
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Table 6-3. Labeling of amino acids at the end of the exponential growth on amino 
acids. (summed fractional labeling in % per carbon atom, average values from 
several amino acids fragments) 
SFL normalized per atom, % 
Amino acid M600 M570 
Alanine 8.3±0.6 9.3±0.4 
Valine 2.3±1.6 2.9±2.1 
Leucine 1.1 1.1 
Isoleucine 1.5 2.1 
Lysine 3.4 3.6 
Aspartic acid 6.4±2.3 7.0±2.2 
Threonine 3.1±0.6 3.2±0.4 
Glycine 9.1±0.6 9.5±0.7 
Serine 11.6±3.7 10.3±1.7 
Proline 1.1 1.1 
Glutamic acid 4.9±1.0 5.7±0.8 
Phenylalanine 3.7±0.9 4.7±0.2 
6.4.3 Transcriptional changes are largest during transition phase and only in 
stringent strain 
We found how many genes have significantly changed their expression between time 
points 1 and 2, 2 and 3 and 3 and 4 in the tested strains. The largest changes were 
observed in the reference strain between time points 2 and 3, which correspond to 
the transition phase (Figure 6-5). 2200 genes have significantly changed their 
expression, while in the mutant strain the number was only 900.  
 
Figure 6-5. Pairwise comparisons of gene expression between different time points. 
 
 
In the context of ppGpp response we were mostly interested in those genes that 
have changed their expression significantly either between time points 1-2 or 2-3 
either in mutant or reference strain or both. We clustered the expression profiles of 
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those genes using K-means consensus clustering with 1000 iterations (Figure 6-7), 
the amount of clusters was set to 12 (Figure 6-6). 
 
Figure 6-6. Figure of merit. 
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Figure 6-7. Consensus clustering of significantly regulated genes. Samples 1 to 4 
represent reference strain M600 samples taken at four time points and samples 5-8 
are four time point samples of mutant strain M570. 
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The genes that have been significantly up- or down–regulated during transition phase 
in the references strain but not in the mutant strain were sorted into functional 
categories (up- clusters 6 and 9, down – clusters 1 and 3) (Figure 6-8). The 
functional categories were as proposed in protein classification scheme by the 
Sanger Institute (http://www.sanger.ac.uk/Projects/S_coelicolor/scheme.shtml). We 
hypothesized that these genes directly or indirectly are regulated by ppGpp. The 
genes with unknown functions are not shown on the graph. The categories with most 
of the genes are marked by red circles. 
Downregulation of genes involved in ribosomes constituents’ biosynthesis and 
modification as well as energy metabolism was observed. 
Among the genes involved in energy metabolism, the most represented were 
cytochrome subunits and ATP synthase chains, while cytochorome P450, known to 
be involved in secondary metabolism [O’Keefe et al, 1991] was upregulated. 
Among the macromolecules synthesis and modification genes the downregulated 
were tRNA acyl synthases and genes participating in protein translation and 
modification (peptide chain release factor 1, translation initiation factors IF1 and IF3, 
elongation factor G). 
Putative amino acid permease (SCO2914) and glutamate permease (SCO5775) 
were downregulated, while ammonium transporter (SCO5583) was upregulated, 
indicating the shift from growth on amino acids to growth on inorganic ammonium.  
Secondary metabolism included actinorhodin cluster activator gene, which induces 
the transcription of actinorhodin cluster [Malpartida et al, 1986; Fernandez-Moreno et 
al, 1994].  
Many changes occurred in genes coding for membrane proteins. Noteworthy even 
though morphological differentiation with aerial mycelium and spores formation does 
not occur in liquid cultures, the composition of the membrane still changes. 
Multiple regulatory genes were up- or down- regulated in the transition phase in the 
reference strain, pointing to the fact that ppGpp regulation in Streptomyces is a multi-
step hierarchical regulation, involving many regulatory proteins. One of the examples 
is scbA gene, which is involved in the synthesis of gamma-butyrolactone signaling 
molecule SCB1 [Takano et al, 2000; Takano et al, 2001; Butler et al, 2003].  
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Figure 6-8. Supposedly ppGpp regulated genes sorted by functional categories. 
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6.4.4 The up- and down- ppGpp-regulated genes are distributed differently on 
the chromosome 
We plotted the ppGpp affected genes according to their position on the chromosome 
(Figure 6-9). On the arms of the chromosome (left arm 0-1.5 Mb, right arm 6.5-8 Mb), 
80% of the genes were upregulated and only 20% were downregulated. On the other 
hand there was a high concentration of downregulated genes around the origin of 
replication, positioned at around 4.5 Mb. 
 
Figure 6-9. Position of the ppGpp-regulated genes on the chromosome. 
 
6.4.6 Most significantly co-regulated metabolic networks 
Some genes that are metabolically connected also change their expression together. 
We identified the significantly co-regulated metabolic subnetworks during transition 
phase (between time points 2 and 3) in the reference and in the ppGpp-deficient 
strains (Figure 6-10). 
 
Figure 6-10. Subnetworks of co-regulated metabolic genes (left – reference strain, 
right – ∆relA strain), the networks are displayed in hierarchical layout generated with 
Cytoscape (www.cytoscape.org). The yellow lines show connections between genes 
through common metabolites.  
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We used p-values from t-statistical test comparing time point 2 and 3 within each 
strain and genome-scale metabolic model reconstructed previously [Borodina et al, 
2005]. The significant subnetwork was found using algorithm described by Ideker et. 
al [Ideker et al, 2002]. The subnetworks for M600 and M570 had almost the same 
significance score, but the first contained 181 genes and the second 132 genes. The 
most obvious difference between the networks of the two strains is the absence of 
cytochrome genes (electron transport chain), ATP synthase subunits and RNA 
polymerase genes from the network of ppGpp lacking mutant. These genes are 
crucial for cellular function and apparently ppGpp is important for their coordinated 
regulation in the transition phase. Otherwise the most significantly regulated genes 
are the ones from amino acids and nucleotides metabolism as well as peptidoglycan 
biosynthesis, all the metabolic pathways that involve nitrogen-containing 
intermediates. Significant regulation of these pathways correlates well with nitrogen 
exhaustion in the medium in the transitionary phase. It is notable that genes from 
these pathways are highly regulated both in the reference and mutant strains pointing 
to ppGpp-independent regulation. 
6.5 Discussion 
Guanosine 3 -´diphosphate, 5 -´diphosphate is a global signaling molecule, which was 
originally found in bacteria but recently also observed in the chloroplasts of higher 
plants [Takahashi et al, 2004]. The intracellular concentration of ppGpp is regulated 
by ppGpp synthase and hydrolase and can increase very rapidly in response to 
stress. Some residual amounts of ppGpp are always present in the cells. We 
observed that the S. coelicolor strain, which had a deletion of ppGpp synthase and 
didn’t have any residual amounts of ppGpp at any stage of cultivation, was growing 
slightly faster than the reference strain but was consuming more glucose and amino 
acids to generate a unit of dry weight biomass. In contrast, E. coli with deleted relA 
and spoT genes was shown to grow 10-30% slower than the wild type strain on 
several complex media [Hernandez et al, 1993], it was not, however, investigated if 
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the specific biomass yield was changed. On the other hand, overexpression of relA in 
E. coli caused inhibition of rRNA synthesis and slower growth [Schreiber et al, 1991; 
Tedin et al, 1992].  
Our labeling experiments showed that biosynthesis of many amino acids occurred 
even while there was sufficient supply from the medium, meaning weak regulation on 
transcriptional/enzymatic levels. Exception was biosynthesis of proline and branched 
chain amino acids, which were not synthesized de novo, while the cells grew on 
amino acids. As the labeling of amino acids was very similar in the reference and 
mutant strains, we can conclude that ppGpp does not participate in regulation of 
amino acids biosynthesis in S. coelicolor. Interestingly, in E. coli ppGpp is essential 
for cells in order to synthesize amino acids, therefore the ppGpp-deficient E. coli 
mutants are auxotrophic for several amino acids [Xiao et al, 1991; Imaizumi et al, 
2006]. Weakly regulated amino acids biosynthesis can also explain why S. coelicolor 
∆relA mutants do not have a growth defect in contrast to E. coli. 
When S. coelicolor goes from exponential into stationary growth phase and 
intracellular ppGpp concentration peaks, more than one fifth of the genes change 
their expression level significantly. Most of these changes were not observed in the 
ppGpp- strain. The functional categories that are particularly effected are involved in 
stable RNA biosynthesis and secondary metabolism, which has been described 
before [Strauch et al, 1991; Chakraburtty et al, 1997]. What was not known before 
was an extensive effect on the cellular envelope constituents and on regulatory 
proteins. During growth on complex medium morphological differentiation occurs on 
nutrients starvation, therefore the composition of the cellular envelope is expected to 
change. In submerged cultures, however, S. coelicolor normally doesn’t sporulate 
and no particular changes in morphology can be detected microscopically. S. 
coelicolor has over a thousand genes that are putative transcriptional regulators, 
obviously part of the ppGpp effect is generated through these regulators, meaning 
that ppGpp, besides direct regulation of transcription, starts a signaling cascade, 
which results in the stringent response. Some groups of metabolically connected 
genes were found to be significantly regulated in the reference strain, but not in the 
mutant. These were cytochrome-coding genes involved in electron transport chain, 
ATP-synthase subunits and RNA polymerase genes.  
Interestingly, at the arms of the chromosomes the genes up-regulated by ppGpp 
were more abundant, with 80% of the genes being up-regulated. There was a high 
concentration of down-regulated genes around the origin of replication. It’s been 
shown previously by Karoonuthaisiri et al. that the core of the chromosome is 
downregulated in the stationary phase, but the authors did not find a trend in 
upregulation of chromosome arms, they rather saw genes across all the genome 
being up-regulated [Karoonuthaisiri et al, 2005].  
6.6 Conclusions 
Antibiotics production in Streptomyces is under a pleotrophic regulation of many 
transcription factors, σ-factors, signaling molecules and global regulatory proteins. 
ppGpp is an important global regulator as it most probably influences the binding of 
numerous σ-factors to promoters, therefore it is an interesting object for future 
studies.   
The cascade of regulatory events is so complicated in Streptomyces that it’ll take 
many more years before we’ll be able to decipher it even for the most studied model 
streptomycete – S. coelicolor A3(2). As reconstruction of regulatory pathways is 
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simply non-feasible for all the industrially interesting Streptomyces species, one 
might hope that some general rules will be discovered in S. coelicolor A3(2) that will 
help us improve antibiotics production in other strains. So far the work on the 
regulation in Streptomyces mainly concentrated on separate major regulators or 
regulatory cascades. Now the genomic techniques that have become available for S. 
coelicolor open up possibilities for a more structured and systematic approach. We 
hope that directed efforts from a number of scientific groups interested in 
Streptomyces will be coordinated and will result in a deeper understanding of 
regulation in these complex bacteria. 
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7.1 Streptomyces as superhosts 
Some of the common soil microorganisms are actinomycetes, Gram-positive bacteria 
with high GC content. Because of their mycelial habit they were initially believed to 
be fungi, which reflected in their name (mucus (lat.) means fungus). In 1939, one 
year before rediscovery of penicillin by Florey and Chain, soil microbiologist 
Waksman has set his lab on a quest for new antimicrobial drugs. From the previous 
studies he knew that actinomycetes can inhibit the growth of other soil bacteria 
through secretion of bioactive compounds, which he named “antibiotics” (anti (lat.) 
against, bio (lat.) life). Systematic search for antibiotics produced by actinomycetes 
resulted in the discovery of actinomycin (1940), clavacin and streptothricin (1942), all 
of them sadly turned out to be toxic in animal tests. In 1943 Waksman’s student 
Schatz isolated streptomycin-producing strain of Streptomyces griseus.1 
Streptomycin was not particularly toxic to animals and humans, but remarkably was 
the first compound active against tuberculosis bacteria. Many pharmaceutical 
companies and research laboratories started to collect soil samples from all over the 
world in search of antibiotics-producing organisms. Most of the discoveries were 
made in the first ten years of the “hunt”, the larger part involved Streptomyces 
species. Streptomyces is a genus in the genera of actinomycetes, many of these 
bacteria produce volatile compounds that give the earth its characteristic odor. 
Streptomyces proved to be an excellent source of secondary metabolites, including 
antibiotics, anticancerous agents, antihelmintic drugs and other useful compounds 
(Table 7-1). At present more than half of antibiotics in clinical use are produced in 
Streptomyces species. 
 
Table 7-1. Examples of industrial processes that use Streptomyces 
Product Type Product Streptomyces sp. Companies* 
Antibacterial Rifampicin S. mediterranei Sanofi-Aventis 
(France) 
Antifungal Nystatin S. noursei Bristol-Myers Squibb 
(USA), Bayer 
(Germany) 
Antihelmintic Ivermectin S. averimitilis Merck 
Herbicidal Bialaphos S. hygroscopicus Meiji Seika Kaisha, 
Ltd (Japan) 
Insecticidal Avermectins S. averimitilis Novartis 
(Switzerland) 
Antitumour Bleomycin S.  verticillus Bristol-Myers Squibb 
(USA) 
Immunosupressants Tacrolimus S. tsukubaensis Fujisawa (Japan) 
Enzymes Glucose isomerase S. murinus Novozymes 
(Denmark) 
Heterologous 
proteins 
Human Granulocyte-
Macrophage Colony-
Stimulating Factor (GM-
CSF) 
S. lividans expressing 
rhGM-CSF gene on a 
plasmid 
Cangene (Canada) 
* Only few examples of the producing companies are given. For most of the drugs the original patents 
have expired and multiple generic variants are available. 
 
Besides secondary metabolites biosynthesis, Streptomyces have also been exploited 
for enzymes production. Namely Streptomyces spp. are capable of decomposing 
cellulose, lignin, chitin and other complex polymers thanks to excretion of efficient 
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hydrolyzing enzymes. These enzymes can be applied for degradation of cellulose in 
bioethanol production, for making high fructose corn syrup, and other processes.2-4 
Some streptomycetes can degrade toxic compounds and are used in 
bioremediation.5-8 Due to their ability of protein secretion Streptomyces have recently 
also been used for manufacturing of pharmaceutical recombinant proteins.9, 10 So 
Streptomyces besides being indispensable in nature as decomposers, also are of 
high industrial importance.  
Very few Streptomyces strains are pathogenic, one of them being S. scabies, 
causing scab on tubers of potatoes, beets, etc. Most of the Streptomyces strains are 
nonpathogenic and nontoxic and some of the products made in Streptomyces 
fermentations have a GRAS status (”generally regarded as safe”), e.g., glucose 
isomerase made by S. rubiginosus (Food Standards Agency, UK). 
Typical features of Streptomyces are mycelial growth and morphological 
differentiation, which makes them one of the most sophisticated groups of bacteria. 
In favorable conditions Streptomyces spores germinate and produce vegetative 
mycelium (hyphae); when the nutrients become sparse or the cells get stressed in 
another way, morphological differentiation begins. Parts of mycelial colonies undergo 
lysis and hereby nutrients are supplied for the growth of aerial mycelium, which later 
segments into spores (Figure 7-1). The spores are unicellular with a single copy of 
the genome, which is in contrast to the hyphae that consist of cells with several 
nucleoids. Streptomyces spores are resistant to the absence of nutrients and dry 
environments. It is anticipated that many Streptomyces strains survive in the soil in 
the form of spores.11 During transition from vegetative growth to aerial mycelium 
formation, Streptomyces often secrete bioactive compounds, e.g. antibiotics. Keith 
Chater has proposed a theory that Streptomyces are quite vulnerable at the stage of 
differentiation and that antibiotics production has been developed as a defense 
mechanism preventing other soil bacteria to use the nutrients that are released 
during differentiation.11 Indeed, about half of the Streptomyces strains isolated in the 
laboratory proved to produce an antimicrobial compound of one or another kind, and 
many strains produced several antibiotics. Sequencing of Streptomyces genomes 
revealed many secondary metabolite gene clusters per genome, but quite a few of 
these clusters seem to be silenced under laboratory conditions.12 Streptomyces are 
the cell factories of choice for production of many secondary metabolites, particularly 
antibiotics. They are easy to grow in submerged cultures, they can utilize cheap 
complex industrial media and they secrete metabolites into the broth. It is most 
common for industry to optimize natural Streptomyces isolates employing random 
mutagenesis and screening and to use the resulting overproducing mutants in 
production. The strains optimized in this way are not considered to be genetically 
modified organisms (GMOs), which easies the regulatory requirements around 
production facilities and the process. 
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Figure 7-1. Streptomyces life cycle. The pictures show cross-sections of S. coelicolor 
colonies on agar medium. In the upper right corner of each picture the development 
stage is drawn schematically. 
 
As for production of enzymes and heterologous proteins, Streptomyces is one of the 
hosts to consider. In general, bacterial processes are usually preferred for protein 
production compared with eukaryotic expression systems, because they are cheaper 
and easier to run in reactors and give higher yields. In comparison to the typical 
bacterial host Escherichia coli, which accumulates proteins intracellularly in insoluble 
form, Gram-positive bacteria as Bacillus subtilis and Streptomyces can efficiently 
secrete proteins into the medium. They can also express genes with a wide range of 
GC content without codon adjustment, while E. coli has difficulties with high-GC 
genes expression. The folding of proteins differs in B. subtilis and streptomycetes 
and some proteins are better expressed by the latter. For instance, a large 
xylogluconase protein from Jonesia sp. was successfully secreted in functional 
soluble form by an engineered S. lividans, while attempts to express it in E. coli and 
B. subtilis failed.13 Streptomyces are also less susceptible to phage infections than E. 
coli and B. subtilis.  
On the other hand, there are also disadvantages of using Streptomyces instead of 
classical bacterial hosts as E. coli and B. subtilis, e.g.: 
• mycelial growth limits mass transfer and complicates mixing and oxygen 
supply; 
• tools for genetic manipulation are not as well developed; 
• Streptomyces genomes are usually very large with many regulatory proteins, 
which makes it difficult to predict an outcome of a genetic modification. 
All in all, Streptomyces are very suitable for secondary metabolites production and as 
more knowledge is accumulated they are also becoming more attractive hosts for 
production of other compounds. 
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In this chapter we will briefly discuss Streptomyces genomic organization and tools 
available for genetic modifications. We will thereafter describe the application of 
some analysis tools that allow more advanced knowledge-based strain design, like 
microarrays, proteomics, fluxomics, etc. The chapter will end with a review of various 
strategies that have been used to enhance production of secondary metabolites and 
proteins in Streptomyces species. 
7.2. The Streptomyces genome and its modification 
7.2.1 Streptomyces genomes 
It is an implication for metabolic engineering that genetic tools for changing gene 
expression are available. Knowing the genome sequence of the organism gives a 
tremendous advantage and improves both the speed and the quality of genetic 
modifications. Until 2002 only sequences of single Streptomyces genes or clusters 
were available. In 1999 Hopwood and co-workers from the John Innes Centre and 
the Sanger Institute started an initiative on sequencing the whole genome of S. 
coelicolor A3(2), the best genetically studied Streptomyces strain, often used as a 
model antibiotics producer. In 2002 the genome sequence was published in Nature 
and this marked a new era for Streptomyces research.14 At the time of publication it 
was the largest bacterial genome sequenced with 8.7 Mb base pairs (Figure 7-2). 
The coding density was high as also found for other bacteria, and about 8,000 open 
reading frames were predicted. Thus the bacterium contained more genes than the 
eukaryotic yeast Saccharomyces cerevisiae. The chromosomes of most of 
Streptomyces spp. are linear in contrast to more common circular chromosomes in 
prokaryotes.15, 16 To the ends of the chromosome terminal proteins are covalently 
bound, these proteins probably act as primers for the replication of the last fragment 
of the lagging strand when the transcriptase reaches the end of the chromosome. 
The ends contain long terminal inverted repeats. The origin of replication is often 
positioned around the center of the chromosome. The genes essential for growth are 
mostly allocated on the core of the chromosome, while the arms contain genes for 
secondary metabolism and alternative nutrients utilization. The arms of a 
chromosome are often subjected to mutations, which can cause deletions of up to 2 
kb of sequence, duplications of parts of the sequence or circularization of the 
chromosome17, consequently the industrial producers are often genetically unstable, 
that is the product titers can decrease in the course of propagation or cultivation due 
to spontaneous genetic rearrangements. The genes for secondary metabolism are 
grouped into clusters, which usually include biosynthetic, resistance and regulatory 
genes. In the S. coelicolor genome 20 clusters were predicted, of which only 3 were 
known prior to the genome sequencing. It was predicted that around 1,000 proteins 
play a regulatory role as transcription factors, response regulators, σ−factors, etc. 
This renders Streptomyces one of the most sophisticatedly regulated bacteria and 
thus makes metabolic engineering of this organism more challenging. 
A year after publication of the S. coelicolor sequence, the genome sequence of S. 
avermitilis, an industrial producer of the antiparasitic compounds avermectins, was 
released.18 The sequence of the plant parasite S. scabies has become available in 
2006, although the annotation of the genome was not yet completed at the time of 
writing. Other Streptomyces genomes are in the pipeline for genomic sequencing: S. 
ambofaciens, S. peucetius (Genomes OnLine Database, www.genomesonline.org). 
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S. diversa genomic sequencing was performed by Diversa/Celera but the sequence 
remains proprietary so far. 
 
Figure 7-2. Streptomyces coelicolor chromosome. The outer scale is numbered 
anticlockwise in megabases and indicates the core (dark blue) and arm (light blue) 
regions of the chromosome. Circles 1 and 2 (from the outside in), all genes (reverse 
and forward strand, respectively) color-coded by function (black, energy metabolism; 
red, information transfer and secondary metabolism; dark green, surface associated; 
cyan, degradation of large molecules; magenta, degradation of small molecules; 
yellow, central or intermediary metabolism; pale blue, regulators; orange, conserved 
hypothetical; brown, pseudogenes; pale green, unknown; grey, miscellaneous); circle 
3, selected ‘essential’ genes (for cell division, DNA replication, transcription, 
translation and amino-acid biosynthesis, color coding as for circles 1 and 2); circle 4, 
selected ‘contingency’ genes (red, secondary metabolism; pale blue, exoenzymes; 
dark blue, conservon; green, gas vesicle proteins); circle 5, mobile elements (brown, 
transposases; orange, putative laterally acquired genes); circle 6, G + C content; 
circle 7, GC bias ((G - C/G + C), khaki indicates values >1, purple <1). The origin of 
replication (Ori) and terminal protein (blue circles) are also indicated.14 
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7.2.2 Molecular biology of Streptomyces 
Molecular biology work with Streptomyces has its own rules and tricks, which are well 
described in an excellent handbook “Practical Streptomyces Genetics” by Kieser et 
al. from the John Innes Center.11 Here we will just briefly go through the main 
difficulties that one might stumble into in the beginning of working with Streptomyces. 
Streptomyces have a very high GC content, e.g. 72% in the S. coelicolor genome. 
This complicates PCR reactions, sequencing and might render plasmids unstable in 
E. coli. Furthermore many Streptomyces have a restriction barrier, which makes it 
impossible to transform them with methylated DNA.19 To avoid methylation the 
plasmids can be passed through non-methylating E. coli strains (as ET12567)19 or 
through S. lividans before introduction into the host. It is common to use conjugation 
from E. coli to deliver the DNA into Streptomyces and the method works well with 
nearly all species.20, 21  Some strains can be transformed by PEG-assisted protoplast 
transformation or transfected by phages. One should be careful when choosing 
antibiotics selection markers because many strains will be naturally resistant to 
certain antibiotics. 
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7.2.2.1 Overexpression of genes 
Many vectors for over-expression of genes in Streptomyces have been published 
and patented recently. These include both self-replicating and integrating vectors. 
There have been some reports that multicopy vectors reduce antibiotics production, 
so it is advisable to use integrating vectors whenever possible. High-producing 
strains seem to be particularly sensitive to the metabolic load imposed by multicopy 
plasmids and vectors are therefore lost in the absence of selection pressure.11 
Integrative vectors often contain the attachment site attP and the gene int, coding for 
integrase from phage phiC31.22, 23 Many Streptomyces carry a attB sequence, 
identical to attP, in their chromosome. The integrase protein promotes recombination 
between att sites and thus causes vector integration. Even when there is no attB 
sequence present in the chromosome, integration can still occur through 
recombination with sequences, which are homologous to attB.24 A range of strong 
constitutive and inducible promoters are available, e.g. thiostrepton-inducible tipA25, 
modified constitutive ermP* [personal communication with Mervyn Bibb, John Innes 
Centre, UK], and snpR-activated snpA26, 27. To achieve a range of expression levels 
one can also use synthetic promoter libraries.28, 29  
7.2.2.2 Replacement of genes 
The classical gene inactivation method works by interrupting the desirable gene by a 
plasmid through homologous recombination. Depending on the number and position 
of homologous sites on the plasmid single or double crossover occurs and the gene 
is either interrupted by insertion of a foreign fragment or is partly or totally substituted 
by a selection marker. The selection marker can be afterwards removed leaving a 
small nucleotide sequence, called “scar”, in the place of the deleted gene. The 
process of plasmid construction and mutant selection is normally quite time-
consuming and can easily take several man-months. The real breakthrough for yeast 
genetics was the discovery of a PCR-based gene replacement method30, which 
reduced the time needed to make a mutation down to a few days and furthermore it 
could be almost fully automated. Later they found out that a similar strategy could be 
applied in E. coli by expressing λ-recombinase from a low-copy number easily 
curable plasmid.31 The success with E. coli has paved the way for a faster gene 
replacement method for Streptomyces.32 The method, called REDIRECT, is based 
on replacement of a gene on a cosmid by a PCR fragment in an E. coli strain, 
engineered for efficient λ-recombination and for low degradation of linear DNA 
strands. The mutated cosmid is then extracted from E. coli and introduced into 
Streptomyces, where it by homologous recombination replaces the gene of interest. 
In comparison to the plasmid-based methods, the mutant cosmid construction is 
quite fast and the success of recombination in Streptomyces is increased due to very 
large homologous regions on the cosmid. It is possible to loop out the resistance 
cassette later, leaving a “scar”, which will not disturb the transcription of the 
surrounding genes. This allows studying an effect of single gene deletion even when 
the gene is a part of an operon.32 The removal can either be done using FLP 
recombination or Cre-loxP  system. In FLP recombination method the mutated 
cosmid is transferred into an E. coli strain carrying FLP recombinase on a plasmid. 
After the recombination has occurred the cosmid with the “scar” can be isolated from 
the E. coli and transferred into the mutated Streptomyces strain. The replacement of 
resistant marker by “scar” in Streptomyces is selected by loss of antibiotics 
resistance.32 Another procedure suggests to use loxP sequences instead of FLP 
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recombination targets and to use an engineered Cre phage to infect the mutated 
Streptomyces strain and to perform the loxP recombination directly inside the 
Streptomyces cell. The phage infection can be cured in a few sub-cultivations.33  
The prerequisite for using this knock-out method is the availability of a cosmid with 
the gene of interest, which is not always readily available for industrial strains. 
 
Figure 7-3. Flowchart of gene disruption in Streptomyces using PCR targeting.32 1 – 
The knock-out cassette, containing antibiotics resistance marker, origin of transfer 
and elements for cassette loop-out, is cut from the plasmid and purified. 2, 3 – The 
cassette is amplified by PCR using primers which carry upstream and downstream 
sequences of the gene which should be replaced. 4 – Streptomyces cosmid is 
transformed into an E. coli strain BW25113/pIJ790, which was designed for improved 
homologous recombination. 5 – The E. coli carrying the cosmid with the gene of 
interest is transformed with the knock-out cassette. On induction of λ-RED genes by 
arabinose, the cassette integrates into the cosmid by homologous recombination. 
The λ-RED plasmid with a temperature sensitive replicon is cured by inoculation at 
37ºC. The mutated cosmid is isolated and transformed into a non-methylating E. coli 
strain ET12567, which carries transfer functions on plasmid pUZ8002. 6 – The 
mutated cosmid is transferred into Streptomyces by conjugation from E. coli and the 
mutants screened, the double cross-over transformants should be resistant to the 
chosen resistance marker and sensitive to kanamycin. 7 – The knock-out cassette 
can be removed from the mutated cosmid in E. coli with expressed FLP-recombinase 
gene and the newly made cosmid with a “scar” can be introduced into the mutated 
Streptomyces strain. The double cross-over event is selected by loss of antibiotics 
resistance. 
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7.2.2.3 Transposon mutagenesis 
Genome-scale mutant libraries are interesting for systems biology approaches, for 
example to relate phenotypic features to the genotype. To generate large libraries, 
transposon-based mutagenesis techniques have been successfully applied.34-36 
Transposons are mobile genetic elements, which can change their position in the 
genome. Depending on their structure they are divided into class I and class II 
transposons. Class I transposons are composed of some gene (e.g., drug resistance 
gene) flanked by insertion sequences (IS). ISs are typically 0.7-1.8 kb long 
sequences with repeats at the termini; they code for a single protein, which is 
involved in transposition. Class I transposons can transpose as a unit, but the 
flanking ISs can also transpose separately. Class II transposons carry a transposase 
and some other gene (-s) flanked by indirect repeats of 30-40 bp, they can only 
transpose as the whole unit. Genetically altered transposons lacking transposase 
have been designed. Transposase can be supplied in trans for the transposition 
event and then removed; without transposase the transposon insertion is stable in 
the genome.  
There are some difficulties associated with transposon mutagenesis. More than one 
insertion per genome can occur and hence some mutants can carry insertions in 
several places of DNA. The problem can be circumvented by using Tn3-like 
transposon, which insertion results in transposition immunity whereby a second 
insertion in the DNA molecule is inhibited.37 Another problem is that transposons are 
usually biased towards integrating in particular sequences and so the obtained 
mutations will not be evenly distributed over the chromosome.11, 38 Finally, the 
transposons are usually polar, that is upon insertion they will disturb expression of 
the downstream genes. This is because the flanking regions of the transposons 
normally serve as termination signals for RNA transcription and transposons have 
nonsense codons in all reading frames causing translation termination.  
In vivo transposon mutagenesis is performed by introducing transposase on a suicide 
plasmid and a transposon into the host and selecting for antibiotics resistant 
phenotype caused by transposon insertion into the chromosome (Figure 7-4A). The 
result of in vivo mutagenesis is a mix of mutants, which can further be isolated and 
characterized to find out which gene that has been disrupted. Because identification 
of insertion position is at present a time-consuming procedure, only strains with 
interesting phenotypes are generally investigated. A mutant library of S. lividans has 
been generated by in vivo transposon mutagenesis.39 Screening identified a bald 
mutant, which was investigated further. By inverse PCR and sequencing it was 
determined that the mutant had an insertion in the osmoadaptation regulator osaB 
gene. The mutant turned out to overproduce antibiotics on medium with high 
osmolytes concentration.40 In vitro mutagenesis can be used as a targeted approach. 
Here the mutagenesis can be performed by mixing the cosmids containing the 
sequence of the host organism with the transposon and purified transposase (Figure 
7-4B). The mutagenized cosmids are transformed into E. coli, isolated and the 
insertion position is determined. To obtain a desired insertion, a suitable cosmid is 
transformed into the host, where its integration by double cross-over can be detected 
using selection markers. A collection of S. coelicolor mutagenized cosmids is being 
constructed with the funding from The Biotechnology and Biological Sciences 
Research Council (BBSRC, UK) and is available for academic research from 
Swansea University, UK. The positions of the insertions are shown on the SCODB 
website (http://streptomyces.org.uk/sco/index.html). At the moment of writing the 
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library contained mutagenized cosmids for disruption of about 60% of the open 
reading frames. In the cosmids that have been processed single insertions were 
obtained for about 90% of the open reading frames; the rest of the ORFs will have to 
be inactivated by a different method (e.g., REDIRECT). 
 
Figure 7-4. Simplified scheme of in vivo (A) and in vitro (B) transposon mutagenesis. 
A. 1 –Streptomyces is transformed with a suicide plasmid containing transposon and 
transposase gene. 2 – Streptomyces insertion mutants are selected by apramycin 
resistance. 3 – Mutants with interesting phenotypes are characterized by PCR to 
determine the transposon insertion position. B. 1 – Cosmid containing a part of 
Streptomyces genome is mixed with transposon and purified transposase in vitro, the 
resulting mutated cosmids are electroporated into E. coli. 2 – Antibiotics resistant 
clones are selected; the position of insertions is characterized by PCR for a large 
number of clones. 3 – For disruption of a particular gene (yellow) a suitable mutated 
cosmid is transformed into Streptomyces by conjugation from E. coli. 4 – 
Streptomyces colonies that are apramycin resistant and kanamycin sensitive are 
selected; they result from double cross-over event and carry insertion in the gene of 
interest. 
 
The disadvantage of gene inactivation by insertion instead of deletion is that: firstly, 
the gene can remain partly or fully functional with insertion, particularly if the insertion 
is further from the 3 -´end of the gene41, 42 and secondly, the expression of the 
downstream genes will most likely be disturbed by transposon, making the method 
unsuitable for studying knock-outs of genes, which are parts of an operon.  
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7.3 Analysis of Streptomyces strains 
During the past years we have witnessed an extensive development of analytical 
techniques in biological sciences. They have allowed quantitative measurements of 
various cellular components from RNA and proteins to metabolites. The advances in 
analytical methods along with progress in computer driven analysis of data gave birth 
to systems biology, where the cells are viewed as a system of various interacting 
components. One outcome of systems biology is integrative models that allow us to 
make better estimations of how we can change the cellular metabolism in a desired 
direction, so we can make metabolic engineering with a higher success rate.  
7.3.1 Transcriptome 
As soon as the genomic sequence of S. coelicolor started to be released, the first 
cDNA arrays appeared. All of the transcriptome work published until today are done 
with PCR – or oligonucleotide arrays available for academic research from Stanford 
School of Biomedical and Molecular Sciences (USA) and from Surrey University 
(UK). It is also possible to buy on-situ synthesized arrays (NimbleGen Systems Inc., 
USA), though the high price is a barrier for their extensive use. 
Gene expression analyses have cast light on many transcriptionally regulated 
processes in Streptomyces. In the first published study the authors monitored gene 
expression during the course of a batch fermentation of S. coelicolor. They observed 
that expression of secondary metabolite gene clusters as well as expression of many 
biosynthetic, ribosomal and regulatory genes was changing during the different 
developmental phases. This paper also presented an algorithm for finding 
boundaries of clusters of co-expressed genes.43 In another study the same group 
tested the hypothesis that the genes in the central part of the chromosome encode 
“core” functions connected to growth. They found that during the non-limited growth 
indeed the expression level was higher in the core of the chromosome than on its 
right and left arms. During the stationary phase and at different stress conditions the 
expression of the core genes decreased and various other genes throughout the 
chromosome composed the bigger part of the transcripts. Those were genes related 
to stress, morphological differentiation, and other less characterized genes.44  
There has also been a few studies on regulatory mutants of S. coelicolor, e.g. with 
deletions of specific activators of antibiotics gene clusters (actII-4 and redD)43, 
deletion of the heat shock protein hspR45 and deletion of the two-component element 
absA1 with an effect on antibiotics genes expression46.  
A range of bioinformatic tools have been used for prediction of operons in S. 
coelicolor.47 When expression data from some of the previous studies was overlaid 
on the predicted operons, it was observed that expression usually decreases from 
the first to the last gene in a given operon. This polarity of gene expression is not 
observed in E. coli and is thought to be attributed to the Streptomyces high GC 
content, which complicates the transcription process. A few genes positioned in the 
middle of the operon were expressed higher than the first gene, but in front of those 
genes internal promoters were commonly found.47 The global transcriptional studies 
have revealed regional fluctuations of gene expression across the chromosome 
(Colin Smith, Surrey University, UK, presentation at Genetics of Industrial 
Microorganisms 2006). One of the explanations could be the variation in the binding 
of histone-like proteins to DNA. The S. coelicolor histone-like proteins are small 
proteins around 12-16 KDa, which bind to the chromosome in form of dimers or 
heterodimers, making the nucleoid. It’s been proven that genes transcription was 
 Metabolic engineering of Streptomyces 
 
143 
positively correlated with their exposure as determined by sensitivity to DNase I 
treatment.48 Hopefully further research in gene expression will provide system-level 
knowledge on transcriptional regulation in Streptomyces.  
Microarrays can also be used to analyze overproducing mutants generated by 
random mutagenesis in order to understand why overproduction occurs and use the 
knowledge for directed design of strains, in the process of inverse metabolic 
engineering. The industrial overproducers of erythromycin and tylosin, 
Saccharopolyspora erythraea and S. fradiae respectively, were compared to the 
corresponding wild type strains using spotted arrays. The arrays were based on the 
S. coelicolor genomic sequence but additionally contained spots for the erythromycin 
and tylosin gene clusters. The industrial S. erythraea was found to have longer and 
more extensive expression of antibiotics biosynthetic genes than the wild type, while 
the industrial S. fradiae strain had changes in the expression of some metabolic 
genes involved in biosynthesis of the tylosin precursor.49 
7.3.2 Proteome 
The levels of mRNA, which can be measured by microarrays, do not necessarily 
correlate with protein concentrations. Besides, protein activity, function and half-life 
time are greatly affected by posttranslational modifications. Protein concentrations 
and modifications can be estimated in proteomics analysis and the information may 
be helpful in metabolic engineering.  
Hesketh et al. reported results of 2D gel electrophoresis of S. coelicolor whole cell 
extracts followed by MALDI-TOF mass spectrometry.50 About 10% of all the 
predicted S. coelicolor proteins were detected. Positively, the sequences of all the 
proteins agreed with previously predicted sequences,14 signifying the high quality of 
the genome annotation. On average 1.2 spots were detected per protein sequence, 
which shows that there is a high degree of posttranslational modifications. 2D gels 
provide more qualitative than quantitative information, which limits data interpretation. 
A more advanced approach to proteome analysis is multidimensional LC-LC-MS, 
which has been applied for analysis of the industrial S. diversa strain (Steve Briggs, 
Diversa, USA, presentation at the conference Metabolic Engineering V).  
7.3.3 Metabolome 
There are no published data on metabolome analysis in Streptomyces. For the 
analysis of intracellular metabolites a popular quenching method with cold methanol 
is not advisable because of the substantial leakage of intracellular metabolites.51, 52 
Rapid filtration followed by quenching with liquid nitrogen can be an alternative53, but 
this is not very suitable for metabolites with high turnover rates. 
7.3.4 Fluxome 
In metabolic engineering comparison of flux maps for reference and mutant strains 
represents an invaluable source of information about operation of the metabolic 
network in the two strains. Metabolic fluxes for Streptomyces have often been 
calculated applying metabolic models of various sizes based on only a few 
measurements of fluxes in and out of the cell.54-56 One should be careful in 
interpretation of these data, as these metabolic models often have a high degree of 
freedom and hence the solution identified, i.e. the set of fluxes, may not be unique. 
More sound flux data is generated by applying isotope labeling technique for 
metabolic flux analysis (13C MFA), where metabolite balancing is supplemented by 
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isotope balancing making the models more determined. The enrichment of 
compound with isotopes can be determined by gas chromatography coupled to mass 
spectrometry (GC-MS) or 13C nuclear magnetic resonance (NMR). Besides enabling 
robust quantification of the metabolic fluxes this approach may be used to map the 
network topology. Thus, GC-MS analysis of cells grown on [1-13C]-glucose led to 
discovery of a glycolytic pathway unusual for actinomycetes in Nonomuraea sp. 
3972757 and in S. tenebrarius58. In both these organisms the Entner-Doudoroff (ED) 
pathway was identified, and its presence has implications on the reducing cofactor 
biosynthesis and energy metabolism, because of a different stoichiometry in this 
pathway compared with the Embden-Meyerhof-Parnas (EMP) pathway. In vivo 13C 
and 15N NMR analysis of actinomycin D-producing Streptomyces parvulus, grown on 
fructose-glutamate medium, revealed high flux via gluconeogenesis as well as the 
origin of some of actinomycin D precursor amino acids.59 In other studies using C13 
MFA it was possible to spot changes in metabolism occurring over the time course of 
cultivation when the cells progress from exponential growth to the stationary 
production phase. In both actinorhodin-producing S. lividans and in nystatin-
producing S. noursei, a decrease in the pentose phosphate (PP) pathway activity 
was observed upon onset of antibiotics production.54, 60 In actinomycetes that have 
an active ED pathway (Nonomuraea sp. 39727 and S. tenebrarius), the ED pathway 
flux was found to decrease and more glucose was diverted to the EMP and pentose 
phosphate (PP) pathways upon onset of production.58, 61 C13 flux analysis of a S. 
coelicolor mutant with deletion of one of the phosphofructokinase isoenzymes 
(PFKA2) showed that this mutant had a higher flux through the PP pathway. Pentose 
phosphate pathway supplies NADPH, a cofactor used in many antibiotics 
biosynthesis. The increase of PP flux correlated with overproduction of the 
pigmented antibiotics actinorhodin (ACT) and prodigiosins (RED) in the mutant.52  
7.4 Modeling and design of Streptomyces strains 
Whole cellular models still remain only a far-away perspective, even for such well-
studied organisms as E. coli and yeast. For the complex Streptomyces bacteria 
availability of whole cell models, which include metabolism, regulation, kinetics, etc. 
is not likely for a very long time. However, for the purpose of metabolic engineering 
simpler genome-scale metabolic models have proven to be useful.  
Genome-scale metabolic models represent most of the metabolic reactions known to 
be performed by a given organism either from its genomic sequence or from 
physiological and biochemical data. As an example of genomic evidence, the 
presence of lactate dehydrogenase in the S. coelicolor genome implies that the cells 
can reduce pyruvate into lactate at the expense of NADH. As an example of 
physiological evidence could be the ability of S. coelicolor to degrade starch, telling 
that the organism possesses amyloglucosidases. Furthermore, biochemical data tells 
for instance that the S. coelicolor proteins contain histidine and as the cells don’t 
require amino acids supplementation for growth, all the enzymes for histidine 
biosynthesis must be present.  
A genome-scale metabolic model has been reconstructed for S. coelicolor62 and 
models for a few other Streptomyces are under way (e.g., S. scabies). The models 
can be useful for – omic data interpretation63 and for predictions, e.g. of strain 
improvement targets64, 65.  
The reporter metabolite methodology,66 which identifies around which metabolites 
most pronounced transcriptional  changes have occurred, was applied for analysis of 
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transcriptional data from phosphofructokinase deletion mutant (∆pfkA2) as compared 
to the reference strain. One of the most scoring reporter metabolites was NADPH, 
which is consistent with the increased pentose phosphate pathway flux in the 
mutant.52  
Model guided strain design is a new phenomena, and hasn’t been used for 
Streptomyces yet, however it has been successfully applied for other organisms, e.g. 
for improvement of lycopene production in E. coli.67, 68 This systematic metabolic 
engineering approach could allow design of superhosts for production of different 
classes of secondary metabolites. Another application could be design of strains with 
certain metabolic problems (like excess production of NADPH). These strains can be 
used for improvement of enzymes properties. For example, for improvement of 
NADPH-dependent reductase, it is inserted into an engineered NADPH-
overproducing strain and the strain is grown for many generations until the growth 
rate is improved. The resulting enzyme-coding gene is isolated and it will often carry 
mutations that have improved enzymatic activity. (METEVOL® technology from 
METabolic EXplorer, France).  
7.5 Examples of metabolic engineering in Streptomyces 
7.5.1 Using an optimized host 
Development of industrial Streptomyces production strains usually starts (and often 
ends) with chemical or UV mutagenesis followed by selection. Another popular 
method is protoplast fusion, which often results in breeds performing better than the 
parental strains. These methods are simple and relatively easy to apply; they do not 
require priory knowledge about the biosynthetic pathway, coding genes, etc. The 
disadvantages are that they are random, non-reproducible, can take long time and 
have to be applied to each strain that produces a new product.  
Many new secondary metabolite-producing organisms have been discovered 
recently. To evaluate the bioactivity of new metabolites it is necessary to produce 
them in fair amounts, which is often a problem with natural producers. Optimizing 
each wild type strain is tedious and expensive. For secondary metabolite genes, 
which are isolated from soil samples or generated by gene shuffling and other 
procedures, there is no strain to start with at all. A good expression host would 
greatly speed up the testing process and further enable high level production if the 
metabolite turns out to possess interesting properties.  
The most natural solution would be to have a range of optimized hosts for production 
of compounds from a particular class (β-lactams, polyketides, non-ribosomal 
peptides, etc.). The hosts should be clean, that is not being able to produce native 
secondary metabolites in significant amounts. They should also be capable of 
producing precursors for many compounds belonging to the same class. One of the 
options is to develop superhosts from already optimized industrial strains. Industrial 
strains of S. fradiae and Saccharopolyspora erythraea have been engineered into 
plug&play superhosts for polyketide production.69 To start with, the whole native 
clusters of tylosin and erythromycin were deleted. S. erythraea did not contain a 
specific attB site for phage integration and hence this site was introduced to allow 
integration of the plasmid delivering biosynthetic genes for a new product. To test the 
hosts, the biosynthetic genes were then cloned from wild type low-producing strains 
of S. fradiae and S. erythraea and introduced into the engineered hosts using 
integrative plasmids. The levels of antibiotics production did not differ from that 
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obtained with the endogeneous antibiotic clusters in the original industrial strains, 
even when native promoters for the endogenous biosynthetic genes were used. It 
was found that the promoter sequences did not differ in the mutated industrial and 
the wild-type strains, indicating that during the optimization of these strains most of 
the changes did not occur in the sequences of the biosynthetic genes or their 
promoters, but elsewhere. Better production in industrial strains might instead have 
been caused by increased substrates uptake rates, better production of Gibbs free 
energy and precursors and most probably also deregulation of secondary metabolite 
genes expression. One should, however, keep in mind that sometimes the strains 
can be overproducing for other reasons, like multiplications of the biosynthetic 
clusters (see also below, section 5.2), and obviously such strains do not represent a 
suitable superhost platform for production of other antibiotics. Interestingly, 
expressing the biosynthetic gene clusters behind a strong constitutive promoter like 
ermEP* or by using the S. coelicolor actUIp/actII2-4 expression system in the above 
mentioned industrial strain backgrounds resulted in 20-fold decrease in antibiotics 
titers.69 This is curious because there has been a successful attempt to improve 
erythromycin production through substitution of the native promoter in a wild type S. 
erythraea to the actUIp/actII2-4 system.70 However, in the industrial strains the 
regulation might be changed and the expression of the biosynthetic genes from the 
newly introduced promoters might have been weaker than from the original ones.69 
The barrier in using industrial strains as superhost platforms is that they are usually 
proprietary and not sequenced. Alternatives could be well-studied strains such as S. 
coelicolor and S. lividans.  Both of these strains have been used for heterologous 
expression of secondary metabolites biosynthetic genes from other organisms that 
are poorly characterized genetically or are problematic to grow in the lab. Expression 
of a large modular polyketide synthase from S. erythraea of about 30.8 kb long in S. 
coelicolor71 and in S. lividans72 gave good yields of 6-deoxyerythronolide B, the 
aglycone unit of erythromycin. The myxobacterium Sorangium cellulosum is a natural 
producer of the valuable anti-cancer agent epothilone, but the bacterium is slow-
growing and forms multicellular fruiting bodies on agar plates, which complicates 
genetic engineering.73 The epothilone-coding genes were therefore cloned into S. 
coelicolor CH999 host, which has the actinorhodin biosynthetic genes deleted and 
the prodigiosins production blocked.74 This resulted in a strain that could produce up 
to 0.1 mg/L epothilones A and B in non-optimized fermentation.75 The titer was lower 
than in Sorangium cellulosum fermentations (up to 20 mg/L), but similar values could 
be reached after medium optimization. The main advantage of this strategy is that S. 
coelicolor grows ten times faster than the native host and is well amenable for 
genetic manipulations, which is useful for generating epothilone analogues. 
7.5.2 Increasing expression of genes from the biosynthetic cluster 
In the wild type strains secondary metabolite genes are often weakly expressed or 
not expressed at all under the given conditions and the yields of the compounds are 
very low. Over-expression of the whole cluster or of some of the rate-controlling 
enzymes will often result in higher production. Multiplication of the whole cluster was 
observed in industrial strains that have undergone empirical selection. A commercial 
S. kanamyceticus strain (Meiji Seika Kaisha Ltd., Japan) used for kanamycin 
production contains up to 36 copies of the kanamycin biosynthetic cluster.76 The 
cluster is located within an amplifiable unit of DNA (AUD), which made this high copy 
number possible. AUD consists of internal sequence flanked by direct repeats, AUDs 
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usually are located in the arms of the chromosome, which are genetically unstable. 
AUDs can make tandem repeats, which include several hundred copies of the DNA 
unit.39 The amplification is often accompanied by deletions of other regions of DNA. 
Interestingly, Meiji Seika Kaisha’s strain is maintained as a mycelial culture because 
the high producing kanamycin phenotype gets lost in a single sporulation round. The 
authors hypothesized that the problem lies in the limited space for chromosome 
packaging in the spore, which can not accommodate the 5 Mb long amplification.76 
Another way to increase gene expression is to replace a native promoter with a 
stronger, possibly inducible, promoter. Promoter substitution has been used to 
increase the expression of the xylose isomerase gene (xylA). This gene is normally 
induced by xylose and inhibited by glucose, and in order to have constitutive 
expression the xylA gene was put under control of a constitutive promoter and the 
construct was integrated on the chromosome of Streptomyces violaceoniger. This 
resulted in four to five fold improved xylose isomerase activity in the absence of 
xylose as inducer.77 Higher expression of whole biosynthetic gene clusters has been 
achieved by overexpressing positive regulators of the pathway or by deleting 
negative regulators. When the activator of the actinorhodin cluster (actII-4) or the 
activator of the prodigiosin cluster (redD) were introduced into S. coelicolor on a 
multicopy plasmid, the production of ACT and RED increased.78, 79 In another study 
two polyketide synthase clusters were found by DNA fingerprinting in Streptomyces 
sp. PGA64:  rubromycin cluster and a putative augucycline cluster. The second 
cluster was most probably silent under the given fermentation conditions because the 
strain produced only rubromycin in detectable amounts. Disruption of a putative 
augucycline cluster repressor resulted in a partial activation of the cluster and in 
secretion of two new augucycline metabolites - UWM6 and rabelomycin.80 
Overexpression of one or a few enzymatic genes from the biosynthetic cluster has 
also been a successful strategy. The challenging part is to determine which enzyme 
that has high flux control. In the fermentations of S. fradiae two major macrolides 
were found: tylosin, which is the product of interest and the tylosin precursor – 
macrocin. In the industrial strains from Eli Lilly they reported that tylosin accounted 
for 50-55% of all macrolides produced, while macrocin accounted for about 40%.81 
This clearly indicated that the conversion of macrocin into tylosin is rate-limiting in 
these strains. This process is catalyzed by a single enzyme macrocin O-
methyltransferase TYLF, and by inserting a second copy of the tylF gene it was 
possible to increase the fraction of tylosin in the macrolide pool from 50 to 80-85%.81 
7.5.3 Increasing precursor or cofactor supply 
Other approaches to enhance secondary metabolite production are to increase the 
biosynthesis of the precursor metabolites and to remove or hamper pathways that 
compete for this precursor with the secondary metabolites reactions. For example, 
malonyl-CoA and methylmalonyl-CoA serve as precursors for many polyketide 
antibiotics. To escalate the supply of these precursors the dicarboxylate transporter 
matC and malonyl-CoA synthase matB from Rhizobium trifolii were expressed in S. 
coelicolor, resulting in a strain that could take up relatively cheap substrates as 
malonate and methylmalonate and convert them into corresponding CoA thioesters. 
The strategy was tested in S. coelicolor, producing macrolactone 6-
deoxyerythronolide B, and resulted in a 3-fold increase in the macrolactone titer.82 
Also overexpression of acetyl-CoA carboxylase, which converts acetyl-CoA into 
malonyl-CoA had a positive effect on production of polyketide compound 
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actinorhodin in S. coelicolor.83 Nikkomycin production in S. ansochromogenes was 
improved by overexpressing two genes sanU and sanV, which together with 
coenzyme B12 form an active glutamate mutase, the latter participates in the 
biosynthesis of a precursor of nikkomycin.84 A more straightforward approach is to 
add precursors directly to the fermentation medium, and if the precursor(s) price is 
low this can be a feasible industrial solution. Thus, it has been found that addition of 
glycine, arginine, phenylalanine and tyrosine improve vancomycin production in 
Amycolatopsis orientalis.85 Tyrosine is a direct precursor in the pathway, whereas 
phenylalanine degradation leads to formation of another precursor 4-
hydroxyphenylpyruvate.  
Some precursors also lead to induction of the genes encoding enzymes involved in 
biosynthetic pathways. For example, lysine is a precursor for the first enzyme of 
cephalosporin biosynthetic pathway (L-Lysine epsilon-aminotransferase (LAT)), but it 
also induces expression of this enzyme in S. clavuligerus, and addition of lysine to 
defined medium improved cephamycin production.86An example of removing a 
competing pathway is blocking of clavams and cephamycin C biosynthesis in 
industrial S. clavuligerus, which improved clavulanic acid titers by 10%.87 Disruption 
of glyceraldehydes-3-phosphate dehydrogenase gap1 in the wild-type S. clavuligerus 
doubled clavulanic acid titers most likely because of higher diversion of 
glyceraldehyde-3-phosphate to clavulanic acid biosynthesis rather than glycolysis 
pathway.88 An interesting finding was that polyphosphate kinase ppk gene deletion 
causes antibiotics overproduction in S. lividans.89 In vivo, in condition of phosphate 
limitation, Ppk likely acts as a nucleoside di-phosphate kinase regenerating ATP from 
ADP and polyphosphates.90 The absence of this important ATP regenerating enzyme 
is predicted to lead to the lowering of  the intracellular energetic charge (low 
ATP/ADP ratio), which further triggers a strong activation of central metabolism 
coupled to respiratory chain in order to regenerate the necessary ATP.90 The 
increased antibiotics production can be caused by higher supply of precursors from 
the central carbon metabolism, though regulatory events due to lower ATP/ADP ratio 
are probably important as well. 
7.5.4 Changing morphology 
Filamentous bacteria pose certain challenges in connection with large scale 
fermentation processes when compared to unicellular organisms. During 
fermentation there are problems with nutrients and oxygen transfer and shear 
damage of cells from agitation. Filtration/centrifugation in the downstream processing 
is also complicated by the high viscosity of the fermentation broth. In many strains 
hyphae clump together in so-called pellets, which are spherical hyphal clumps. The 
cells in the center of the pellet may lack nutrients and oxygen, and these cells are 
often stressed or dead resulting in an inactive core of the pellets. Effectively, it is only 
the cells on the surface of the pellets that grow and synthesize the product. It has 
been observed for S. noursei, that when pellet size increased above a certain critical 
value, the growth and nystatin production ceased.91 In S. tendae submerged 
cultivations it was found that maximal productivity of nikkomycins was achieved at a 
pellet diameter of 1.4 mm, and the productivity was lower for both smaller and bigger 
pellets.92 Possibly, pellet formation protects S. tendae mycelia from hyphal 
fragmentation and hereby has a positive effect until the pellets reach a critical 
diameter where nutrient diffusion becomes a problem.  There is still much unknown 
about the impact of morphology on production and in some cases formation of larger 
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pellets seems to be desirable. For instance, S. lividans engineered for production of a 
hybrid antibiotic, was making the product only in the presence of compact mycelial 
pellets.93  
Apart from physical methods that can be applied to decrease pellets formation (high 
agitation rates, addition of viscosity-increasing agents, etc.), one can change the 
morphology at the genetic level. The SsgA protein that accumulates just before the 
onset of spore formation was first described in S. griseus (Yamamoto 1995). The 
protein is involved in formation of cross walls called septa. Vegetative septa are thin 
single-layer walls that divide vegetative mycelium into compartments, in contrast 
sporulation septa are thick double-layer walls that often form synchronically and 
divide sporogenic hyphae into chains of spores.94 When ssgA was over-expressed, 
S. griseus failed to sporulate in the submerged culture and the mycelium was highly 
fragmented.95 A homologous gene was also found in S. coelicolor; and 
overexpression of this gene caused increased septa formation in the vegetative 
mycelium.96 This resulted in a more fragmented mycelium and smaller and fewer 
pellets. The specific growth rate was increased 40 to 70% depending on the medium 
and the final concentration of undecylprodigiosin was higher by an order of 
magnitude.97 Over-expressing the S. coelicolor ssgA gene in other Streptomyces had 
similar effects: in S. roseosporus and S. lividans mycelial clumps got smaller and S. 
venezuelae did not longer sporulate in liquid medium. Excess of SsgA also improved 
growth and productivity of a S. lividans strain making a model protein tyrosinase, i.e. 
the specific growth rate was increased by 45% and tyrosinase productivity more than 
2 fold.97  
7.5.5 Improving oxygen supply 
Because of the filamentous character of Streptomyces, oxygen supply during 
fermentations is often limited. Streptomyces are strictly aerobic organisms and proper 
oxygen supply is essential for obtaining good biomass yields in the initial growth 
phase. Sufficient aeration is also necessary for some oxygen-dependent steps in 
product biosynthesis. For instance, there are two oxygen-dependent reactions in the 
biosynthesis of erythromycin.98, 99 Oxygen uptake of Saccharopolyspora erythraea 
was improved by over-expressing the bacterial hemoglobin gene vhb from 
Vitreoscilla sp. on an integrating vector, resulting in 60% higher erythromycin 
production.100 Positive effect of vhb expression on antibiotics production has also 
been observed in other Streptomyces species.101 
7.5.6 Improving secretion and reducing degradation of recombinant proteins 
The commonly used host for recombinant protein production E. coli often 
accumulates large amounts of heterologous proteins as insoluble aggregates in the 
form of inclusion bodies. Recombinant protein purification consequently has to 
involve cell disruption, separation of inclusion bodies as well as laborious protein 
refolding. Production of pharmaceutical proteins in secreted form has some major 
advantages over intracellular production: the secreted target protein is usually 
natively folded, yields can be as high as or higher than that obtained from 
intracellular E. coli accumulation and finally there is a reduced requirement for 
expensive extraction and purification procedures. In E. coli, as Gram-negative 
bacterium, secreted proteins accumulate in the periplasm due to the presence of an 
outer membrane. Secretion of proteins directly into the fermentation medium can be 
obtained using Gram-positive bacteria as production host, i.e. B. subtilis. Lately S. 
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lividans has also been employed for a number of recombinant protein processes.9, 10 
Streptomyces are good at secreting proteins because their survival in soil depends 
on their ability to secrete enzymes for degrading complex substrates. In the genome 
of S. coelicolor 819 genes encoding secreted proteins were predicted. These 
proteins include various enzymes for the degradation of exogenous substrates: 
proteases/peptidases, chitinases/chitosanases, cellulases/endoglucanases, 
amylases and pectate lyases. Extracellular proteins accumulate in the culture broth 
of S. coelicolor mostly during transition and stationary phases.102  
Proteins in Gram-positive organisms are transported through the Sec and the twin-
arginine translocation (Tat) pathways, but some polypeptides can be exported by 
ABC transporters and for some specific proteins other Sec/Tat-independent 
mechanisms exist (Paul Dyson, Swansea University, UK, presentation at Genetics of 
Industrial Microorganisms 2006).  
The Sec pathway is the most commonly used pathway. In B. subtilis deletion of the 
gene encoding SecA, a major player in the Sec pathway, reduced the extracellular 
proteome by 90%, suggesting that all these proteins used Sec transport.103 The Sec 
pathway consists of a few components (Figure 7-5). Membrane proteins SecY, SecE 
and SecG form a channel through which proteins are transported.104-106 SecA is the 
main driver of the transport process: it exists in a free form in the cytoplasm and in 
the SecYEG-bound form. SecA binds pre-proteins and, using the energy from ATP 
hydrolysis, step by step pushes the largely unfolded pre-proteins through the 
cytoplasmic membrane channel.107-110 SecDF associate with the SecYEG complex 
and contribute to the efficiency of protein secretion.111-114 Targeting of proteins to the 
SecYEG channel can occur in a post-translational process by chaperones or via the 
SRP-mediated pathway in a co-translational fashion. In the so-called co-translational 
translocation, protein translocation is coupled to their synthesis on the ribosomes.115, 
116
 When these proteins are emerging from the ribosome, their signal peptide is 
recognized by the signal recognition particle (SRP), which binds to the SRP receptor, 
FtsY protein117, conserved among all studied bacteria, including S. lividans.118, 119 In 
B. subtilis, SRP is required for the targeting of most secretory proteins.120 Other 
proteins are first completely synthesized and then exported in a so called post-
translational translocation. It is important that the folding of those proteins in the 
cytoplasm is prevented, because fully folded proteins can not be transported through 
the Sec system. A secretion-dedicated E. coli chaperone SecB stabilizes pre-proteins 
inside the cytoplasm, so they preserve the translocation-competent state.121, 122 SecB 
binds to SecA and in this way directs the proteins towards the translocation 
channel.123, 124 SecB homologs supporting post-translational targeting are not present 
in Gram-positive organisms.125 The role of other common chaperones and heat 
shock proteins (GroE and DnaK series) in the process of protein secretion is not very 
clear, but there is some evidence that they enhance secretion of proteins by reducing 
formation of protein agglomerates. Higher expression of GroE and DnaK operons, 
mediated by deletion of a negative regulator hrcA, combined with overexpression of 
extracytoplasmic molecular chaperone PsrA improved production of single chain 
antibody fragments in B. subtilis.126, 127 In Streptomyces the GroE operon is under 
negative regulation by the HrcA repressor128 and the DnaK operon is repressed by 
HspR.45, 129, 130 Deletion mutants ∆hrcA and ∆hspR have been constructed in S. 
coelicolor, S. lividans and S. albus strains.45, 128-130 So far, only the effect of hrcA and 
hspR deletion was investigated in S. lividans and, here, no positive effect on Sec-
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dependent protein secretion was observed (personal communication with Jozef 
Anné, Katholieke Universiteit Leuven, Belgium). 
 
Figure 7-5. Co-translational (whole line) and post-translational (dashed line) 
translocation of proteins via Sec pathway.125 
 
The twin-arginine translocation (Tat) pathway can transport already folded proteins 
often bound to redox cofactors. The pathway only uses proton-motive force as the 
energy source for transport. The proteins transported through the Tat pathway 
possess a signal peptide with a particular motif S/T-R-R-x-Φ-Φ (with Φ being a 
hydrophobic residue) with two neighboring arginines. The Tat pathway is well studied 
in E. coli131 and B. subtilis132 and was recently found in S. lividans133. The search for 
Tat-dependent signal peptides in the sequenced genomes of S. coelicolor and S. 
avermitilis gave a list of 230 proteins, which is the highest number of predicted Tat-
substrates for a bacterial genome.134 Very recently, experimental data provided 
strong evidence that the Tat system is used as a major general export pathway in 
Streptomyces.135 S. lividans with deletions of principal components of the Tat 
pathway, such as TatC or TatB, had retarded growth as well as impaired 
morphological differentiation on solid medium, confirming the importance of Tat-
dependent secretion.134 Some proteins require Tat-dependent secretion for being 
active. For instance, when xylanase C, a Tat-substrate, was directed to the Sec 
pathway through replacement of the signal peptide, the result was an inactive 
protein, which was quickly degraded after secretion.136 Overexpression of the tatABC 
genes in S. lividans, however, improved xylanase C production.137 To compare the 
transport through the Sec and Tat pathways, two human proteins (tumor necrosis 
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factor and interleukin 10) were expressed in S. lividans with fused Sec- or Tat- 
dependent signal peptides. The secretion was lower for the Tat pathway, which might 
be attributed to suboptimal combinations of signal peptide and target protein or to the 
lower capacity and speed or higher energetics of the Tat pathway itself.138 The 
authors made an interesting discovery: secretion through the Sec pathway was 
several fold (up to 15) improved in the strain with an impaired Tat-pathway (∆tatB). It 
seems that the presence of Tat proteins has a negative effect on the Sec pathway, 
because it has also been shown that in a S. lividans strain with overexpressed 
TatABC proteins, the secretion of Sec-substrates was reduced.137 In some cases 
combination of both secretion pathways can be beneficial: xylanase B production 
was improved in S. lividans when xylanase B1 was engineered to be secreted by Sec 
pathway and xylanase B2 by Tat pathway.139 The signal peptide, which directs the 
pre-protein towards a secretion pathway, is an important determinant of how 
efficiently the protein is secreted. A library of naturally occurring signal peptides from 
B. subtilis has recently been constructed.140 The library screening was successfully 
used to optimize production of cutinase from Fusarium solani pisi and of a 
cytoplasmatic esterase. However, the signal peptide, which was optimal for one 
protein was not efficient for another protein secretion.140 This study highlights that 
secretion depends both of the signal peptide sequence and of the sequence of the 
mature part, hence signal peptides should be optimized individually for different 
proteins. Li et al. mutagenized the signal peptide of xylanase C, exported through the 
Tat pathway, but did not achieve improvement of secretion in S. lividans.141 In 
contrast, it was possible to enhance the secretion of mouse tumor necrosis factor 
alpha through Sec pathway by decreasing the positive charge in the signal peptide 
sequence.142, 143  
During the export through the Sec or Tat pathways the signal peptide has to be 
cleaved off by signal peptidases. There are four known type I signal peptidases in S. 
lividans: sipW, sipX, sipY and sipZ.144 Deletion of one of the peptidases does not 
influence protein secretion, with an exception of sipY deletion, which decreases 
extracellular proteins concentration and gives a sporulation delay.145 Overexpression 
of sip genes had a positive effect on protein processing in S. lividans (personal 
communication with Nick Geukens, Katholieke Universiteit Leuven, Belgium), as also 
observed in B. subtilis.146, 147 Recently, it was also shown that phage-shock protein A 
(PspA), which is supposed to play a role in the maintenance of the proton motive 
force (PMF),148 affects the protein secretion yield in S.  lividans. As also observed in 
E. coli,149 pspA overexpression was found to improve the Tat-dependent protein 
secretion in S. lividans. The effect on Sec-dependent secretion was less pronounced 
and appeared to be protein dependent.150 During the whole process of translocation 
as well as after secretion the proteins are targets of endo- and extracellular 
peptidases/proteases. S. lividans is a popular strain for heterologous protein 
production due to its low protease activity.151 Growing S. lividans in a pelleted form 
further reduces the activity of extracellular peptidases.152 Some intra- and 
extracellular proteases have, however, been identified in S. lividans.153, 154 
Actinomycetes were also found to contain 20S proteosome, a structure made of self-
compartmentalizing protease, which otherwise occurs only in eukaryotes and 
archaea.155  Deletion of 20S proteosome in S. lividans had a positive effect on 
production of two heterologous proteins: soluble human tumour necrosis factor 
receptor II (shuTNFRII), secreted via Sec-pathway and salmon calcitonin (sCT), 
secreted via Tat-pathway, but did not affect the production of soluble human tumour 
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necrosis factor receptor I (shuTNFRI).156 This suggests that only some of the proteins 
are subjected to the proteosome activity and can benefit from proteosome deletion. 
7.5.7 Changing regulation 
By changing the central transcriptional regulators it is possible to introduce global 
changes in the metabolism. The outcome of such a modification is difficult to predict, 
but the increasing amounts of protein-DNA interactions and transcriptional data will 
hopefully allow designing modifications of this magnitude in the future.  
One of the best studied global regulators of secondary metabolism is the regulatory 
protein AfsR. It was first discovered in S. coelicolor as an element that induced 
overproduction of the signaling molecule A-factor and of the antibiotics actinorhodin, 
undecylprodigiosin157 and CDA158 when cloned into S. lividans.158 The effect on 
antibiotics production was mediated by enhancing transcription of secondary 
metabolic genes. Antibiotics production was reduced but not eliminated in a ∆afsR 
mutant.159 A homologue of asfR gene was found in S. peucetius, and when 
overexpressed it resulted in antibiotics overproduction in S. peucetius (doxorubicin), 
S. lividans TK 24 (γ-actinorhodin), S. clavuligerus (clavulanic acid) and S. griseus 
(streptomycin). AfsR is believed to activate transcription of a sigma-like gene afsR2, 
which in turn enhances transcription of the secondary metabolic genes by a yet 
unknown mechanism.160 Overexpression of afsR2 caused antibiotics overproduction 
in S. coelicolor161, S. lividans162, S. avermitilis163 and S. noursei164.  
Another regulator is S-adenosylmethionine (SAM), the methyl donor in methylation of 
nucleic acids, proteins and small metabolites. SAM levels in S. coelicolor peak 
around the point when actinorhodin appears in the medium.165 When SAM synthase 
coded by the metK gene was overexpressed in S. coelicolor, the intracellular SAM 
levels increased and it caused overproduction of actinorhodin, prodigiosins and 
calcium-dependent antibiotic (CDA). Actinorhodin biosynthesis was influenced 
through increased expression of the actinorhodin cluster activator actII-4. The 
antibiotics were also synthesized earlier than normally. Similar effect was observed 
when SAM was added into the culture of a wild type strain.165 Positive effect of SAM 
on antibiotics production has also been observed in S. lividans166 and other 
Streptomyces spp.167 
7.5.8 Modifying the product 
The increasing resistance of pathogens to antibiotics in current use raises the need 
for discovery of new antibiotics. The screening of soil isolates continues to bring new 
antibiotic-producing Streptomyces, but the process is slowing down as more and 
more species become known. It is speculated that 99% of all microorganisms can not 
be cultivated under laboratory conditions. To capture the antibiotics that could be 
produced by non-cultivatable Streptomyces and other microorganisms, researchers 
have started to look for DNA instead of microbes themselves. DNA can be isolated 
from environmental samples and incorporated into libraries, which can for example 
be screened by hybridization of the conserved genes sequences (like PKS).168-170 
Subsequently the discovered genes can be expressed in a heterologous host to 
study possible products encoded by the DNA.  
Another way of obtaining new products is by varying the genes coding for their 
biosynthesis. Most of the work has been done on polyketide synthases, which are 
large modular enzymes, encoding the synthesis of complex polyketide molecules. 
Polyketides are made in a mechanism that resembles the biosynthesis of long fatty 
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acids, but the units added at each step are often larger than an acetyl unit and 
moreover the molecules are subjected to various transformations during extension. 
Polyketide synthases consist of modules, each module containing transferases, 
reductases, dehydrases and other enzymes in different amounts and order. The 
modular structure and modules position in the cluster defines the final product. This 
unique organization of polyketide synthases allows generation of new products by 
combinatorial biosynthesis.74 Native parts of the module can be substituted with 
analogous enzymes from different strains: replacement of the acyl carrier protein in 
S. coelicolor actinorhodin cluster by homologues from other clusters resulted in 
production of new actinorhodin analogues.171 Other strategies are to change the 
substrate specificity of PKS enzymes by mutations172 or to shuffle the positions of the 
modules in the PKS173 or to delete certain enzyme functionalities174. Finally, it has 
been shown possible to reconstruct a desirable PKS from required elements175. 
Other genes that are very amenable for “genetic molecules design” are non-
ribosomal peptide synthases (NRPS), where different subunits are responsible for 
incorporating a particular amino acid into the peptide. A number of new daptomycin 
derivatives with antibacterial activity were obtained by substitution of the native 
NRPS subunit by a homolog from a different cluster.176 Feeding of slightly changed 
antibiotics precursors which can still be recognized and processed by the 
biosynthetic enzymes can also be used as a strategy to obtain new products.177 
7.6 Perspectives 
Over the past 50 years Streptomyces have been a rich source for production of many 
valuable secondary metabolites. With the recent development in genomic techniques 
Streptomyces studies have entered the post-genomic level, and this may allow better 
understanding of the metabolism, morphological differentiation and overall regulation 
in these complex bacteria. The accumulated knowledge will allow us to faster 
optimize industrial Streptomyces strains for the production of secondary metabolites, 
enzymes and other products. We envisage improvement of genetic manipulation 
techniques, which will facilitate the molecular biology of streptomycetes. 
We hope that large amounts of projects on screening of environmental DNA and 
RNA samples will bear fruits and new bioactive compounds, including efficient 
antibiotics, will be discovered to help us fight infections caused by drug-resistant 
pathogenic bacteria and other diseases. Thus, we foresee that Streptomyces will 
continue to play a very important role as workhorses for the production of natural 
products that serves as important pharmaceuticals also in the next 50 years. 
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Table 7-2. Useful links for Streptomyces 
http://streptomyces.org.uk  Streptomyces resource, contains links to S. 
coelicolor A3(2) genome annotation, 
pathway/genome database ScoCYC, microarray 
and proteomics data 
http://www.surrey.ac.uk/SBMS/Fgenomics/Microarr
ays/html/Facility.html  
Microarray production facility in Surrey University, 
making S. coelicolor DNA arrrays 
http://genome-www5.stanford.edu/  Stanford MicroArray Database contains some 
expression data from Streptomyces 
Strep-microarray.sbs.surrey.ac.uk/stropE.html Operon predictions in S. coelicolor47 
http://streptomyces.org.uk/redirect Web tools for design of REDIRECT knock-out in S. 
coelicolor 
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8.1 Abstract 
Streptomyces are important industrial organisms, producing more than half of the 
antibiotics currently in clinical use. We used a model-guided approach to improve 
actinorhodin production in the model organism Streptomyces coelicolor A3(2). A 
genome-scale model was applied to analyze the changes in metabolic fluxes for 
single gene-knockouts. The mutants, which were predicted to have higher 
actinorhodin flux, were constructed and characterized in submerged cultivations. 
Antibiotics production was not increased significantly in any of the mutants, however, 
the citrate synthase A deletion mutant and the malate dehydrogenase deletion 
mutant both secreted pyruvate and acetate, which is an indication of increased pool 
of a common polyketides precursor – acetyl-CoA. Further work is necessary to direct 
the excess acetyl-CoA into polyketides biosynthesis. 
Keywords 
Streptomyces, metabolic model, in silico design.  
8.2 Introduction 
Antibiotics resistance of human pathogens is a rising healthcare problem, particularly 
in the countries with extensive use of antibiotics (e.g., USA).  At the same time the 
release of new antimicrobial drugs to the market has been decreasing over the past 
20 years. Classical discovery methods where soil bacteria are cultivated and tested 
for inhibition of bacterial growth or other biological activities tend to find mostly 
compounds that are already known. New post-genomic techniques are emerging; 
they are based on DNA from non-cultivable species, on activation of silenced 
biosynthetic clusters and on combinatorial biosynthesis of new drugs by DNA 
manipulation. These techniques require a good plug&play host to test the activity of 
the isolated or synthesized biosynthetic clusters. Streptomyces species have yielded 
more than half of the drugs that we currently use and are believed to provide more 
drug candidates by the usage of post-genomic techniques. Hence, model 
Streptomyces strains are interesting starting points for development of such 
plug&play systems. Streptomyces are soil filamentous bacteria, capable of 
morphological differentiation and sporulation. Due to their high GC-content (around 
70%) and complex regulation of secondary metabolites genes, it is generally the 
easiest to express Streptomyces genes in a Streptomyces host.   
We chose S. coelicolor A3(2) as a model superhost for polyketides production. Our 
choice was determined by the availability of genomic sequence [1], gene 
replacement techniques [2], genome-scale metabolic model [3] and extensive 
physiological characterization of this species [4-6]. S. coelicolor is as well a natural 
producer of polyketide antibiotic actinorhodin and prodigiosins [7, 8]. Genome-scale 
metabolic models can be used to predict the response of an organism to 
environmental and genetic perturbations. By performing in silico simulations, one can 
in a matter of minutes test the outcome of all single gene deletions and find out which 
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deletions that will improve the yield of a desired product or productivity [9, 10]. The 
method was successfully used to improve lycopene [11, 12] and lactate [13] 
production in engineered E. coli. By using genetic algorithms optimal combinations of 
several knock-outs/overexpressions can be found [14].   
In this study we test whether model-guided strain design can be applied for improving 
antibiotics-producing Streptomyces bacteria. 
8.3 Methods 
8.3.1 Construction of single deletion mutants 
The reference strain was S. coelicolor M145 (SCP1-, SCP2-), a prototrophic 
plasmidless derivative of S. coelicolor A3 (2) strain 1147 [1, 15]. The strain was a 
kind gift from Mervyn Bibb (John Innes Centre, UK). Deletion mutants were 
constructed using the REDIRECT method [2]. The required S. coelicolor cosmids 
[15], REDIRECT plasmids and E. coli strains were kindly supplied by Nick Bird (John 
Innes Centre, UK). The replacement cassettes carrying apramycin resistance marker, 
FLP recognition sites and origin of transfer, flanked by 39 and 40 bp upstream and 
downstream sequences of the to-be-deleted genes were synthesized by PCR. The 
template for PCR reaction was a fragment of pIJ773 plasmid, cut by EcoRI and 
HindIII and purified. The primers were designed to additionally include restriction 
sites for NheI, XbaI or SpeI, these sites can be used to cut the replacement cassette 
of the mutated cosmid and to ligate the complementary overhangs, generating “scar” 
in the place of replaced gene. All the details are given in Table 8-1. For each gene 
deletion the purified replacement cassette was transformed into BW25113 E. coli 
strain, carrying a plasmid pIJ790 with λ RED recombination genes under control of 
arabinose-inducible promoter and a cosmids with the gene of interest on it (Table 8-
1). After recombination event induced by short cultivation on arabinose, the strains 
were cured from temperature sensitive plasmid pIJ790 by growth at 37ºC and 
apramycin-resistant clones were selected. The mutated cosmids were isolated and 
replacement of the genes with cassette was confirmed by PCR and restriction. The 
cosmids were transformed into non-methylating E. coli ET12567, carrying transfer 
functions on plasmid pUZ8002. The resulting E. coli strains were used to deliver the 
mutated cosmid into the S. coelicolor M145 by conjugation. AprRKanaS S. coelicolor 
clones were selected and the gene deletion was confirmed by PCR and restriction; 
primer sequences used for control PCR are given in Table 8-1. The strains are 
available on request. 
 
Table 8-1. Primer sequences for construction and confirmation of deletion mutants 
Mutant Cosmid Primers for deletion1,2 Primers for confirmation of 
deletion 
∆zwf 
(SCO6661) 
St5A7 SCO6661_pIJ773_fw: 
TGATCTTGCTTGCCGTGGTGTCGGTCAGGTCG 
        SpeI 
ATCCTCAACTAGTTGTAGGCTGGAGCTGCTTC 
SCO6661_pIJ773_rv: 
GACGAAGTCCCTCGACAGCAAGGGAGTTGACG 
        NheI 
GGGAATGGCTAGCATTCCGGGGATCCGTCGACC 
SCO6661_ch_fw: 
TCCTCGTCCGTGACGATGAC 
SCO6661_ch_rv: 
TGTCGTACGACGAGGTGGTG 
∆zwf2 
(SCO1937) 
StC54 SCO1937_pIJ773_fw: 
GAGCTCAAGCGCCTCGCTCCCTCGAAGGGCTG 
        SpeI 
SCO1937_ch_fw: 
CGGACCTCGACGCGATCGAG 
SCO1937_ch_rv: 
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AGAATTGACTAGTATTCCGGGGATCCGTCGACC 
SCO1937_pIJ773_rv: 
TGATCTTGCTGGCCGTGGTGTCCGTGAGGTCG 
        XbaI 
GTCTTCATCTAGATGTAGGCTGGAGCTGCTTC 
TCAGCGCGTCGTACGCGTTC 
∆gap1 
(SCO1947) 
StC54 SCO1947_pIJ773_fw: 
CCCTGCTACCGCATCGAGGTGCCTCGCTGAAG 
         SpeI 
TCGATCAACTAGTTGTAGGCTGGAGCTGCTTC 
SCO1947_pIJ773_rv: 
CACATCGGGCCGGCGTACCAACGAGGAGATCG 
        XbaI 
GTTCGTGTCTAGAATTCCGGGGATCCGTCGACC 
SCO1947_ch_fw: 
CGTCTTCAAGAGGGCTCCTG 
SCO1947_ch_rv: 
ATGGGGCGTCTCGATGTCAC 
∆gap2 
(SCO7040) 
St2C3 SCO7040_pIJ773_fw: 
CGCGCTCGCGCCCCGCGTCGCCCCGACCGGAC 
        SpeI 
CGGATCAACTAGTTGTAGGCTGGAGCTGCTTC 
SCO7040_pIJ773_rv: 
AGCATATGAGCGCCGCCTAGCTCGAAAGATAG 
        XbaI 
AGACGTGTCTAGAATTCCGGGGATCCGTCGACC 
SCO7040_ch_fw: 
GTGGGCACAGCGTCGTCGTC 
SCO7040_ch_rv: 
ACGCGCACGATCCCGTACTC 
∆citA 
(SCO2736) 
StC57A SCO2736_pIJ773_fw: 
GGACTCACCAGACGCGCTGCGGGGGTGCCGTG 
        SpeI 
CGGCTCAACTAGTTGTAGGCTGGAGCTGCTTC 
SCO2736_pIJ773_rv: 
CCTCGAAGATGAGGCACTACGTCGGTGAGGGA 
        XbaI 
AGACGTGTCTAGAATTCCGGGGATCCGTCGACC 
SCO2736_ch_fw: 
TCTGCTGTCCGGGTCCGTTC 
SCO2736_ch_rv: 
GAGGGGGCAGGATGAGGAAG 
∆mdh 
(SCO4827) 
St5G8 SCO4827_pIJ773_fw: 
GGACGCCCCACCGCCAGCTGTCATACGGAGAA 
        SpeI 
CGCCATGACTAGTATTCCGGGGATCCGTCGACC 
SCO4827_pIJ773_rv: 
AACCGGAACGGGGCCCGTGCGGGCGTCGGGGC 
        NheI 
GGACTCAGCTAGCTGTAGGCTGGAGCTGCTTC 
SCO4827_ch_fw: 
TTGGACGGCTCGGTCCTGTG 
SCO4827_ch_rv: 
GCTCCGTTTGCATGCCGAATC 
∆gdhA 
(SCO4683) 
StD31 SCO4683_pIJ773_fw: 
CGCCGAGCGCCTCCCACCGGTCGCTGTATGCG 
ACCGGTGATTCCGGGGATCCGTCGACC 
SCO4683_pIJ773_rv: 
CGCCGGCTCGCGGTGGGGCCCGGTCCGTCGGGT 
CCGTCATGTAGGCTGGAGCTGCTTC 
SCO4683_ch_fw: 
GGGTAGCGTCGACGGGAG 
SCO4683_ch_rv: 
CACGCCGCTACGGTCTTTG 
1
 The sequences complementary to replacement cassette ends on plasmid pIJ773 are shown in bold 
2
 Restriction sites, which can be used for deletion of the replacement cassette in order to generate 
clean mutants (“scar” instead of deleted gene), are underlined 
8.3.2 Construction of plasmid pIJ6902_act for over-expression of actinorhodin 
cluster activator 
The actinorhodin cluster activator gene actII-ORF4 was amplified from plasmid pIJ68 
[16] in PCR reaction using the following primers: fw_act 5 -´
TGCAGGCATATGAGATTCAACTTATTG-3  ´ and 5 -´
AATTTCTAGAACTACACGAGCACCTTCTC-3 .´ The fragment was digested with 
NdeI and XbaI and ligated into plasmid pIJ6902 [GenBank accession number 
AJ937361, obtained from Mervyn Bibb, John Innes Centre], which was cut with the 
same restriction enzymes and dephosphorylated. The ligation products were 
transformed in DH5α E. coli cells. Transformants which grew on apramycin were 
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screened for the presence of actII-ORF4 by colony PCR with the same primers as 
above. The resulting plasmid containing actII-ORF4 under control of thiostrepton 
inducible promoter PtipA (pIJ6902_act) was isolated, confirmed by restriction, and 
transformed into S. coelicolor strains by conjugation from E. coli ET12567/pUZ8002. 
The positive transformants of S. coelicolor M145 were selected by apramycin and 
thiostrepton resistance, while the mutants with integrated pIJ6902_act were selected 
by thiostrepton resistance only because they already possessed apramycin 
resistance genes from gene deletion procedure. 
8.3.3 Cultivation 
The S. coelicolor spores were densely plated on mannitol soya flour medium [17]. 
For preparation of spore plates for transformants with plasmid pIJ6902_act, 
thiostrepton was added to the plates at concentration 25 µg/ml. The spores from 
each plate were harvested by 1 ml 20% glycerol and used to inoculate 50 ml of 2xYT 
medium (16 g·l-1 tryptone, 10 g·l-1 yeast extract, 5 g·l-1 NaCl) in 200 ml shake flasks 
with 20 glass beads of 0.3 mm diameter. The cultures were grown at 30ºC on an 
orbital shaker with agitation rate 150 rpm for 24 hours. The mycelium was collected 
by centrifugation at 4,000 g for 5 min, the supernatant was decanted. The mycelium 
was mixed with the residual liquid and crushed in a crusher, consisting of a glass 
cylinder and a tight glass plunger. Crashed mycelium was resuspended in 20% 
peptone to the OD340 of 24-25 and stored at -20ºC until further use as inoculum. 
500 ml shake flasks with 2 baffles and 20-30 glass beads 4 mm in diameter were 
used for cultivations. Each shake flask contained 100 ml of defined phosphate limited 
medium of the following composition: 30 g/L glucose, 4 mM NaH2PO4, 100 mM 
NH4Cl, 10 mM KCl, 2 mM Na2SO4, 2 mM citric acid, 1.25 mM MgCl2, 0.25 mM CaCl2, 
5 ml/L trace metal solution, 100 mM 3-(N-morpholino)propanesulfonic acid sodium 
salt (MOPS), 1 ml/L vitamin solution and 200 µl/L antifoam (Sigma). The trace metal 
solution contained: 20 mM FeCl3, 10 mM CuCl2, 50 mM ZnCl2, 10 mM MnCl2, 0.02 
mM Na2MoO4, 20 mM CoCl2, and 10 mM H3BO4. The vitamin solution contained (per 
liter): 0.05 g biotin, 1 g Ca-pantothenate, 1 g nicotinic acid, 25 g myo-inositol, 1 g 
thiamine-HCl, 1 g pyridoxine-HCl and 0.2 g para-aminobenzoic acid. All solutions 
were prepared using MilliQ water (Millipore, USA). The salts and antifoam were 
dissolved in water, pH was adjusted to 7.0 and the medium was autoclaved. 
Concentrated glucose solution was autoclaved separately and added to the medium 
after it was cooled down. Vitamins solution was added after autoclavation by sterile 
filtration. For cultivation of strains carrying integrated plasmid pIJ6902_act 25 µg/ml 
thiostrepton was added to induce the actII-ORF4 gene expression. The shake flasks 
were incubated 30ºC at agitation rate of 150 rpm. The samples were taken 
aseptically in laminar flow bench. 
8.3.4 Biomass estimation by dry cell weight measurements and optical density 
To estimate biomass dry weight the whole broth samples of 2.5 - 5 ml volume were 
filtered through dried and pre-weight 0.45-mm pore size filters (Supor-450, Pall 
Corporation, Ann Arbor, USA). The biomass on the filter was washed with distilled 
water and the filter was dried in a microwave oven at 170 W for 20 min, cooled down 
in a desiccator for 15 min and the mass gain was measured. The optical density was 
measured at 600 nm using UV-Mini 1240 Shimadzu spectrophotometer (Shimadzu 
Scientific Instruments, USA). When necessary the samples were diluted with distilled 
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water to obtain OD600 below 0.3, which was within the linear range of the 
spectrophotometer.  
8.3.5 Analysis of pigmented antibiotics 
The blue actinorhodin pigment was extracted by vortexing the sample with 3N KOH, 
the total volume of the mixture being 1.5 ml. The sample volume was from 0.75 ml to 
0.075 ml, decreasing for the higher actinorhodin concentrations in the broth. The 
mixture was centrifuged at 10,000xg for 5 min and the absorbance of the supernatant 
was measured at 640 nm. The concentration of actinorhodin was calculated using 
extinction coefficient of 25,320 M-1cm-1.  
For measuring the red prodigiosin pigments, 0.75 ml of the broth was vortexed with 
an equal volume of methanol buffered to pH 1.5 with concentrated hydrogen chloride. 
The extraction was carried out under shaking for 3 hours. The mixture was 
centrifuged as above and the absorbance of the supernatant was measured at 530 
nm. The concentration was found with extinction coefficient of 100,500 M-1cm-1. 
8.3.6 Analysis of extracellular metabolites by HPLC 
Glucose and several extracellular primary metabolites were analyzed by HPLC with 
an Aminex HPX-87H column (Bio-Rad Laboratories, Hercules, CA, USA) operating at 
60°C. The compounds were eluted with 5 mM H2SO4 at a flow rate of 0.6 mlmin-1. 
Glucose, ethanol, glycerol, succinate, fumarate, malate and acetate were quantified 
using a differential refractometer (Waters 410; Millipore, Bedford, MA, USA) whereas 
pyruvate was quantified using a tunable absorbance detector set at 210 nm (Waters 
486; Millipore, Bedford, MA, USA).  
8.4 Results 
8.4.1 Identification and construction of optimal single knock-out mutants 
To simulate the changes in metabolic fluxes upon single gene deletions we used S. 
coelicolor genome-scale model reconstructed previously [3]. A change was 
introduced into the model: the transhydrogenase reaction was made irreversible and 
worked in the direction of NADPH generation from NADH with the usage of 
membrane protons as described for membrane-bound transhydrogenase from E. coli 
PntAB [18]. S. coelicolor genes SCO7623 and SCO7622 encoding correspondingly 
the α- and β-subunits of transhydrogenase were predicted to contain 5 and 9 
transmembrane helices [TMHMM Server, v. 2.0]. Cytoplasmic transhydrogenase, 
which works in the opposite direction was not identified in the S. coelicolor genome 
using BLAST search with E. coli UdhA protein sequence. The outcome of the change 
was that NADPH could not be converted into NADH by the action of 
transhydrogenase or some futile transhydrogenations cycles; hence NADPH and 
NADH were decoupled. 
To calculate the distribution of metabolic fluxes in the wild type S. coelicolor on 
minimal mineral medium we introduced constrains for the principal split node ratios 
as found by C13 metabolic network analysis and performed linear optimization for 
growth rate considering the experimentally determined glucose uptake rate [6]. The 
predicted growth rate was in good correspondence to the one determined 
experimentally (predicted 0.097 h-1 versus experimental 0.11 h-1). We then set each 
flux to zero and calculated the new fluxes using minimization of metabolic adjustment 
approach (MOMA) [19] (Figure 8-1). 
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Figure 8-1. Optimal gene deletions (first four by productivity, last by yield) for 
increase of antibiotics production.  
 
The top four deletions that gave maximal actinorhodin productivity using this 
approach were: deletion of malate dehydrogenase, deletion of succinate-CoA ligase, 
decrease of phosphate uptake and deletion of glutamate dehydrogenase. The flux 
solutions for the mutants explained how actinorhodin increase was obtained. In 
malate dehydrogenase mutant malate was converted into oxaloacetate through malic 
enzyme and pyruvate carboxylase, a route, which caused consumption of ATP. 
There is only one gene coding for malate dehydrogenase (SCO4827), hence the 
deletion would be easy to make.  
Succinate-CoA ligase mutant featured an alternative pathway to malonyl-CoA. 
Malonyl-CoA is normally synthesized from acetyl-CoA in a single reaction catalyzed 
by acetyl-CoA carboxylase. In the simulation a 7-reaction route that leads from 
succinyl-CoA to malonyl-CoA was active (Figure 8-2). It is not highly likely that these 
reactions can carry a high flux, therefore we chose not to perform this deletion.  
 
Figure 8-2. Alternative pathway for biosynthesis of polyketide precursor malonyl-
CoA. 
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In the third mutant the phosphate uptake by proton symport was deleted and the 
ATP-dependent phosphate uptake was functioning instead, however with a lower 
flux. This simulation was equivalent to phosphate limitation: specific growth rate was 
slower and antibiotics were produced. It is known from experiments that out of 
several nutrients limitations, carbon-, nitrogen- and phosphate, phosphate-limitation 
gives the highest actinorhodin titers [5]. Our results show that the positive effect of P-
limitation on antibiotics formation is highly influenced by metabolic changes on top of 
possible transcriptional effects because our model does not account for 
transcriptional regulation through PhoP boxes and similar. 
Another candidate for deletion was glutamate dehydrogenase, which is the main 
enzyme used for ammonium uptake at high ammonium concentrations in the 
environment. The enzyme uses NADPH as reducing co-factor per each uptaken 
ammonium ion and is therefore the most NADPH-consuming enzyme in the cells 
growing on ammonium (in our simulations it consumes about 60% of all NADPH 
produced). The model predicted that deletion of the glutamate dehydrogenase would 
shift the ammonium uptake to the GS-GOGAT system, where ammonium is taken up 
at the expense of NADH and ATP. This is however not likely to happen in practice 
because the GS-GOGAT system is inhibited by ammonium and is therefore only 
active at low ammonium concentrations. According to the genome annotation there is 
only one glutamate dehydrogenase coding gene – gdhA (SCO4683). If this indeed 
was the only gene, then its deletion would severely impair or even eliminate the 
growth of our strain on mineral medium with ammonium as nitrogen source. Usually 
in addition to NADPH-dependent glutamate dehydrogenase, organisms possess 
NADH-dependent enzyme GdhB, which has lower affinity to glutamate and normally 
is used for glutamate uptake. In the absence of GdhA, this enzyme was, however, 
shown to be capable of ammonium uptake [20]. BLAST search with the 
Mycobacterium tuberculosis gdhB gene gave hits to three Streptomyces genes: 
NAD-glutamate dehydrogenase gdhB in S. avermitilis, putative gdhB in S. 
clavuligerus and a hypothetical protein in S. coelicolor (SCO2999). The activity of 
GdhB in S. clavuligerus has been confirmed experimentally [21]. SCO2999 contains 
a motif for bacterial NADH-glutamate dehydrogenase (PFAM05088, Bac_GDH) and 
has 82% identity to S. clavuligerus gdhB and 87% identity to S. avermitilis gdhB, it is 
therefore highly likely that SCO2999 codes for the NAD-dependent glutamate 
dehydrogenase in S. coelicolor. We included the new reaction in the model and 
simulated what would be the flux distribution in the ∆gdhA mutant, if glutamine 
synthase was inhibited (flux=0) and glutamate dehydrogenase B would be less active 
than gdhA (half flux of the gdhA in the wild type). The solution was a lower growth 
rate (0.05 h-1 instead of 0.097 h-1) and some actinorhodin production, though less 
than initially predicted.  
The deletion that gave the highest yield of actinorhodin was deletion of citrate 
synthase, however, the deletion was predicted to be lethal for cells. Obviously, the 
deletion would eliminate the activity of TCA cycle and direct most of the acetyl-CoA 
into actinorhodin biosynthetic pathway instead. Citrate synthase is encoded by 3 
genes in the genome, of which citA (SCO2736) was shown to have the major role in 
S. coelicolor MT1110 [22]. We speculated that deletion of this gene would not 
eliminate the citrate synthase activity completely, but would reduce the flux through 
TCA flux and increase the supply of Acetyl-CoA precursor for polyketides (Figure 8-
3). 
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Figure 8-3. Influence of citrate synthase activity on growth and actinorhodin 
production (computer simulation). 
 
To compare with the model-predicted strategies we chose deletion of zwf (SCO6661) 
and zwf2 (SCO1937), which were previously shown to improve actinorhodin 
production in S. coelicolor and S. lividans [23, 24]. We also chose an empirical 
strategy – an important glycolytic enzyme, NAD-dependent glyceraldehyde-3-
phosphate dehydrogenase (Gap) E.C. 1.2.1.12. Our aim was to block the conversion 
of glyceraldehyde-3-phosphate (G3P) through 1,3-diphosphateglycerate (13PDG) 
into 3-phosphoglycerate (3PG) with generation of NADH and ATP and to substitute it 
with a single-step conversion of G3P into 3PG by NADP-dependent GapN (E.C. 
1.2.1.9), generating NADPH and no ATP. We speculated that decreased ATP 
production and increased supply of NADPH could benefit polyketides production.  
We constructed ∆mdh, ∆gdhA, ∆citA, ∆gap1, ∆gap2, ∆zwf, ∆zwf2  deletion mutants in 
S. coelicolor M145 by replacing the whole coding sequences with apramycin 
resistance cassette [2].  
8.4.2 Growth 
The strains were characterized in shake flasks in defined phosphate-limited mineral 
medium. Maximal specific growth rate was calculated from the measurements of the 
optical density at 600 nm in the exponential phase. For all samples taken at 23.5 
hours, dry weigh biomass was measured in addition to optical density. There was an 
80% correlation between dry weight biomass and OD600 (Appendix 8-1). The µmax 
calculated for the reference strain M145 was higher than normally measured in 
fermentor (0.11 h-1), but can be due to evaporation of some water from the culture 
broth. As evaporation effect would be the same for all the shake flasks, comparisons 
of the µmax across the strains can be made. 
The strains that had significantly (p<0.05 in t-test) changed maximal specific growth 
rates are ∆gap1, ∆gap2 and ∆gdhA (Figure 8-4). Glyceraldehyde-3-phosphate 
dehydrogenase is a key enzyme in glycolysis pathway and should carry a high flux, 
therefore it is not surprising that gap deletion causes growth defects. Deletion of 
gap1 decreases the µmax by almost 70%, while knocking out a homologous gap2 only 
leads to a 20% decrease. This finding indicates that at least in the exponential growth 
phase more flux is carried though enzyme Gap1 rather than its isoenzyme Gap2. 
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Figure 8-4. Maximal specific growth rates of the reference strain M145 and knock-out 
mutants. Averages of biological triplicates are shown; the whiskers indicate 1 
standard deviation. The strains are positioned as following: 1 – M145, 2 – ∆zwf, 3 – 
∆zwf2, 4 – ∆gap1, 5 – ∆gap2, 6 – ∆gdhA, 7 – ∆citA, 8 – ∆mdh. 
 
In the strain with glutamate dehydrogenase gdhA deleted the µmax is lower by 16%. 
The fact that the strain is not auxotrophic for glutamate and can grow on ammonium 
as the sole nitrogen source implies that another ammonium uptake system is 
functional in the cells. As GC-GOGAT should be repressed at high ammonium 
concentrations, it is most likely that the ammonium assimilation is carried our by 
GdhB, though with a slightly lower efficiency. 
Surprisingly, the mutants with knock-outs in the important TCA cycle genes mdh and 
citA were not severely affected in growth. For citrate synthase, which is expressed 
from three genes, the isoenzymes might be taking over. For the malate 
dehydrogenase either the predicted two-step route through malic enzyme and 
pyruvate carboxylase is quite efficient or some non-annotated additional malate 
dehydrogenases are present in the genome. 
∆zwf1 and ∆zwf2 mutants were not affected in their specific growth rates. Most 
probably they are mutually interchangeable and can easily take over the pentose 
phosphate flux, which is not that large in S. coelicolor and composes only about 10% 
of the glucose uptake rate (see Chapter 5). 
We also monitored the increase of biomass dry weight in the course of cultivation 
(Figure 8-5). The final biomass concentration was similar for the reference strain and 
for most of the mutants. Three mutants, however, accumulated much less biomass, 
these were ∆gap1, ∆citA and ∆mdh. The two later mutants experienced drop of pH to 
4-5 already on the second day of cultivation, while for the rest of the strains pH was 
maintained above 6 until the end of fermentation. It is highly likely that it was the low 
pH that prevented the citrate synthase and malate dehydrogenase deletion strains 
from further growth. pH drop must have been due to formation of some organic acids, 
which could also be expected for mutants in TCA cycle enzymes. We analyzed 
cultivation broth collected on the 4th day of fermentation from ∆citA and ∆mdh strains 
on HPLC and detected pyruvic acid at concentration about 0.7 g/L, acetic acid at 0.9 
g/L in ∆citA mutant and 0.5 g/L in ∆mdh mutant. Additionally we found 1.1-1.2 g/L 
malic acid and 0.2 g/L fumaric acid. 
 CHAPTER 8 
 
 
178 
 
Figure 8-5. Biomass dry weights of the reference strain M145 and knock-out mutant. 
 
The ∆gap1 mutant was severely growth deficient; it accumulated less than 2 g DW/L 
biomass, while biomass level was around 6 g DW/L for non-affected strains. 
Obviously Gap1 enzyme is important for glycolysis flux not only in the exponential, 
but also in the later stages of growth. 
 
Figure 8-6. pH change during the shake flask cultivation. 
 
8.4.3 Antibiotics production 
We analyzed concentrations of blue pigmented antibiotic actinorhodin and red 
pigmented prodigiosin antibiotics. Final antibiotics concentrations were proportional 
to antibiotics volumetric production rates (data not shown). The variations of 
actinorhodin production in mutant strains were much higher than in reference strain. 
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Most commonly one out of three shake flasks would have lower actinorhodin 
production, while all other parameters as biomass dry weight, pH and prodigiosin 
production would not differ. It is not clear what caused this high frequency of outliers 
among the knock-out mutants, considering that mutantions performed by 
replacement of the whole gene by a resistance cassette should be non-revertable.  
The production of both antibiotics did not differ significantly between the reference 
strain and ∆zwf, ∆gap2 and ∆gdhA mutants. If the outlier shake flasks, which 
produced 3-4 times less actinorhodin than the other shake flasks, were excluded 
from the analysis, then the average final actinorhodin concentration would be 10-13% 
higher in the ∆gap2 and ∆gdhA mutants than in the reference strain, though the 
significance of this change would be low due to the small number of replicates and 
standard deviation of about 10%. 
Antibiotics production was significantly lower in ∆zwf2, ∆gap1, ∆citA and ∆mdh 
strains. For the latter two strains the low antibiotics production can be explained by 
low pH, which inhibits γ-actinorhodin biosynthesis. At low pH only intracellular 
actinorhodin is synthesized in small amounts in strain M145 [7]. The major pigment 
for this strain, however, is the lactone form of actinorhodin - γ-actinorhodin – and it is 
only produced both intracellularly and in secreted form at neutral pH. To understand 
the effect of the mutations on antibiotics production, fermentations have to be carried 
out under pH control. Apparently the capacity of the buffer we used was not sufficient 
to maintain constant pH and we could not use higher MOPS concentrations because 
it inhibits cellular growth at concentrations above 100 mM (personal communication 
with Prashant Bapat). 
 
Figure 8-7. Actinorhodin (A) and prodigiosin (B) concentrations during cultivation of 
reference strain and single deletion mutants. Averages of biological triplicates are 
shown, the whiskers indicate 1 standard deviation. The strains are positioned as 
following: 1 – M145, 2 – ∆zwf, 3 – ∆zwf2, 4 – ∆gap1, 5 – ∆gap2, 6 – ∆gdhA, 7 – 
∆citA, 8 – ∆mdh. 
        
       A 
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By introducing a copy of actinorhodin cluster activator actII-ORF4 under a strong 
thiostrepton-inducible promoter PtipA into the M145 strain and its knock-out 
derivatives, we achieved earlier growth phase-independent actinorhodin production 
(Figure 8-8). The final titers were, however, not higher than in the strains without the 
activator overexpressed, and we hypothesize that it was due to a certain inhibition by 
thiostrepton. We also observed that the lag phase for growth was a bit longer in 
these than in previous cultivations. The final titers of antibiotics were not improved in 
any of the deletion strains, but were even significantly lower for many of them (ACT 
was significantly lower at p<0.1 for ∆gap1, ∆gap2, ∆gdhA and ∆citA strains and RED 
for all above listed strains plus ∆zwf2 strain). The acidification of the fermentation 
broth during growth of ∆citA strain could not be prevented by overexpression of ACT 
cluster activator and the pH decreased rapidly during the first three days of cultivation 
as it did before.  
 
Figure 8-8. Actinorhodin (A) and prodigiosin (B) concentrations during cultivation of 
reference strain and single deletion mutants with integrated plasmid carrying 
actinorhodin cluster activator gene actII-ORF4 under control of thiostrepton-inducible 
promoter. The fermentation medium contained 25 µg/ml thiostrepton. Averages of 
biological triplicates are shown, the whiskers indicate 1 standard deviation. The 
strains are positioned as following: 1 – M145, 2 – ∆zwf, 3 – ∆zwf2, 4 – ∆gap1, 5 – 
∆gap2, 6 – ∆gdhA, 7 – ∆citA. 
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8.5 DISCUSSION 
Polyketides are an important group of secondary metabolites with a wide 
pharmaceutical application: polyketides are used as antibiotics, immunosupressants, 
antiparasitics, cholesterol lowering agents, anti-fungals and anti-cancer drugs [25]. A 
number of polyketides are made by Streptomyces spp. These compounds are 
synthesized by polyketide synthase enzymes from simple precursors as malonyl-
CoA, methylmalonyl-CoA and similar [26]. Malonyl-CoA, which is the precursor for 
actinorhodin biosynthesis, is formed by carboxylation of acetyl-CoA. It is of interest to 
alter the cellular metabolism in such a way that the production of polyketides 
precursors is increased. We used genome-scale metabolic model to predict 
strategies for increasing supply of acetyl-CoA precursor and NADPH co-factor, which 
are used in biosynthesis of many polyketides including actinorhodin. We 
approximated the fluxes in the wild type cells, using the experimentally determined 
substrate uptake rates, specific growth rate and the split ratios at the major nodes 
determined from C13 flux analysis [6]. Then we deleted each gene one by one in 
silico and calculated the new flux distribution assuming that the cells will adjust the 
fluxes minimally to compensate for the mutation (minimization of metabolic 
adjustment approach [19]). It is also possible to predict the effect of increase of flux 
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through certain reactions. It is, however, much more difficult to implement such 
predictions in practice, because overexpression of an enzyme-coding gene does not 
necessarily lead to increased flux through that enzyme. Even if overexpression of the 
gene increases the activity of the corresponding enzyme, the flux through it will only 
increase if the enzyme has a high flux control coefficient and that is rarely the case. 
We therefore simulated only gene deletions as those most commonly will lead to flux 
decrease both in simulations and in practice. We did not observe a significant 
increase in antibiotics final titers for any of the generated mutants, however a number 
of interesting observations could be made. 
Deletion of NADPH-dependent glutamate dehydrogenase was predicted to be one of 
the strategies for increasing NADPH supply. We found that the ∆gdhA strain was 
capable of growing in defined minimal medium without glutamate supply and had 
only 16% lower maximal specific growth rate as compared with the reference strain. 
This is a strong evidence for the presence of an active NAD-dependent glutamate 
dehydrogenase GdhB, most likely encoded by SCO2999, which has 82% identity to 
S. clavuligerus gdhB and 87% identity to S. avermitilis gdhB. Other attempts of 
changing NADPH and NADH balance through deletion of ghdA have been made in 
yeast Saccharomyces cerevisiae [20] and in filamentous fungus Penicillium 
chrysogenum. In both cases it was necessary to concurrently overexpress alternative 
ammonia uptake routes to avoid growth defects caused by gdhA deletion. In yeast 
the primary metabolism was altered as predicted: glycerol biosynthesis decreased 
and ethanol production was improved [20]. The outcome with P. chrysogenum was 
however totally unexpected: deletion of gdhA fully eliminated production of the 
antibiotic penicillin (personal communication with Jette Thykær).  
Another strategy that we hoped would increase the NADPH production was deletion 
of glyceraldehyde-3-phosphate dehydrogenase (GAP). We found that Gap1 
obviously carried most of the flux because its deletion decreased the µmax with 80% 
and also lead to a very low biomass accumulation throughout the cultivation. Deletion 
of gap2 had a less severe effect on the strain with only 20% decrease in µmax and 
basically unaltered antibiotics production.  
While we did not observe improvement of actinorhodin production in ∆gdhA, ∆gap1 
and ∆gap2 mutants, it still remains to be investigated whether the actually production 
of co-factor NADPH has been achieved and if yes, then why it did not positively affect 
antibiotics production.  
According to the data of Ryu et al, deletion of glucose-6-phosphate dehydrogenase 
zwf1 did not have an effect on actinorhodin production, while zwf2 deletion increased 
actinorhoding titers [24]. Perhaps the lack of the positive ∆zwf2 effect in our study is 
due to a different S. coelicolor strain we are using and due to making fermentations 
in shake flasks instead of fermentors. However, as we observed positive effect of a 
mutation under these conditions before for ∆pfkA2 mutant (Chapter 5), we can 
conclude that the beneficial influence of zwf2 deletion is marginal and only true under 
certain circumstances. 
The strains with deletion of citrate synthase A and malate dehydrogenase acidified 
the fermentation medium to pH 4-5 during the first two days of cultivation, making it 
impossible to characterize them in shake flasks. Due to time constraints their 
physiological characterization in fermentors with pH control has not been carried out, 
but it is a plan for the future. Before the medium acidification occurred we could 
monitor the exponential growth of these strains and found that their µmax was not 
significantly changed in comparison to the wild type. In ∆citA mutant citA2 and/or 
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citA3 might be compensating for the citA deletion. The outcome is quite different from 
S. coelicolor MT1110 strain, where deletion of citA resulted in glutamate auxotrophy, 
meaning that CitA activity could not be compensated by other isoenzymes [22]. In 
∆mdh mutant either the alternative two-step route through malic enzyme and 
pyruvate carboxylase is fairly efficient or some non-annotated malate dehydrogenase 
isoenzymes are playing the role. Both ∆citA and ∆mdh strains produced a range of 
organic acids as pyruvic, acetic, malic and fumaric acids. Secretion of pyruvic and 
acetic acids signals that the flux of pyruvate product – acetyl-CoA – into TCA is 
disturbed. The excess of acetyl-CoA that can not be excreted is converted into acetic 
acid and the latter is secreted into the extracellular medium. So in both ∆citA and 
∆mdh strains we achieved lower consumption of acetyl-CoA for growth, which most 
likely lead to higher intracellular acetyl-CoA concentration. A critical question is why 
this larger pool of acetyl-CoA was not used for actinorhodin biosynthesis, but was 
rather converted to acetic acid? Whether the fluxes through a node will be 
redistributed when the node is perturbated depends on the concentrations of the 
node enzymes and on their affinity to the common substrate. There are many 
enzymes that compete for acetyl-CoA, like citrate synthase, phosphate 
acetyltransferase, acetyl-CoA carboxylase, fatty acids synthases, etc. Obviously on 
deletion of citrate synthase, it was phosphate acetyltransferase that took over the 
excessive portion of acetyl-CoA. If the affinities of the phosphate acetyltransferase 
and acetyl-CoA carboxylase to the substrate are in the similar range, then 
overexpression of acetyl-CoA carboxylase can increase malonyl-CoA biosynthesis 
and perhaps also polyketides production. The positive effect of acetyl-CoA 
carboxylase overexpression on actinorhodin production has been shown in the study 
by Ryu et al. [24]. If, however, the affinity of acetyl-CoA carboxylase is much lower, 
then deletion of the phosphate acetyltransferase might be necessary to change the 
distribution of acetyl-CoA flux in favor of polyketides production. 
Considering that model-based computer prediction of optimal metabolic strategies is 
a very young discipline, a few successes have already been made indicating a large 
potential of the methodology. One of the most prominent was the increase of 
lycopene production in recombinant E. coli overexpressing lycopene biosynthetic 
genes [11, 12]. The improvement of secondary metabolites production promises 
though to be more challenging in Streptomyces. For the first, secondary metabolites 
are usually produced in a stationary phase in growth-independent manner, hence, 
the flux predictions based on growth optimality might not be valid. For the second, 
the expression of the secondary metabolic genes is often regulated by complex 
signalling cascades, which can be unintentionally disturbed while metabolically 
engineering the strains. For the third, pathways for secondary metabolites are often 
long with many steps and are adjusted to carry low fluxes. The capacity of these 
pathways has to be improved before engineering the precursor and co-factor supply, 
which otherwise will not have an effect. 
In conclusion, we made the first attempt to use computer simulations, based on 
stoichiometric metabolic model, to predict metabolic engineering strategies for 
improved polyketides production in the model Streptomyces species, S. coelicolor. 
While we succeeded in increasing the supply of acetyl-CoA in some of the strains, 
more work is needed to re-direct this polyketides precursor into the desired product. 
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9.1 Abstract 
Streptomyces tenebrarius is an industrially important microorganism, producing an 
antibiotic complex, which mainly consists of the aminoglycosides apramycin, 
tobramycin carbamate and kanamycin B carbamate. When S. tenebrarius is used for 
industrial tobramycin production, kanamycin B carbamate is an unwanted byproduct. 
The two compounds differ only by one hydroxyl group, which is present in kanamycin 
carbamate, but is reduced during biosynthesis of tobramycin. 13C metabolic flux 
analysis was used for elucidating connections between the primary carbon 
metabolism and the composition of the antibiotic complex. Metabolic flux maps were 
constructed for the cells grown on minimal medium with glucose or with 
glucose/glycerol mixture as the carbon source. Addition of glycerol, which is more 
reduced than glucose, led to a three times reduction of the kanamycin part of the 
antibiotic complex. The labeling indicated an active Entner-Doudoroff (ED) pathway, 
which was previously considered to be non-functional in Streptomyces. The activity 
of the pentose phosphate (PP) pathway was low (10-20% of glucose uptake rate). 
The fluxes through Embden-Meyerhof-Parnas (EMP) and ED pathways were almost 
evenly distributed during the exponential growth on glucose. During the transition 
from growth phase to production phase a metabolic shift was observed, 
characterized by a decreased flux through the ED pathway and increased fluxes 
through the EMP and PP pathways. Higher specific NADH and NADPH production 
rates were calculated in the cultivation on glucose/glycerol, which was associated 
with lower percentage of non-reduced antibiotic kanamycin B carbamate.  
Keywords 
Streptomyces, Entner-Doudoroff pathway, C13 Metabolic Flux Analysis (MFA), 
tobramycin, kanamycin 
9.2 Introduction 
The ability of actinomycetes to make secondary metabolites with different useful 
properties (antibacterial, antitumor agents, immunosuppressants, etc.) is widely 
exploited in the pharmaceutical industry. Two thirds of the antibiotics produced by 
microorganisms are made by actinomycetes. Particularly, the Streptomyces genus is 
remarkable in this aspect, representing about 80% of the actinomycete-antibiotics16. 
Antibiotics are formed from specific precursors that are drained from the central 
carbon metabolism, and over-production of antibiotics therefore requires that the 
precursors are supplied in sufficient quantities. Improvement of antibiotics production 
has traditionally been based on random mutagenesis methods, and also in the future 
these methods will play an important role. However, metabolic engineering enables 
introduction of rational changes of the central carbon metabolism in order to increase 
fluxes of precursors and cofactors to antibiotics. Metabolic flux analysis is a valuable 
tool in guiding the metabolic engineering strategies as it enables rapid phenotypic 
characterization of different mutants, and through analysis of different mutants one 
may gain insight into the correlation between antibiotics production and the fluxes 
through specific branches of the metabolic network.  
In this study correlations between the primary and the secondary metabolism in the 
antibiotics producer S. tenebrarius11,25 was investigated. This species produces the 
aminoglycoside antibiotic complex nebramycin, consisting primarily of tobramycin 
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carbamate, kanamycin B carbamate and apramycin17,18,22. Tobramycin and 
kanamycin B carbamates can be hydrolysed into the active forms (tobramycin and 
kanamycin B, respectively) in a chemical modification step. When S. tenebrarius is 
used for tobramycin production, synthesis of other nebramycin complex components 
decreases the tobramycin yield and causes problems in the downstream processing. 
Particularly kanamycin B is difficult to separate from tobramycin due to their chemical 
similarity. The compounds differ only by one hydroxyl group, which is present in 
kanamycin B, but is reduced during biosynthesis in tobramycin (Figure 9-1).  
 
Figure 9-1. Chemical structures of tobramycin, tobramycin carbamate, kanamycin B 
and kanamycin B carbamate. 
 
 
 
Strain development and cultivation optimization at the company Alpharma, Denmark, 
has been used in the past in order to increase the tobramycin carbamate yield and 
reduce the kanamycin B carbamate content in the complex. Further improvement of 
the process requires better knowledge of the cellular metabolism, and it is therefore 
valuable to know whether changes in the antibiotics ratio are connected to the 
changes in the primary metabolism and how this can be used for directed 
improvement of the strain. For analysis of the primary metabolism of S. tenebrarius 
metabolic flux analysis was combined with carbon labeling experiments. The cells 
were grown on 13C-labeled substrate, the labeling of amino acids derived from the 
cell proteins was analyzed by GC-MS, and through computer modeling the fluxes in 
the central carbon metabolism were calculated 4,6. 
9.3 Materials and methods 
9.3.1 Chemicals 
All chemicals were of chemical purity degree or higher, purchased from Merck (NJ, 
USA) or Sigma-Aldrich Co. (MO, USA). The [1-13C]-labeled glucose was from 
Omicron Biochemicals Inc. (IN, USA).  
9.3.2 Strain and culture conditions 
Streptomyces tenebrarius strain TD507 (Alpharma ApS, Copenhagen, Denmark) was 
used as the nebramycin complex producing microorganism. The strain originates 
from S. tenebrarius ATCC 17920 and has been developed by successive mutations 
either by UV or N-methyl-N'-nitro-nitrosoguanidine treatments. The strain was stored 
in 1 ml cryotubes at – 80°C, at a biomass concentration of 9.3 g DWl-1. 
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Cultures were grown in batch fermentors with 300 ml growth medium. The medium 
contained: 2 gl-1 (NH4)2SO4, 0.08 gl-1 KH2PO4, 0.5 gl-1 MgSO47H2O, 10 mgl-1 
ZnSO47H2O, 10 mgl-1 FeSO47H2O, 0.2 mgl-1 MnSO4H2O, 0.02 mgl-1 
CuSO45H2O, 0.02 mgl-1 CoCl26H2O, 2 gl-1 CaCl2, and 1 mll-1 pluronic as antifoam. 
As carbon source one of the following was used: 8 gl-1 glucose or 4 gl-1 glucose and 
4 gl-1 glycerol. 
For labeled substrate cultivations one of the following carbon source combinations 
was used:  4 gl-1 [1-13C]-glucose and 4 gl-1 naturally labeled glucose or 4 gl-1 [1-
13C]-glucose and 4 gl-1 naturally labeled glycerol.  
The fermentors were autoclaved with water and pluronic and all other components 
were added afterwards by sterile filtration. Fermentors were inoculated with 0.3 ml 
(0.1% v/v) of stock culture. The aeration rate was 1 vvm. For carbon labeling 
experiments the inlet air was bubbled through a 2 N NaOH solution in order to 
remove atmospheric carbon dioxide. The pH of the medium was kept at 6.8 by 
automatic addition of 0.1 N NaOH and the temperature was kept at 37°C throughout 
the cultivation. 
9.3.4 Biomass dry weight 
5 ml of culture broth was filtered through a 0.45-µm pore size pre-dried filter (Supor-
450, Pall Corporation, Ann Arbor, USA). The filtrate was collected and used for 
metabolites analysis on HPLC and for analysis of antibiotics. The biomass on the 
filter was washed twice with distilled water; the filter with biomass was then dried in a 
microwave oven at 170 W for 20 min, cooled down in a desiccator for 15 min and the 
mass gain was measured. 
9.3.5 Glucose, glycerol and extracellular metabolites analysis 
Glucose and several extracellular metabolites were analysed by HPLC with an 
Aminex HPX-87H column (Bio-Rad Laboratories, Hercules, CA, USA) operating at 
60°C. The mobile phase was 5 mM H2SO4 at a flow rate of 0.6 mlmin-1. Glucose, 
ethanol, glycerol and succinate were quantified using a differential refractometer 
(Waters 410; Millipore, Bedford, MA, USA) whereas acetate and pyruvate were 
quantified using a tunable absorbance detector set at 210 nm (Waters 486; Millipore, 
Bedford, MA, USA).  
9.3.6 Antibiotics analysis 
Tobramycin, tobramycin carbamate, kanamycin B, kanamycin B carbamate and 
apramycin concentrations were analyzed on a Waters HPLC-system (Milford, MA, 
USA), equipped with a WISP 717 column, and a fluorescence detector (Waters 474), 
set on 338 nm for excitation and 418 nm for emission measurement.  The total eluent 
flow was 1.2 mlmin-1. One liter of the eluent solution contained 175 ml methanol, 3.2 
g sodium hexanesulfonate, 12.8 g sodium sulphate, 0.8-1.2 g acetic acid (to obtain pH 
3.4), and Milli-Q water (Milli-Q ultrapure water purification system, Millipore, MA, USA).  
Eluent B differed from eluent A by having twice the amount of methanol. The antibiotics 
were derivatised by o-phthalaldehyde (OPA) and a mercaptan to give fluorescent 
compounds. The derivatisation was performed at room temperature in a reaction coil 
installed after the separation column.  
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9.3.7 GC-MS analysis 
From the labeled substrate cultivations samples of 20-30 ml were taken in duplicates 
for the analysis of cell mass labeling. Samples were filtered through 0.45-µm pore 
size filter (Supor-450, Pall Corporation, Ann Arbor, USA), the cells were washed 
twice with distilled water, collected from the filter and stored at –20 °C until further 
analysis. 
15 mg of wet cell mass was hydrolyzed with 6M HCl at 105 ºC for 24 hours to release 
free amino acids from protein molecules or for 0.5 hours to free glucose molecules 
from the cell wall. The hydrolysate was centrifuged at 15,000 x g to remove the cell 
debris, divided into two aliquots and dried at 105°C. The crude hydrolysates were 
subjected to derivatisation that rendered them volatile: amino acids were converted 
to N-ethoxycarbonyl amino acid ethyl esters and N-(N,N-dimethylaminomethylene) 
amino acid methyl esters and glucose to glucose pentaacetate4. Analysis was made 
by gas chromatography coupled with mass spectrometry as previously described 4. 
The signal intensities were corrected for occurrence of natural isotopes in the atoms 
of the derivative part and in oxygen and nitrogen atoms of the amino acids. The 
corrected intensities were used for calculating the summed fractional labeling (SFL) 
of a fragment according to the formula:  
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, where ij is the peak 
intensity of mass isotopomer mj and n is the number of carbon atoms in the fragment. 
The SFL value shows the amount of 13C atoms per 100 fragments. 
In order to compare the labeling states of two metabolites with different numbers of 
carbon atoms carbon normalized labeling (CNL) was calculated as: 
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
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where SFL is the summed fractional labeling of all the carbons in the fragment and n 
is the number of carbon atoms in the fragment. 
9.3.8 Modelling of metabolic fluxes 
A mathematical framework used for quantification of the fluxes was described 
previously 27,28. The input to the program included the stoichiometric model, the 
transitions of carbon atoms in each reaction, the measured SFLs of metabolite 
fragments, the measured fluxes of substrate uptake and the calculated fluxes 
towards cell mass. The primary metabolic network of S. tenebrarius was 
reconstructed based on data about carbon metabolism in related species12. The 
fluxes towards cell mass were calculated based on precursor requirements for cell 
mass biosynthesis in Corynebacterium glutamicum 20.  
The numeric method (described in more details elswhere5) can be summarized as 
following: first an arbitrary set of fluxes was chosen that fits the stoichiometric 
constraints and using this set of fluxes the SFLs were calculated. The differences 
between the measured and the calculated SFLs gave an error, if the error was more 
than the set value, a new set of fluxes was made and the procedure was repeated 
until a good fit was obtained. The set of metabolic fluxes that resulted in the best fit 
were found by an iterative process of error minimization. 
9.3.9 Identification of the edd gene 
Degenerate primers for the amplification of internal edd gene fragment were 
designed to match regions of high identity in multiple alignments of protein 
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sequences from Nonomuraea sp. ATCC 39727 and other bacterial species. The 
conserved amino acid regions were chosen with a maximum distance from each 
other in order to amplify the biggest part possible of the gene. To reduce degeneracy 
of the primers, codon preference of Streptomyces coelicolor was considered (Kazusa 
DNA Research Intitute, Japan [http://www.kazusa.or.jp/codon/]). The primers were 
extended with 20-nucleotides long tags at the 5’-ends to facilitate subsequent 
sequencing. PCR reactions were performed using the GC-RICH PCR system 
(Roche, Mannheim, Germany) and S. tenebrarius genomic DNA as template. The 
coding strand was sequenced at MWG Biotech AG (Reinach, Switzerland) and the 
sequence was submitted to GenBank (accession number AY618459). 
9.4 Results 
9.4.1 Influence of carbon source on antibiotics production 
The biosynthesis of kanamycin and tobramycin is likely to differentiate only by a 
reductive reaction, and we therefore investigated how the degree of reduction of the 
substrate influenced the formation of the antibiotic complex composition in S. 
tenebrarius cultivations. Cultivations were performed with two different carbon 
sources: pure glucose and an equimolar mixture of glucose and glycerol, where 
glycerol is a more reduced carbon source than glucose.  
Cultivations were performed under controlled conditions on defined minimal medium. 
The concentrations of antibiotics in the medium were analyzed when the carbon 
source (-s) was exhausted (Figure 9-2). Tobramycin concentration was not 
significantly influenced by the nature of the carbon source, while the kanamycin 
concentration decreased 2.6 times and the apramycin concentration increased 2.9 
times when half of the glucose was substituted by glycerol. 
 
Figure 9-2. Final concentrations of antibiotics in S. tenebrarius cultivations on 
glucose and on equimolar mixture of glucose and glycerol. Tobramycin shows the 
summed concentrations of tobramycin and tobramycin carbamate, kanamycin shows 
the summed concentrations of kanamycin B and kanamycin B carbamate. 
Concentrations shown are means of three (glucose) or two (glucose/glycerol) 
cultivations.  
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9.4.2 Cultivations on labeled substrate 
In order to estimate the fluxes in the central carbon metabolism during growth on 
glucose and on the glucose/glycerol mixture, carbon labeling experiments were 
performed. Two batch cultivations were carried out under the same conditions as 
mentioned above. However, in the glucose cultivation half of the glucose was labeled 
in the 1st position and the other half was naturally labeled and in the other cultivation 
a mixture of [1-13C]-glucose and naturally labeled glycerol was used as carbon 
source. The cells grew at similar specific growth rates and had similar specific 
glucose uptake rates in the exponential phase of both cultivations (Figure 9-3, Table 
9-1). 
 
Figure 9-3. Cultivation profile on minimal medium with [1-13C]-glucose (A) and [1-13C]-
glucose/glycerol (B) as the carbon source. The arrows indicate when samples for 
biomass labeling analysis were taken. Biomass dry weight , glucose , glycerol , 
tobramycin and tobramycin carbamate , kanamycin and kanamycin carbamate   , and 
apramycin . 

Table 9-1. Some kinetic parameters of growth in the labeled substrate cultivations 
Life phase Parameter Symbol Dimension glucose glucose/glycerol 
Growth ratea µ h-1 0.061 0.063 
Specific glucose consumptionb Yxgluc g gluc·g-1 DW 1.963 1.838 
Specific glucose consumption 
ratec qgluc g gluc·g
-1
 DW·h-1 0.120 0.116 
Specific glycerol consumptionb Yxglyc g glyc·g-1 DW - 0.867 
Growth 
phase 
Specific glycerol consumption 
ratec qglyc g glyc·g
-1
 DW·h-1 - 0.055 
Biomass level x g DW·l-1 1.750 1.000 Production 
phase Volumetric glucose consumption 
rated vgluc g gluc·l
-1
·h-1 0.136 0.094 
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Specific glucose consumption 
ratee qgluc g gluc·g
-1
 DW·h-1 0.077 0.094 
Volumetric glycerol consumption 
rated vglyc g glyc·l
-1
·h-1 - 0.082 
Specific glycerol consumption 
ratee qglyc g glyc·g
-1
 DW·h-1 - 0.082 
Volumetric antibiotics production 
rated vantib mg·l
-1
·h-1 3.47 4.08 
Specific antibiotics production 
ratee qantib mg·g
-1
 DW·h-1 1.98 4.08 
a
 At the exponential growth phase growth rate µ was estimated as the slope of the line, representing 
natural logarithm of biomass concentration versus time. 
b
 The specific glucose consumption Yxgluc was found as the slope of the curve used glucose versus 
biomass. The specific glycerol consumption Yxgly was found analogically. 
c
 Specific glucose consumption rate qglucwas calculated as the result of µ and Yxgluc (analogically, 
qglyc=µ⋅Yxgly).   d
 For production phase standard approach (c) was not suitable, because there was no net biomass 
production. From the curve of glucose concentration versus time volumetric glucose consumption rate 
was calculated instead. Volumetric glycerol consumption rate and volumetric antibiotics production 
rate were found analogically. 
e
 Specific glucose consumption rate was found by dividing volumetric rate of glucose consumption by 
the approximate level of biomass during production phase. The same method was used for calculation 
of glycerol specific consumption rate and antibiotics specific production rate. 
 
Even though the final tobramycin concentration was lower in the fermentation with 
glucose as carbon source when a labeled carbon source was used (Figure 9-3) 
compared with a non-labeled carbon source (Figure 9-2), the change in the relative 
production of the different components of the antibiotic complex was the same upon 
shift of carbon source in the two sets of experiments. During the production phase, 
which starts when the cells are still growing exponentially but continues into the 
growth decelleration phase, the substrate uptake continued to be higher in the 
cultivation with glucose/glycerol as carbon source and the specific rate of antibiotics 
production was two times higher. The tendency of higher tobramycin and lower 
kanamycin production in cultivation on glucose/glycerol was preserved in labeled 
substrate fermentations. During the fermentation, biomass samples were taken at the 
end of the exponential growth phase (47 h for glucose fermentation and 33 h for 
glucose/glycerol fermentation) and during the production phase (70 h for glucose 
fermentation and 49 and 68 h for glucose/glycerol fermentation) and the summed 
fractional labelings (SFLs) of derivatized proteinogenic amino acids were determined 
by GC-MS analysis (Table 9-2). 
 
Table 9-2. Measured summed fractional labelings*  
Summed fractional labellings SFLs, % 
glucose glucose/glycerol Monomer Derivat. method m/z 
C atoms in 
measured 
fragment 
Precursor 
(-s) 
C atoms in 
precursor (-
s) 47 h 70 h 33 h 49 h 68 h 
Glucose 
(broth) Glc pentaacet 331 1, 2, 3, 4, 5, 6 - - 61.7±0.1 - - - - 
Glucose 
(biomass) Glc pentaacet 331 1, 2, 3, 4, 5, 6 G6P 
1, 2, 3, 4, 5, 
6 60.1±3.1 63.2±1.1 85.1±2.8 82.1±3.1 76.6±0.5 
Alanine Ala DMFDMA 99 2, 3 2, 3 10.9±0.0 15.7±0.0 9.3±0.2 11.6±0.0 10.1±0.1 
Alanine Ala ECF 116 2, 3 2, 3 10.8±0.3 16.6±1.0 9.6±0.2 13.0±0.4 9.9±0.1 
Valine Val DMFDMA 127 2, 3, 4, 5 2, 2, 3, 3 20.4±0.2 29.5±0.0 17.0±0.0 21.4±0.0 20.2±0.1 
Valine Val ECF 144 2, 3, 4, 5 2, 2, 3, 3 20.7±0.2 30.4±0.8 17.6±0.7 22.9±0.9 19.8±0.2 
Alanine Ala DMFDMA 158 1, 2, 3 1, 2, 3 25.6±0.2 26.3±0.7 31.8±0.3 28.3±0.2 25.2±0.2 
Valine Val DMFDMA 186 1, 2, 3, 4, 5 
PYR 
1, 2, 2, 3, 3 37.2±0.0 42.0±0.0 46.0±0.1 43.7±0.2 43.2±1.3 
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Valine Val DMFDMA 143 1, 2 1, 2 16.9±0.1 14.0±0.4 25.1±0.2 20.4±0.2 19.2±0.0 
Leucine Leu ECF 158 2, 3, 4, 5, 6 PYR + ACCOA 2, 2, 3, 3 + 2 29.1±0.6 39.6±1.5 23.9±1.3 30.2±1.4 25.6±0.2 
Isoleucine Ile ECF 158 2, 3, 4, 5, 6 2, 3, 4 + 2, 3 26.6±0.4 36.8±1.8 21.3±1.1 24.2±0.6 23.9±1.9 
Lysine Lys ECF 156 2, 3, 4, 5, 6 
OAA + 
PYR 2, 3, 4 + 2, 3 31.5±0.5 41.1±0.2 28.2±0.1 33.0±0.3 29.0±0.2 
Aspartic acid Asp ECF 188 2, 3, 4 2, 3, 4 20.3±1.2 29.8±0.4 20.7±0.3 23.5±0.6 17.5±0.2 
Threonine Thr ECF 146 2, 3, 4 2, 3, 4 19.3±1.2 23.9±0.0 19.8±0.5 21.7±0.2 19.6±1.7 
Aspartic acid Asp DMFDMA 216 1, 2, 3, 4 1, 2, 3, 4 31.3±0.4 36.6±0.8 49.3±6.2 42.7±1.3 53.0±5.3 
Aspartic acid Asp DMFDMA 115 2 2 6.0±0.3 8.4±0.2 8.7±2.5 8.1±0.0 8.7±1.0 
Threonine Thr ECF 175 1, 2 
OAA 
1, 2 13.7±0.7 16.2±0.2 17.0±0.5 15.7±0.3 14.7±0.8 
Glycine Gly DMFDMA 144 1, 2 1, 2 4.4±0.1 5.0±0.2 6.3±0.1 5.5±0.0 6.5±0.3 
Glycine Gly ECF 175 1, 2 1, 2 5.8±0.4 7.0±1.1 7.9±0.2 7.7±0.2 6.4±0.5 
Serine Ser ECF 175 1, 2 1, 2 4.0±1.7 3.6±3.2 3.1±0.8 3.4±1.3 4.3±1.2 
Glycine Gly DMFDMA 85 2 2 2.4±0.1 2.2±0.0 4.1±0.0 2.9±0.2 3.7±0.8 
Serine Ser ECF 132 2, 3 
3PG 
2, 3 14.4±0.2 17.7±0.3 10.0±0.2 12.0±0.7 10.5±0.5 
Proline Pro ECF 142 2, 3, 4, 5 2, 3, 4, 5 23.2±0.3 30.3±0.8 17.5±0.4 23.7±2.1 22.2±0.4 
Glutamic acid Glu DMFDMA 230 1, 2, 3, 4, 5 1, 2, 3, 4, 5 34.8±0.7 46.9±0.4 43.0±4.7 40.1±0.1 36.1±2.3 
Glutamic acid Glu DMFDMA 143 1, 2 
AKG 
1, 2 17.6±0.9 22.0±1.4 24.9±2.8 22.1±0.8 18.5±3.1 
Phenylalanine Phe DMFDMA 143 1, 2 PEP 1, 2 3.5±0.3 4.1±0.1 4.0±0.1 3.9±0.2 3.5±0.2 
Phenylalanine Phe ECF 192 2, 3, 4, 5, 6, 7, 8, 9 
E4P + 
PEP 
1, 2, 3, 4 + 2, 
2, 3, 3 40.0±1.8 49.6±0.1 31.1±0.5 38.6±0.6 36.5±0.0 
* Mean values and standard deviations between samples 
9.4.3 Labeling analysis 
9.4.3.1 Pyruvate labeling 
Pyruvate is a central carbon metabolite, which labeling pattern can be deduced from 
the labeling patterns of the amino acids alanine and valine as these have pyruvate as 
precursor. The amount and diversity of the fragments measured allowed calculation 
of the fractional labeling of all three carbon atoms in pyruvate (Figure 9-4, Table 9-2). 
 
Figure 9-4. Labeling of pyruvate atoms in the cultivation on glucose. The SFL of the 
pyruvate 2nd and 3rd carbon atoms was calculated as an average between SFLs of 
Ala116, Ala99, half SFLs of Val127 and half SFLs of Val144. The labeling of the 1st 
pyruvate carbon atom was found as average between differences: Ala158 – PYR(2, 
3) and Val186 – PYR(2, 3). The SFL of pyruvate 2nd carbon was calculated as 
difference between Val143 and PYR(1). Eventually the SFL of the third position was 
found as difference between SFL of PYR(2, 3) and PYR(2). 
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When [1-13C]-glucose is metabolized into pyruvate via the Embden-Meyerhof-Parnas 
(EMP) pathway, 50% of the pyruvate formed is labeled in position 3. If glucose is 
metabolized via the Entner-Doudoroff (ED) pathway 50% of the pyruvate formed will 
be labeled in position 1. This pathway is less energetically favorable than the more 
common EMP pathway. When the pentose phosphate (PP) pathway is active, the 
labeled carbon atom is converted to carbon dioxide and the resulting pyruvate does 
not carry any 13C atoms.  
For the cultivation on glucose the labeling of the first pyruvate position was much 
higher than the natural labeling (1.1%), clearly pointing to an active ED pathway. The 
EMP pathway was, however, also active as could be judged from the labeling of the 
third carbon atom in pyruvate. When comparing pyruvate labeling at the exponential 
growth phase and after onset of the production phase an interesting change in the 
incorporation pattern was observed: the labeling of the 1st atom decreased, while the 
labeling of the 2nd and 3rd atoms increased. This can be interpreted as a metabolic 
shift from ED towards EMP activity when the cells passed from growth to secondary 
metabolites production. It is possible to judge about activity of the oxidative branch of 
the PP pathway in the glucose cultivation from the data of glucose labeling in the 
medium. The SFL of glucose atoms in the medium was equal to 61.7±0.1%. If 
glucose was metabolized solely through the EMP and ED pathways, the summed 
fractional labeling of pyruvate should be about 31% (one mole of glucose gives 2 
moles of pyruvate). However, at 47 hours the measured SFL was 26.1%, and this 
SFL value implies that glucose is partly metabolized through the oxidative PP 
pathway.  
9.4.3.2 Tricarboxylic acid (TCA) cycle metabolites 
The average labeling of carbon atoms (CNL) in the two TCA cycle metabolites 
oxaloacetate and -ketoglutarate was found from the fragments of aspartate 
(Asp216) and glutamate (Glu230), respectively (Figure 9-5). The CNL values were 
equal as expected because there is a constant interconversion between oxaloacetate 
and α-ketoglutarate atoms in the TCA cycle. The increase of labeling with time can 
be explained by the increase of the labeling of the 2nd and 3rd carbon atoms of 
pyruvate, which enters the TCA cycle in the form of acetyl-CoA.  
 
Figure 9-5. Labeling of the TCA cycle metabolites: oxaloacetate and α-ketoglutarate 
in cultivation on glucose. The labelings are normalised in respect to carbon atoms. 
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9.4.4 Computer simulations of fluxes at the exponential phase 
Based on the knowledge about the primary metabolism of streptomycetes 12, a 
metabolic model was constructed for S. tenebrarius. Using this model the fluxes 
through the different pathways were estimated (see material and methods) for cells in 
the exponential growth phase, where the system can be considered to be in pseudo-
steady state (Figure 9-6). 
 
The irreversibility of fructose-6-phosphate conversion into fructose-1,6-biphosphate 
(which was initially imposed in the model) resulted in a poor fit of the glucose-6-
phosphate labeling in the fermentation on the two carbon sources (104% predicted 
against 85.1% measured). One factor that could explain this deviation would be that 
the model predicts too low flux through the oxidative PP pathway activity, but this 
option was excluded due to an almost complete accumulation of the label from 
glucose in pyruvate. Thus, there must be a route resulting in dilution of the labeling at 
the level of glucose-6-phosphate and the only possible option is reversibility of the 
reactions converting fructose-6-phosphate into glyceraldehyde-3-phosphate and 
dihydroxyacetone-phosphate. Dihydroxyacetone-phosphate is an intermediate 
product of glycerol catabolism, and part of it will therefore be only naturally labelled. 
Hence activity of fructose-1,6-biphosphatase was included in the model for the 
simulations of growth on glucose/glycerol. 
9.4.4.1 Glycolysis pathways 
The distribution of fluxes around the G6P branch point was quite different for the two 
different carbon sources. 
In the cultivation on glucose the ED and EMP pathways were equally important for 
glucose conversion, while about 20% of the glucose was shunted through the PP 
pathway (some G6P was channeled into biomass). Less than half of the carbon that 
was oxidized in the first step of the PP pathway returned to the EMP pathway, 
whereas the remaining glucose that entered the PP pathway was used as building 
blocks for nucleotides and aromatic amino acids. 
In the glucose/glycerol cultivation most of the G6P (85.1%) was directed towards the 
ED pathway. The remaining 12.4% went to the PP pathway, which was just sufficient 
to satisfy the needs for precursor metabolites required for biomass synthesis. Thus, 
in this cultivation the main role of the PP pathway was supply of precursors and not 
the formation of NADPH. Despite the presence of labeling in the 3rd position of 
pyruvate there was no net flux of G6P into the EMP pathway. This can be explained 
by high exchange rates in the reactions leading from G6P to G3P. The lower PP 
pathway activity in the glucose/glycerol cultivation is also reasonable from a 
biological point of view: the ED pathway supplied the cell with NADPH required for 
growth, and it is therefore not necessary to use the PP pathway for supply of NADPH 
and this pathway is exclusively used for supply of biomass precursors.  
9.4.4.2 Anaplerotic pathways 
Out of the two anaplerotic pathways that were included in the model, pyruvate 
carboxylation was chosen as the one that gave the best fit to the labeling patterns in 
the glucose cultivation. This was surprising because PEP carboxylase is regarded as 
the enzyme primarily responsible for TCA cycle metabolite replenishing in 
Streptomyces 2,8.  
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Figure 9-6. The metabolic fluxes as calculated in computer simulation. The values 
are averages between fluxes obtained in two simulations. Numbers in bold are fluxes 
for the glucose cultivation, numbers in italic are fluxes for the glucose/glycerol 
cultivation. All fluxes are given in mmolg-1 DWh-1. The numbers in circles show 
exchange coefficients for reversible reactions, calculated as: 
)_,_(100
)_,_(
reversevforwardvMIN
reversevforwardvMIN
+
, where forwardv _  is forward flux, reversev _  is reverse flux. The 
function )_,_( reversevforwardvMIN  gives the smaller flux (forward or reverse) as the result. 
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9.4.5 NADH, NADPH production 
With respect to the availability of cofactors for synthesis of antibiotics it is important to 
know how much NADH and NADPH is synthesized and consumed by the cell. In this 
case it was interesting to know, whether more reducing equivalents were produced 
per g dry weight per hour when glucose was partly substituted by glycerol. The cells 
grew at approximately the same specific growth rates during both cultivations and the 
cell compositions were assumed similar. Consequently, the specific fluxes of NADH 
production and NADPH consumption during biomass synthesis were considered 
similar for both cultivations. Therefore, the main difference was determined by the 
amount of cofactors produced, which could be calculated from the estimated fluxes 
and the stoichiometric coefficients for NADH, NADPH in each of the reactions 
included in the model (Figure 9-7).  
 
Figure 9-7. Specific reducing cofactors production in the cultivation on glucose and 
on glucose/glycerol. 
 
The specific net production rate of NADH in the exponential growth phase was higher 
in the cultivation on glucose/glycerol (4.8 mmolg-1 DWh-1) than in the cultivation on 
glucose (3.1 mmolg-1 DWh-1). This can be explained by a higher carbon uptake rate, 
5.66 C-mmol substrateg-1 DWh-1 in the glucose/glycerol cultivation compared to 
4.00 C-mmol substrateg-1 DWh-1 in the cultivation on pure glucose. Another reason 
is the higher degree of reduction of glycerol, which results in the formation of more 
NADH during catabolism.  
The specific net production rate of NADPH was slightly higher in the cultivation on 
glucose/glycerol, 1.6 mmolg-1 DWh-1, compared with the cultivation on glucose, 1.2 
mmolg-1 DWh-1. Dividing these values by the specific growth rate (app. 0.06 h-1), 
one obtains the specific NADPH formation for the two cultivations, 27 and 20 mmolg-
1
 DW, respectively. The requirement for NADPH for biomass biosynthesis varies for 
different organisms; for P. crysogenum it was calculated to be 8.5 mmolg-1 DW21, for 
C. glutamicum the value was 14.9 mmolg-1 DW20. From this it is clear that the 
predicted NADPH formation rate in S. tenebrarius can satisfy the biomass 
biosynthesis. 
Judging from the substrate consumption rate (which was twice as high in the 
glucose/glycerol cultivation), the tendency of higher specific production rates of the 
reduced cofactors in the glucose/glycerol cultivation should also hold for the 
stationary phase, when the antibiotics were produced. 
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9.4.6 Identification of the edd gene 
In order to further confirm the presence of an ED pathway in Streptomyces 
tenebrarius, a 1.272 kb-fragment of the edd gene, encoding the ED pathway specific 
enzyme 6-phosphogluconate dehydratase, was amplified. The amplification was 
performed with degenerate primers on genomic DNA of S. tenebrarius as the 
template. 675 base pairs were successfully sequenced. The putative amino acid 
sequence showed 70% identity over 225 residues to Edd from Pseudomonas putida, 
P. aeruginosa, and E. coli. In a clustering analysis the sequence grouped with Edd 
from other actinomycetes with proven ED pathway activity – Nonomuraea sp. ATCC 
39727 and Mycobacterium smegmatis (Figure 9-8). 
 
Figure 9-8. Unrooted phylogenetic tree derived by neighbor-joining analysis of Edd 
amino acids sequences from different bacteria species with proven Entner-Doudoroff 
pathway presence. The bootstrap values on the branches indicate the number of 
times a given branch appeared in 1000 bootstrap replications. The sequences were 
obtained from the NCBI database (http://www.ncbi.nlm.nih.gov). ClustalX 1.8 was 
used for making multiple sequence alignment and for construction of the tree. The 
tree was drawn with Njplot. 
 
9.5 Discussion 
Actinomycetes are an important group of bacteria for the biotechnological industry, 
mainly due to their ability to produce a wide range of bioactive metabolites. The 
secondary metabolism of actinomycetes has been studied intensively, but the 
primary metabolism of most actinomycetes is, however, poorly characterised. In this 
study, a correlation between the primary metabolism and the aminoglycoside 
production in S. tenebrarius was sought.  
9.5.1 Detection of Entner-Doudoroff pathway 
The Entner-Doudoroff pathway for carbohydrate metabolism9 is most common in 
Gram-negative bacteria, though it has also been encountered in Gram-positive 
bacteria and even in some eucaryotes7. The ED pathway has never been described 
in Streptomyces before and is unusual for actinomycetes altogether. To the best of 
our knowledge the only actinomycetes found to possess an ED pathway are 
Mycobacterium smegmatis1 and Nonomuraea spp. ATCC 3972710. The edd gene 
has not been found in the sequenced genomes of the two Streptomyces species (S. 
coelicolor and S. avermitilis)10. The ED pathway activity was shown in S. tenebrarius 
by labeling experiments, and the presence of the characteristic gene edd was 
confirmed by PCR and subsequent sequencing. The activity of the pathway could not 
be verified using the enzymatic assay of Budgen and Danson3, because of a high 
non-specific NADH-oxidative activity of the cell extract (data not shown).  
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Labeling experiments indicated simultaneous activity of glycolysis and 
gluconeogenesis, which basically means that there is an inefficient energy 
metabolism. Possibly the ED pathway functions in a cyclic mode as in 
pseudomonads, where part of the dihydroxy-acetone phosphate produced in the ED 
pathway is recycled back to fructose-6-phosphate and then to gluconate instead of 
being directly processed into pyruvate7. An alternative explanation is that 
gluconeogenesis is active only during metabolism of glycerol. Analogy could again be 
drawn with pseudomonads, where disruption of the edd gene is deleterious for 
growth on glycerol19, which shows that glycerol is first turned into glucose-6-
phosphate and then metabolized via the ED pathway. Lower S. tenebrarius biomass 
yield during growth on glucose/glycerol (0.34 g DW/g substrate versus 0.50 g DW/g 
glucose) supports the latter hypothesis. Normally the formation of a futile cycle due to 
fructose-6-phosphate and fructose-1,6-diphosphate interconversion is avoided by 
microorganisms. For instance E. coli operates the ED pathway only in a linear mode 
and pseudomonads are devoid of 6-phosphofructokinase and therefore cannot 
metabolise carbohydrates via the EMP pathway. It has been shown that when 6-
phosphofructokinase was introduced into Alcaligenes eutrophus (related to 
pseudomonads), the growth of the organism was impaired. However, when 6-
phosphofructokinase was introduced into an Edd- mutant, the organism successfully 
used the EMP pathway and grew normally26.  
9.5.2 Metabolic shift 
Another interesting discovery was that there is a metabolic shift when S. tenebrarius 
is grown on glucose and the cells pass from the growth phase to the production 
phase.  A change in metabolism has previously been observed in several other 
streptomycetes (Table 9-3). It is apparent that the cells adjust their metabolism to the 
change in function: from growth to secondary metabolite production.  
 
Table 9-3. Metabolic shift in actinomycetes on transition from growth to secondary 
metabolism 
Organism Metabolic shift  Comments 
S. lividans24 PP ↓ EMP ↑  
S. noursei14 PP ↓ TCA ↑  
Nonomuraea sp. ATCC 3972710 
ED ↓ 
PP ↑ 
EMP ↑ 
Observed only during phosphate limitation 
S. tenebrarius 
ED ↓ 
PP ↑ 
EMP ↑ 
Growth on glucose 
 
Some common observations can be made for metabolic shifts in Streptomyces that 
use the EMP pathway and the PP pathway. For Streptomyces lividans, which 
produces the antibiotics actinorhodin and undecylprodigiosin, it has been observed 
that for decreasing specific growth rates the activity of the PP pathway decreases 
and visa versa24. A similar observation of a decreased PP flux during at low specific 
growth rates and production of nystatin in Streptomyces noursei has also been 
reported14. 
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For two antibiotic-producing actinomycetes that use the ED pathway (Nonomuraea 
spp. ATCC 39727 and S. tenebrarius) a common trait is that the activity of this 
pathway decreases after transition from growth to production, and so a larger part of 
the glucose (maybe even all) is metabolized via the EMP and PP pathways.  
The PP and ED pathways both produce reduction equivalents in the form of NADPH. 
Because NADPH is necessary for growth, it is logical that the supplying pathways are 
mostly active during the growth period. When cell growth slows down, the need for 
this cofactor decreases and the energetically more favorable EMP pathway can be 
used. 
9.5.3 Cofactor requirement for antibiotics synthesis 
Could cofactor supply be the limiting factor for antibiotics production? NADPH is 
regarded as the cofactor necessary for biosynthesis of several antibiotics: β-lactams, 
polyketides and glycopeptides. NADPH is produced in the PP and ED pathways, but 
not in the EMP pathway. In overproducing strains of S. lividans the flux through the 
PP pathway during production phase was higher than in strains with lower antibiotics 
production24. Increased activity of the PP pathway has also been observed in 
connection with higher productivity of the polyketide avermectin in S. avermitilis13 and 
the cyclopentanone antibiotic methylenomycin in S. coelicolor A3(2)23. 
The aminoglycosides produced by S. tenebrarius are only slightly more reduced than 
glucose, from which they are made. Tobramycin and apramycin each have one 
hydroxyl group reduced during biosynthesis. However, aminoglycosides need 
glutamate as a source of amino groups for the amination reactions. Glutamate is 
produced in the cell by amination of α-ketoglutarate with concurrent consumption of 
NADPH. If the reducing equivalents used both for uptake of ammonia (5 mol per mol 
of nebramycin component) and for reduction of the hydroxyl group (1 mol per mol of 
tobramycin or apramycin) are taken into consideration, the reducing equivalent 
requirement will be about 10.6 µmol per mg nebramycin (average molecular mass is 
520 gmol-1). The requirements of reducing cofactors for antibiotics synthesis will 
therefore be about 20 µmolg-1 DWh-1 in the cultivation with glucose as carbon 
source and 40 µmolg-1 DWh-1 in the cultivation with glucose/glycerol as carbon 
source. These requirements represent less than 2-3% of the total cofactor production 
flux, and it is therefore not likely that cofactor supply for antibiotics biosynthesis is 
limiting. On the other hand an increased ratio of NADPH:NADP+ in the 
glucose/glycerol cultivation could in principal work as a selective pressure for 
production of more reduced antibiotics (tobramycin and apramycin).  
9.6 Update 
During preparation of this manuscript the tobramycin biosynthetic cluster has been 
isolated from S. tenebrarius15. Two genes were identified as possible candidates for 
paromamine reduction, which is the decisive step directing the aminoglycosides flux 
toward tobramycin instead of kanamycin. Overexpression of this reductase could 
shift the balance from kanamycin B towards tobramycin production. 
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Appendices for chapter 6 
Appendix 6.1. Design of sample hybridization on microarrays with genomic 
DNA as common reference 
gDNA – genomic DNA; M600.Ti – RNA sample of M600 strain taken at time point i; 
M570.Tj - RNA sample of M570 strain taken at time point j. Each arrow corresponds 
to hybridization on one array, the arrow starts at Cy3-labeled probe and ends at Cy5-
labeled probe. 
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Appendices for chapter 8 
Appendix 8.1. Correlation between biomass dry weight and OD600 in S. 
coelicolor 
The samples were taken from shake flask cultivations of S. coelicolor A3(2) M145 
strain and its seven congenic mutants. There were three biological replicates. All the 
samples were taken at the mid exponential growth phase. 
 
 
